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EXECUTIVE SUMMARY 
 
Introduction 
In fiscal year 2011, a Brain Injury Commission was established by legislative action.  
Governor Deval L. Patrick appointed the members of this Commission, who included 
persons with acquired brain injury, state agency representatives, family members of 
persons with ABI, and providers of community-based brain injury services within the 
Commonwealth of Massachusetts. The Commission, which held monthly public meetings, 
identified gaps in service delivery, and other needs, as well as challenges, experienced by 
Massachusetts residents who had experienced an ABI. These service needs and 
associated recommendations are detailed in the Commission’s final report, which may be 
accessed at www.mass.gov/hhs/braininjurycommission. 
 
One recommendation prioritized by the Commission was to complete an epidemiological 
study of ABI in Massachusetts. The findings of the proposed study were judged to be 
critical to informing the development of long-term community-based support services for 
both adults and children living with acquired brain injury. To this end, the Executive Office 
of Health and Human Services (Disability Policies and Programs) requested that the 
Massachusetts Rehabilitation Commission, in collaboration with the Massachusetts 
Department of Public Health, design and complete an epidemiological study of the ABI 
population in Massachusetts, including an estimate of the magnitude of the population; 
affected age groups; region of residence; and other pertinent descriptive information for the 
major subcategories of ABI, including traumatic, neoplastic, infectious, vascular, and 
metabolic causes of acquired brain injury.  
 
This report entitled Acquired Brain Injury in Massachusetts is intended for use by state 
agency administrators and program staff; legislators and other policymakers; educators; 
clinicians and other providers of brain injury rehabilitation and other services; brain injury 
advocacy groups; persons living with acquired brain injury, their families and significant 
others. In addition to fulfilling the Brain Injury Commission’s recommendation to complete 
this epidemiological study, it is hoped that the findings included in this report will serve to 
improve and inform programs and services designed to enhance the quality of life of 
persons living with ABI in Massachusetts.  
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Methodology  
The Massachusetts data sources selected and methodology utilized in this report were 
established through joint meetings between the epidemiology staff at the Massachusetts 
Department of Public Health (MDPH) and authors from the Massachusetts Rehabilitation 
Commission (MRC). For traumatic, infectious, vascular, and metabolic causes of acquired 
brain injury, the Massachusetts statewide inpatient hospital discharge, outpatient 
observation stay and emergency department discharge databases were utilized. The 
Massachusetts Cancer Registry (MCR) was utilized to quantify neoplastic causes of 
acquired brain injury. National consensus definitions were used to define particular 
conditions where they existed. Where they did not (i.e., infectious and metabolic disorders 
associated with ABI), the MDPH epidemiologists worked with authors from the MRC to 
identify the most appropriate inclusion criteria.  Since no data sources were able to be 
identified for developing statewide estimates of Massachusetts residents with 
neurodegenerative or neurotoxic conditions (with the exception of childhood lead 
exposure), only national estimates were provided for these subcategories. 
Summary of Data Findings  
Acquired brain injury (ABI), as defined in Chapters III A- III H in this report, is a substantial 
public health problem in Massachusetts. Figure A summarizes the average annual number 
of hospital stays and emergency department visits (2008-2010), associated with selected 
categories of ABI, including traumatic brain injury, stroke, ABI-related infectious diseases, 
and metabolic disorders affecting the central nervous system. During the same time period, 
1,272 primary brain tumors were newly diagnosed in Massachusetts residents on average, 
annually. 
Figure A. Average Annual Number of Hospital Stays and Emergency Department 
Visits Associated with Select Categories of ABI, MA Residents, 2008-2010 
 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis 
Note: Categories are not mutually exclusive. 
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The findings in this report indicate that all demographic subgroups and geographic regions 
of MA are impacted. By age group, the majority of hospital stays for metabolic disorders 
affecting the central nervous system, stroke, and TBI  were among persons 60 years of age 
or older. These older adults represented 50% of hospital stays for TBI; 84% for stroke; and 
58% for metabolic disorders affecting the CNS. In addition, approximately 50% of both 
malignant and benign brain tumors are newly diagnosed in adults 60 years or older. 
Children and young adults (i.e., ages 0-21 years of age) accounted for an average of 17% 
of the hospital stays and 40% of the emergency department visits for ABI associated with 
traumatic brain injury annually.  
A substantial proportion of individuals with acquired brain injury are covered by public payer 
sources (i.e., Medicaid, Medicare, Free Care/Health Safety Net, Other Government 
Payment, and Commonwealth Care). Further, the majority of inpatient hospitalizations 
associated with TBI, infectious-disease related ABI, metabolic disorders affecting the CNS 
and stroke did not result in the individuals being transferred to either a rehabilitation 
hospital or rehabilitation unit within a hospital. Most resulted in the individual being 
discharged home without services or with in-home services (i.e., IV therapy services), 
including 54% of those with a diagnosis of TBI; 50% of those with a diagnosis of stroke; 
and 70% of those with an infectious disorder affecting the CNS. 
 
Limitations of Findings  
 
These data are subject to numerous limitations, including but not limited to: 
 
 The MA inpatient hospital, outpatient observation stay and emergency department 
discharge databases do not provide information on the initial encounter for a given 
problem. Individual people are also difficult to separate out using these databases as 
there are no names and limited identifiers. Therefore, hospitalization and 
emergency department visit counts presented in the tables do not necessarily 
represent unique individuals or incident (new) cases of a specific condition. 
Note: This differs from the counts presented in the chapter on central nervous 
system neoplasms, which do reflect incident (new) cases. 
 
 For all of the Massachusetts data presented, the severity and long-term outcomes of 
the brain insult/injury are not known. While the “discharge disposition” is available 
through the hospital databases, for individuals who die or who are not discharged to 
home, the factors contributing to this status may or may not be related to the brain 
injury.  
 
 Massachusetts residents receiving care at an out-of-state hospital are not included 
in the totals for traumatic brain injury, stroke, and infectious diseases and metabolic 
disorders affecting the central nervous system. This may particularly impact the 
number and rates of individuals who reside in cities and towns which closely border 
neighboring states. 
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 Data from federal (including the Veteran’s Health Administration-VHA), freestanding 
psychiatric or rehabilitation hospitals and freestanding emergency departments are 
not included. 
 
 The data on traumatic brain injury, stroke, and infectious diseases and metabolic 
disorders affecting the central nervous system are based on billing and other 
administrative purposes. Although the codes utilized to identify a case were 
submitted by hospitals with trained medical records coders, cases receiving a 
diagnosis code for any particular condition have not been validated with the actual 
medical record. 
 
 The Massachusetts Cancer Registry is a population-based surveillance database 
which captures nearly all incident cases of brain and central nervous system (CNS) 
tumors among Massachusetts residents in addition to primary cancers from all other 
parts of the body.  Other than matching annually with the Massachusetts death file to 
determine cases that died, the MCR is not a follow-up database, and therefore, does 
not track the metastasis of disease, such as lung cancer that spread to the 
brain.  Brain and CNS tumor data are only for primary tumors originating in the brain 
and central nervous system. 
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CHAPTER I: BRAIN INJURY COMMISSION HISTORY 
 
The Brain Injury Commission (BIC) was established during the Fiscal Year 2011 budget 
process in order to identify the gaps in service delivery for Massachusetts residents who 
exhibit a history of acquired brain injury (ABI).  The BIC was co-chaired by State Senator 
Harriette Chandler and Representatives Thomas Conroy and Kimberly Ferguson. The 
membership, appointed by Governor Deval L. Patrick, consisted of representatives of the 
Executive Office of Health and Human Services (EOHHS) and other Massachusetts human 
services agencies; individuals who experienced an ABI and family members; and 
community-based brain injury service providers, including representatives from acute care 
and rehabilitation hospitals.  
 
The Commission began its work in February of 2011 and met monthly through September, 
2011.  During the initial meetings of the Brain Injury Commission, members developed and 
reached consensus regarding the intent and focus of the Commission, which is 
summarized in the following Mission Statement:   
 
To advance the present scope of community-based long-term supports and services 
available to individuals with brain injury in Massachusetts by providing an analysis of 
current services, quality of service delivery, the related needs and gaps relative to 
access, capacity and resources, and to subsequently develop a series of prioritized 
recommendations for system change with a focus on positive outcomes for affected 
individuals. 
 
Over the course of the Commission meetings, community-based long-term supports and 
services were operationally defined to encompass a wide range of post-acute services and 
program models, including but not limited to, rehabilitative and other day programs (e.g., 
recreation/social programs); residential supports and programs; case management; respite 
and other family support services. The target population identified by the Commission 
membership was adults, ages 18 to 59 years of age. However, there was recognition by all 
Commission members that individuals with ABI in both the pediatric and older adult 
populations exhibit significant needs that was determined to be outside the BIC’s focus and 
scope of activities.  
 
Strategies for accomplishing the BIC’s goals included an investigation of currently available 
services, both private and public, for persons with ABI in Massachusetts; identification of 
obstacles and challenges to accessing needed services; and review of current and 
potential funding sources. In addition, the Commission convened regional meetings in an 
effort to reach out to a diverse group of providers, as well as individuals and family 
members impacted by brain injury, to ensure that individuals representing all the regions of 
the Commonwealth were involved in discussions.  All Commission meetings were open to 
the public and included opportunities for public input and more specifically, segments of two 
meetings were designated as community forums.  The content of presentations made to 
the Commission and other information were also posted on the Executive Office of Health 
and Human Services website to ensure broad public access. A comprehensive report 
summarizing the Brain Injury Commission’s activities, membership, invited presentations, 
summary of findings and recommendations can be accessed at 
www.mass.gov/hhs/braininjurycommission.    
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With respect to the purposes and scope of this report, the BIC recognized the need for 
current information regarding the epidemiology of acquired brain injury in Massachusetts, 
which had not been comprehensively ascertained and analyzed since 1988. The 
Commission, therefore, recommended that an epidemiological study of ABI in 
Massachusetts be developed and completed by the Massachusetts Department of Public 
Health (MDPH), in collaboration with the Massachusetts Rehabilitation Commission (MRC).  
The scope of this study was to determine the magnitude of the ABI population in 
Massachusetts, including affected age groups, their region of residence, as well as racial 
and ethnic distribution, for all major categories of acquired brain injury, which are defined in 
Chapter II and comprehensively discussed in Chapters III B through III H of this report. 
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CHAPTER II: ACQUIRED BRAIN INJURY: AN OVERVIEW 
 
Acquired brain injury (ABI) refers to a wide range of disorders and diseases affecting the 
central nervous system (CNS), and specifically the cerebral cortex or hemispheres, 
cerebellum, and subcortical structures, including the diencephalon and brain stem (see 
diagram A). While an ABI can occur at any age beginning in the newborn or perinatal 
period, most individuals who sustain an ABI are adults. The sequelae, or consequences, of 
ABI are also related to their severity and the sites within the brain, and other sites within the 
CNS, that are affected which may be focal, multifocal and in some instances diffuse. The 
acute presentation and long-term outcome are also disease-specific and related to etiology, 
described below.  
 
Acquired Brain Injury Subtypes 
 
More detailed information regarding the causes and related epidemiology of each of the 
types of acquired brain injuries is included in Chapters III B through III H of this report. The 
major subcategories of ABI include: 
 
Infectious: This category includes infectious diseases affecting the CNS. 
 
Metabolic: Refers to disorders affecting the brain, which may be related to systemic 
disease (e.g., cardiovascular), nutritional deficiencies, and endocrine disorders. One of the 
leading causes of metabolic disorders of the CNS is anoxia (diminished oxygen levels). 
 
Neoplastic: This category includes primary (i.e., arising within the CNS) and secondary 
tumors of the brain. Secondary tumors represent metastases (spread) of cancer from a 
primary site (e.g., lung) to the brain. 
 
Neurotoxic: Refers to brain injury related to toxins, poisons, alcohol and illicit drug abuse. 
 
Neurovascular: The leading cause of neurovascular insults to the brain is stroke, the 
second leading cause of ABI. This category also includes other diseases and conditions 
affecting the blood supply to the brain. 
 
Traumatic: Traumatic brain injury (TBI), an externally caused ABI, is the leading cause of 
acquired brain injury. The most common cause of TBI is falls. Other external mechanisms 
include, but are not limited to, motor vehicles, firearms, and strikes by an object or person.  
 
Individuals who sustain an ABI may experience residual disorders and impairments. Over 
time, and with the benefit of rehabilitation, recovery and improvement may occur. However, 
within each ABI subcategory certain diseases and disorders may be progressive, 
evidenced in a typically gradual decline in cognitive status (dementia) and functional 
capacity (see Chapter III H for discussion of Progressive Disorders associated with ABI).  
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Consequences of Acquired Brain Injury  
 
Individuals who sustain an ABI may exhibit residual disabilities which necessitate timely 
recognition and rehabilitation, as well as long-term supports and services to facilitate 
optimal independent functioning and quality of life, and to prevent secondary disabilities 
(e.g., muscle contractures related to lack of physical therapy) and in some instances, 
inappropriate placement in institutionalized settings. The reader is referred to the 
references cited at the end of this chapter for a more comprehensive review of the 
neurological, neurocognitive and neurobehavioral consequences of ABI and their 
treatment. However, detailed below are descriptions of some of the common disorders and 
impairments associated with ABI (areas of the brain referenced are depicted in Diagrams A 
and B).  
 
Motor Impairments: Acquired brain injuries affecting the area of the brain that controls 
voluntary movement (i.e., precentral gyrus in the frontal lobe), or the descending pathway 
(pyramidal tract) arising from that area, result in contralateral paralysis (i.e., paralysis on 
the opposite side of the body). Injury and diseases affecting other parts of the brain, 
including the basal ganglia, cerebellum, and brain stem structures (e.g., substantia nigra 
and dopamine pathway) are associated with disturbances in the regulation and control of 
motor movements, or extrapyramidal disorders.  Extrapyramidal symptoms include tremor; 
abnormal muscle tone; ataxia (incoordination); involuntary movement (e.g., chorea); gait 
disorder; slowness (bradykinesia) and decreased movement (akinesia); and dysarthria 
(inarticulate verbal output).  Cerebral palsy (CP) is the most common motor disability in 
childhood, affecting an estimated 1 in 323 children in the United States. Cerebral palsy, 
which may result in paralysis and other disorders of movement (i.e., extrapyramidal 
symptoms), is associated with several risk factors (e.g., prematurity, low birth weight) and 
ABI, including anoxia (lack of oxygen) and stroke in the newborn or early developmental 
period. 1 
 
Physical and occupational therapy are critical in addressing the motor disorders described 
above; for optimizing function and capacity for independently performing activities of daily 
living, or ADLs (e.g., bathing and other self-care); and for preventing secondary physical 
disabilities (e.g., muscle contractures; skin breakdown) in the acute and post-acute stages 
of recovery. For some individuals, orthopedic treatment (e.g., serial casting to improve and 
maintain range of motion: ROM) and surgical intervention (e.g., implantation of a Baclofen 
pump to address spasticity) may be required. Ongoing physical medicine and rehabilitation 
services and therapeutic interventions are also important, with respect to maintaining 
functional capacity in the years following an ABI.  When indicated, an assessment for 
assistive technology needs (e.g., mobility devices) should be explored, and for some, long-
term neurological follow-up, monitoring, and medication management may be required 
(e.g., individuals with Parkinson Disease). 
 
Neurocognitive Disorders: Persons who sustain an ABI may experience a generalized 
impairment of cognitive capacity, which in adults may present as a progressive dementia. 
Children rarely exhibit progressive dementia, but moderate/severe ABI sustained at an 
early age may result in intellectual disability, or developmental disorder, evidenced in mild 
to profound impairment of intellectual and adaptive functioning in the conceptual, social and 
practical domains (e.g., Shaken Baby Syndrome or abusive head trauma). Most commonly,  
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Diagram A: Lateral Surface of Brain 
 
 Associated Functions 
 
Frontal Lobe: Voluntary motor movement; eye gaze; working memory; organization of 
sequential movement; ability to establish, maintain and shift cognitive set; 
regulation of behavior; executive skill; expressive language (Broca’s area)* 
 
Parietal Lobe: Processing of sensory information (e.g., touch) and proprioception (e.g., 
position sense); ability to perform mathematical calculations and cognitive-
linguistic skill (e.g., reading)*; spatial orientation and perception; 
constructional skill 
 
Temporal Lobe: Verbal and non-verbal memory and learning; primary auditory cortex; 
emotional responses to stimuli; processing and recognition of auditory stimuli; 
comprehension of language (Wernicke’s area)* 
 
Occipital Lobe: Primary visual cortex; processing and recognition of visual stimuli 
 
Cerebellum: Coordination, accuracy and timing of voluntary movement; muscle tone 
 
Brain Stem: Includes the midbrain, pons and medulla; motor nuclei of cranial nerves which 
innervate muscles which control facial expression, tongue, swallowing, verbal 
output, mastication, eye movement, and the thoracic and abdominal viscera 
(e.g., heart, lungs); sensory nuclei of cranial nerves for hearing, vestibular 
information (position and movement of head), taste, and sensory input from 
face and viscera; sleep-wakefulness  
 
  * Left Hemisphere 
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however, individuals who experience ABI exhibit specific, acquired neurocognitive 
impairments related to the etiology of the ABI, and the sites and severity of injury within the 
brain. While individuals who sustain moderate/severe acquired brain injury are at greater 
risk for exhibiting residual neurocognitive impairment, certain subpopulations of persons 
with ABI may exhibit mild cognitive deficits which impact functioning and necessitate 
targeted assessment.  With respect to the latter, notable subgroups include individuals 
living with HIV who may exhibit HIV-associated neurocognitive disorder (HAND); and 
individuals who exhibit persistent post-concussion syndrome, which may be related to the 
cumulative effects of repeated head trauma (e.g., sports concussion) or other exposures 
(e.g., blast injuries sustained in military combat).  
 
Comprehensive neuropsychological evaluation is the recommended approach for 
identifying, characterizing, and quantifying the neurocognitive impairments associated with 
ABI. In addition to testing of general intellectual ability, neuropsychological evaluation 
includes assessment with respect to the following domains: 
 
 Attentional Capacity/Arousal including assessment of verbal and non-verbal 
attention span and vigilance; resistance to interference from irrelevant stimuli and 
response inhibition; mental tracking; and capacity for divided attention. 
 
 Executive Skill including ability to establish, maintain and shift cognitive set; planning 
and sequencing; problem-solving skill; verbal and non-verbal conceptualization skill 
and abstract reasoning; and social judgment.   
 
 Constructional Skill including the ability to draw or assemble two and three-
dimensional designs. Impairment of constructional skill, which may impact adaptive 
functioning, is most often associated with injury to the right hemisphere. 
 
 Mathematical Skill including administration of auditory and written calculation tests. 
Impairment of capacity to perform mathematical operations and calculations is 
referred to as dyscalculia and is usually associated with injury to the left side of the 
brain. Injury to the right hemisphere may also result in spatial dyscalculia evidenced 
in the impaired ability to accurately compute written calculations, secondary to 
spatial deficits. Spatial dyscalculia is often associated with impairment of 
constructional skill.  
 
 Language and Cognitive Linguistic Skill including assessment of expressive and 
receptive language skill; naming; verbal fluency; reading and spelling skill. An ABI 
with lateralized injury to the left hemisphere (side) of the brain may result in aphasia 
or dysphasia, an acquired disorder of language and verbal output, which may be 
fluent (e.g., Wernicke’s aphasia) or non-fluent (e.g., Broca’s aphasia). In addition to 
fluency, other qualities of verbal output may be affected by ABI, including impaired 
articulation (dysarthria) and abnormalities in the pitch, rhythm and melody of speech, 
referred to as dysprosodia. These disorders may occur in association with injury to 
other sites within the brain, as well as the left hemisphere. Difficulty with naming 
(anomia or dysnomia) and word retrieval are common language disorders 
associated with ABI.  Aphasia and left hemisphere injury may also be associated  
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Diagram B: Primary Sensory, Motor and Other Selected Functional Areas of the 
Brain (Left Lateral Surface) 
 
 
  Impairment related to site and potentially associated with ABI 
 
Prefrontal Cortex:  Personality change; executive skill deficits; diminished cognitive flexibility;  
compromised capacity to initiate and sustain goal-directed behavior; behavioral 
disinhibition; attentional deficits; diminished verbal and non-verbal fluency 
 
Premotor Cortex: Dyspraxia; difficulty with establishing motor set and/or intention 
 
Precentral Gyrus: Contralateral (opposite side) paralysis of voluntary movement 
 
Broca’s Area: Broca’s (non-fluent) aphasia 
 
Postcentral Gyrus: Contralateral (opposite side) loss of sensation 
 
 
Wernicke’s Area: Wernicke’s (fluent) aphasia  
 
Visual Cortex*: Visual field impairment 
  
*NB: visual cortex includes areas surrounding calcarine sulcus 
on medial surface of cerebral hemisphere-not shown 
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with impairment of reading skill (dyslexia) and/or spelling skill. Individuals who exhibit 
aphasia and other disorders of language and verbal output also necessitate evaluation by a 
speech and language pathologist to elucidate the nature of the acquired language 
impairment, as well as to develop and provide appropriate therapeutic interventions.  
 
 Learning and Memory includes administration of verbal and non-verbal measures of 
immediate (short-term), working and long-term memory, as well as tests of verbal 
and non-verbal learning and recall, retrieval, and/or recognition tasks. Individuals 
with ABI may exhibit  difficulty with remembering events experienced, or information 
learned, prior to sustaining an ABI (retrograde amnesia) and/or difficulty with making 
new memories following injury (anterograde amnesia).  Some memory disorders are 
associated with progressive disorders, while others are transient, such as loss of 
memory associated with seizure activity (transient epileptic amnesia: TEA) or 
transient global amnesia (TGA), which may be associated with a history of migraine 
headaches, mild traumatic brain injury and other factors, though the exact cause is 
unknown. Depending upon the cause of the ABI and associated sites and severity of 
injury to the brain, a range of amnestic disorders may occur, including impairment of 
semantic memory (facts, concepts and symbols); autobiographical memory (self- 
knowledge); episodic memory (events, plans); and/or procedural memory 
(temporally-ordered motor sequences or habits).  
 
 Orientation includes an individual’s knowledge of general, personal, and temporal 
information, as well as topographical (e.g., orientation to home and neighborhood) 
and directional (right-left orientation) ability. 
 
 Perception includes performance on auditory, visual and tactile (haptic) tasks. 
Individuals with ABI may also exhibit disorders of complex processing, or agnosias, 
referring to the loss of the ability to recognize or comprehend perceived stimuli, 
which cannot be explained on the basis of a primary sensory loss, aphasia, 
dementia, delirium or other mental status changes. For example, individuals with 
prosopagnosia, a type of visual agnosia, are unable to recognize familiar faces or 
learn to recognize new faces; they may also fail to recognize stimuli within a class of 
objects (e.g., specific types of birds among a class of birds). 
 
 Praxis refers to the ability to correctly execute motor commands and other 
purposeful actions. Dyspraxia refers to impairment of these functions, which cannot 
be explained on the basis of a primary motor impairment (i.e., paralysis), aphasia, 
dementia, delirium or other mental status disturbance.  
 
Based upon comprehensive assessment of the neurocognitive, and when indicated, 
acquired language disorders associated with ABI, cognitive rehabilitation therapy may be 
recommended to promote recovery and to assist in developing appropriate compensatory 
strategies for individuals with persistent neurocognitive impairments. When indicated and 
applicable, assistive technology devices may be utilized to address the neurocognitive 
deficits associated with ABI, and to optimize performance of instrumental activities of daily 
living (IADL) tasks (e.g., adhering to prescribed medical directives and medications, such 
as insulin regimen and other aspects of diabetes management). 
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Neuropsychiatric Disorders:  The same range and types of psychiatric disorders 
exhibited among the general population may also be diagnosed in persons who sustain an 
ABI. One of the leading types of psychiatric conditions is mood disorder, which affects 
approximately 21 million Americans, or 9.5% of the U.S. population.2 Depression, which in 
part may be correlated with the neuropathological changes evidenced in certain 
neurological diseases (e.g., frontal lobe stroke), is the most common mood disorder 
associated with ABI. Personality change, common among individuals who experience a 
traumatic brain injury, is associated with injury to the prefontal cortex (PFC) of the brain 
(See Diagram B). The neurobehavioral symptoms associated with PFC injury are varied in 
their clinical presentation and may be evidenced in disinhibition (e.g., impulsivity, 
aggression); difficulties initiating and maintaining goal-directed behavior (abulia or apathy); 
sexual and social inappropriateness; suspiciousness or paranoia; attentional disorder and 
other neurocognitive impairments (e.g., executive skill deficits). 
 
Mania and psychotic disorder, evidenced in delusions and hallucinations, are less 
commonly observed in persons with ABI, but may be associated with certain diseases, 
including the progressive, degenerative disorders (e.g., HIV-associated dementia). 
Individuals who sustain an ABI in certain psychologically-traumatizing contexts (e.g., 
combat-related TBI) are also at particular risk for developing Posttraumatic Stress Disorder 
(PTSD). The presence of a premorbid (i.e., prior to ABI) psychiatric or developmental 
disorder; predisposing genetic factors or family history of mental illness; and substance 
abuse may complicate and/or increase the risk for developing a neuropsychiatric disorder 
in persons who have experienced an ABI. Individuals who exhibit 
neurobehavioral/neuropsychiatric sequelae of ABI necessitate evaluation and, when 
indicated, ongoing treatment by neuropsychologists, behavioral psychologists, psychiatrists 
or neuropsychiatrists. When undiagnosed and unaddressed, the neurobehavioral 
consequences of ABI place individuals and others at risk (e.g., suicide attempt or 
aggression), including risk for institutionalization and incarceration. 
 
Sensory Impairment: Acquired brain injuries affecting the primary sensory areas of the 
brain (See Diagram B), associated cranial nerves or ascending sensory pathways to these 
areas, may result in permanent sensory loss. Sensory deficits may include: 
 
 Contralateral (opposite side of body) loss of touch, vibration sense, perception of 
movement and the position of limbs and other body parts (i.e., conscious 
proprioception) may occur with injury to the primary sensory cortex (post-central 
gyrus) in the parietal lobe or ascending sensory pathways. 
 
 Blindness may result from injury to the retina or optic nerve (Cranial Nerve II), which 
partially crosses (decussates) in the brain. Injury to the nerve after it crosses, or 
injury to the visual (calcarine) cortex in the occipital lobe may result in visual field 
impairments, evidenced in contralateral loss of vision in half or a quarter of the visual 
field. Common causes of visual field impairments include stroke and traumatic brain 
injury, while the most common cause of acquired blindness in adults is diabetic 
retinopathy. Blindness, secondary to retinal hemorrhages, may also be a 
consequence of abusive head trauma (i.e., Shaken Baby Syndrome). Acquired loss 
of color vision (achromatopsia) may also be associated with ABI. 
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 Hearing loss and other auditory disorders may occur as a result of damage to the 
auditory nerve (Cranial Nerve VIII), ascending auditory pathway, or auditory cortex 
within the temporal lobe of the brain (i.e., tranverse gyri of Heschl). Acquired hearing 
loss may be a consequence of abusive head trauma in infants and children, 
exposure to neurotoxins, brain infection or a brain stem tumor affecting CN VIII (e.g., 
acoustic neuroma). 
 
 Anosmia, or the loss of sense of smell, is associated with injury to the olfactory 
nerve (Cranial Nerve I). A common cause of unilateral or bilateral anosmia is 
traumatic brain injury. 
 
Depending upon the nature of the sensory impairments associated with ABI clinical 
evaluation by several specialists may be indicated, including a neurologist, audiologist, or 
neuro-ophthalmologist. 
 
Other Sequelae Associated with ABI: Other consequences of ABI may include seizures, 
chronic pain, sleep, and headache disorders. One of the most common comorbid disorders 
exhibited by individuals who sustain ABI is substance abuse which, undiagnosed and 
unaddressed, serves to compromise recovery and functional capacity. 
Some individuals who sustain severe ABI fail to recover and exhibit persistent disorders of 
consciousness. It is estimated that approximately 315,000 individuals in the United States, 
40% of whom are children, are living with a disorder of consciousness.3 Common causes 
include traumatic brain injury and anoxia.   
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CHAPTER III A: DATA SOURCES, METHODS and TECHNICAL NOTES 
Introduction: 
The Massachusetts data sources selected and methodology utilized in this report were 
established through joint meetings between the epidemiology staff at the Massachusetts 
Department of Public Health (MDPH) and authors from the Massachusetts Rehabilitation 
Commission (MRC). Epidemiologists who had expertise in a specific area identified the 
best available data sources to analyze for this report and the case inclusion criteria. 
National consensus definitions were used to define a particular condition where they 
existed. Where they did not, the MDPH epidemiologists worked with authors from the MRC 
to identify the most appropriate inclusion criteria. They began with a list of International 
Classification of Disease Ninth Revision, Clinical Modification codes (ICD-9-CM codes) 1 
that had been used in the previous report regarding the status of people with brain injuries 
in Massachusetts.2  These ICD-9-CM codes were subsequently adopted and are currently 
utilized by the Massachusetts Office of Medicaid (OOM) to determine eligibility for the 
Acquired Brain Injury Home and Community Based Services (HCBS) waiver programs. 
This list of codes was then modified in the individual chapters to reflect conditions that were 
specific to brain injury and conditions which impacted populations which are not covered 
under the waiver programs. According to the National Center for Health Statistics, CDC, 
ICD-9-CM is the official system of assigning codes to diagnoses and procedures 
associated with hospital utilization in the United States.  The data sources and a more 
detailed description of the case definition criteria used for any specific chapter are provided 
in the respective data chapters.  
It is important to note that for all of the Massachusetts data presented, the severity and 
long-term outcomes of the brain insult/injury are not known. While the “discharge 
disposition” is available through the hospital databases, for individuals who die or who are 
not discharged to home, the factors contributing to this status may or may not be related to 
the brain injury. 
Data Sources and Case Definitions: 
Data sources and case definitions used for data tables in the chapters “Infectious Diseases 
Associated with the Central Nervous System,” “Metabolic Disorders Affecting the Central 
Nervous System,” “Neurovascular Diseases and Conditions,” and “Traumatic Brain Injury” 
include: 
Inpatient Hospitalizations 
Source: Massachusetts Inpatient Hospital Discharge Database, Center for Health 
Information and Analysis. 
Outpatient Observation Stays 
Source: Massachusetts Outpatient Observation Stay Database, Center for Health 
Information and Analysis. 
 14 
 
“Hospital Stays” represent a sum total of inpatient hospitalizations and observation stays.  
Emergency Department Visits 
Source: Massachusetts Emergency Department Discharge Database, Center for Health 
Information and Analysis 
Case Definitions:  
An inpatient hospitalization, observation stay and emergency department discharge 
associated with a traumatic brain injury was defined as any case having an 
International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-
CM) diagnosis code in the range listed in Appendix B-5, in any of the diagnosis fields 
in the database (15 fields for inpatient, 6 fields for observation stay and 6 fields for 
emergency department visits).  
An inpatient hospitalization, observation stay and emergency department discharge 
associated with an infectious disease-related acquired brain injury was defined as 
any case having an International Classification of Disease, Ninth Revision, Clinical 
Modification (ICD-9-CM) diagnosis code in the range listed in Appendix B-2, in any 
of the diagnosis fields in the database (15 fields for inpatient, 6 fields for observation 
stay and 6 fields for emergency department visits). 
An inpatient hospitalization, observation stay and emergency department discharge 
associated with a metabolic disorder affecting the central nervous system was 
defined as any case having an International Classification of Disease, Ninth 
Revision, Clinical Modification (ICD-9-CM) diagnosis code in the range listed in 
Appendix B-3, in any of the diagnosis fields in the database (15 fields for inpatient, 6 
fields for observation stay and 6 fields for emergency department visits). 
An inpatient hospitalization, observation stay and emergency department discharge 
associated with a stroke and other neurovascular conditions was defined as any 
case having an International Classification of Disease, Ninth Revision, Clinical 
Modification (ICD-9-CM) diagnosis code in the range listed in Appendix B-4, in any 
of the diagnosis fields in the database (15 fields for inpatient, 6 fields for observation 
stay and 6 fields for emergency department visits). 
Additional methodology applied to above case definitions: In order to reduce 
duplication, inpatient cases with a discharge disposition indicating that the individual 
was “transferred to another short stay general hospital for inpatient care” were 
deleted from all tables except the table describing discharge disposition. Only 
Massachusetts residents are included.  
Note: Since all diagnosis fields were examined for an ICD-9-CM code meeting the 
case definition, the counts presented in the tables in one chapter are not necessarily 
mutually exclusive of the counts presented in another chapter. For instance, an 
individual may have two types of conditions associated with a single hospital event. 
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Data source and case definition used for data tables in the chapter on “Central Nervous 
System Neoplasms” include: 
Tumor Counts 
Source: Massachusetts Cancer Registry, Massachusetts Department of Public Health  
Case Definition 
An incident case of a tumor of the brain and CNS was defined as any case having 
an International Classification of Diseases for Oncology, 3rd Edition3 topography 
code (ICD-O) in the range listed in Appendix B-1. 
Population Data: 
Massachusetts population data, including totals and by sex, age groups, race/ethnicity is 
from the Missouri Census Data Center, accessible at: 
http://mcdc.missouri.edu/websas/estimates by age.shtml.4 Population estimates for 
Executive Office of Health and Human Services Regions (EOHHS) were calculated using 
totals from the Missouri Census Data Center and a linear interpolation of the population 
distribution by EOHHS regions on the Massachusetts Community Health Information Profile 
(MassCHIP), an interactive downloadable query system maintained by the Massachusetts 
Department of Public Health.  
Years of Data: 
The hospital and cancer registry data presented in the data tables represents the latest 
three calendar years of data that were available at the time development began on the 
report (2008-2010).  
Table Groupings: 
The statistics and the demographic groupings presented in the tables across the chapters 
were identified as being the most relevant for service planning.   
General statistics presented include: annual counts, average annual counts, percentages, 
and average annual crude rates. Average annual counts were rounded to the nearest 
whole number. As such, column numbers may not add up to the total number and column 
percentages may not add up to 100 due to rounding.  
Average annual crude rates, which are rounded to the first decimal place, were calculated 
as follows:  
Average Annual   = Average annual count of the event for 3 years   x 100,000 
Crude Rate              Average annual population size for 3 years  
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The tables present crude rates, which are the actual rates and were determined to be the 
most useful for service planning. In some instances, “age adjusted” rates are reported in 
the accompanying bullets. These are not true rates but rates that adjust for age differences 
between different populations. These rates answer the question, “what would the rate of 
these events be if the populations being compared had similar age distributions?” 
Differences in the age distribution of populations can occur across geographic regions and 
racial and ethnic populations. The age adjusted rates attempt to control for these 
differences. All age-adjusted rates in this report have been calculated using the 2000 U.S. 
standard population. 
Methods for grouping the cause and intent of traumatic brain injuries, displayed in Table 
G6, follow the recommended framework of E-code (external cause of injury code) 
groupings for presenting morbidity data put forth by the Centers for Disease Control and 
Prevention.5  This can be found at http://www.cdc.gov/injury/wisqars/ecode_matrix.html 
Average annual counts, percents, and crude rates by select racial and ethnic groups are 
included in the data chapters. These groups include: White, non-Hispanic, Black, non-
Hispanic, Hispanic, and Asian non-Hispanic. “Other and unknown” counts include 
discharges among patients listed as Native Hawaiian, Pacific Islander, American Indian, 
Alaska Native, and “other” and “unknown” race. These categories are not presented 
separately due to the small numbers. Executive Office of Health and Human Services 
administrative regions were utilized to present statistics by geographic region of residence. 
A geographic depiction of the cities and towns represented in each region can be found in 
Appendix C. 
Primary payer type “categories,” shown in subchapters III C, D, F and G are based on 
grouping similar primary payer types (for the inpatient hospital database) or their 
corresponding information from the primary source of payment (for the observation stay 
and emergency department discharge databases). 
Discharge Disposition: 
Discharge disposition categories for the inpatient hospital cases are displayed in the 
chapters “Infectious Diseases Associated with Disorders of the Central Nervous System," 
“Metabolic Disorders Affecting the Central Nervous System,” “Neurovascular Diseases and 
Conditions,” and “Traumatic Brain Injury.”  Since the level of detail on discharge disposition 
that is available in the inpatient hospital database is much greater than that available in 
either the observation stay database or the emergency department discharge database, 
discharge disposition tables for these chapters only provide data for inpatient hospital 
discharges. 
The age categories presented in the disposition tables differ from the age categories 
presented in the demographic tables to reduce the amount of cells requiring suppression 
and to provide detail for the population traditionally covered by Medicare. The in-hospital 
death counts presented in the disposition tables do not include deaths that occur outside of 
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the hospital. Also, as previously stated, the deaths that occur during the hospitalization may 
not necessarily be related to the brain injury.  
The individual discharge disposition categories that were available in the inpatient hospital 
database were grouped in the following manner: 
Disposition Category  Text of the Dispositions Included in this Category 
from the Inpatient Hospital Database 
In-Hospital Death Expired (or did not recover - Christian Science 
Patient) 
Home with or without Services Discharged/transferred to home or self-care (routine 
discharge); Discharged/transferred to home under 
the care of organized home health service 
organization; Discharged/transferred to home under 
care of a Home IV Drug Therapy Provider; 
Discharged to Hospice - Home 
Medicare Long Term Hospital Discharged/transferred to a Medicare certified long 
term care hospital 
Psychiatric Hospital Discharged/transferred to a psychiatric hospital or 
psychiatric distinct part unit of a hospital  
Rehabilitation Hospital or Unit Discharged/transferred to a rehab hospital; 
Discharged/transferred to an inpatient rehabilitation 
facility (IRF) including rehabilitation distinct part units 
of a hospital 
Rest Home Discharged/transferred to rest home 
Shelter Discharged to Shelter 
Skilled Nursing Facility Discharged/transferred to Skilled Nursing Facility 
(SNF) 
Short Stay Hospital Discharged/transferred to another short-term hospital 
for inpatient care; Discharged/transferred to a Critical 
Access Hospital (CAH) 
Other Facility Discharged/transferred to an Intermediate Care 
Facility; Discharged/transferred to another type of 
institution not defined elsewhere; 
Discharged/transferred to a federal healthcare 
facility; Discharged to Hospice Medical Facility 
Other Left against medical advice; Discharge other 
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Statistical Significance: 
Where statistical significance is reported, the methods from the National Center for Health 
Statistics (NCHS) were used. These methods are presented in the following document: 6 
National Vital Statistics Reports, Volume 52, Number 10 
Births: Final Data for 2002 
By Joyce A. Martin, MPH, Brady E. Hamilton, PhD; Paul D. Sutton, PHD; Stephanie J. 
Ventura, MA; Fay Menacker, DrPH; and Martha L. Munson, MS;  
From the Division of Vital Statistics, NCHS. 
This document is available from the following website:  
http://www.cdc.gov/nchs/products/pubs/pubd/nvsr/52/52-23.htm 
Non-overlapping 95% confidence intervals were used to determine statistical significance. 
When two or more statistics are determined to differ significantly they are referred to in the 
text with language such as “higher,” “highest,” “lower” and “lowest.” The lack of statistical 
significance does not mean that the differences between two statistics are not clinically or 
socially significant.  
Technical Notes Pertaining to the Acute Care Hospital and Emergency Department 
Data: 
 These are population-based administrative databases which provide information on 
all inpatient hospital, observation stay and emergency department discharges that 
occur within an acute care hospital in Massachusetts. Observation stays are 
generally stays involving less than 24 hours of care, and may involve similar care as 
inpatient hospitalization; however classification may vary across hospitals and 
conditions.  
 
 These databases do not provide information on the initial encounter for a given 
problem. Individual people are also difficult to separate out using these databases as 
there are no names and limited identifiers. Therefore, hospitalization and 
emergency department visit counts presented in the tables do not necessarily 
represent unique individuals or incident (new) cases of a specific condition. 
Note: This differs from the counts presented in the chapter on central nervous 
system neoplasms, which do reflect incident (new) cases.  
 
o Inpatient hospitalizations with a discharge disposition 
“Discharged/Transferred to another short-term general hospital for inpatient 
care” were deleted from the counts in all tables except for the disposition 
table, in an attempt to limit the double counting of cases. 
 
o Transfers were not deleted from the observation stay or emergency 
department counts, as these databases possess a less specific discharge 
indicator (which may include transfers to institutions not later captured by the 
database such as psychiatric hospitals or other treatment facilities).  
 
 19 
 
 Massachusetts residents receiving care at an out-of-state hospital are not included 
in the totals. This may particularly impact the number and rates of individuals who 
reside in cities and towns which closely border neighboring states. 
 
 Data from federal, including the Veteran’s Health Administration (VHA), freestanding 
psychiatric or rehabilitation hospitals and freestanding emergency departments are 
not included.  
 
 These data are collected primarily for billing and other administrative purposes. They 
contain demographic information as well as primary and associated discharge 
diagnoses for the patient’s condition, which are coded to the International 
Classification of Disease’s Ninth Revision, Clinical Modification (ICD-9-CM). These 
databases are commonly used by states for public health surveillance.  
 
o Although all ICD-9-CM codes are submitted by hospitals with trained medical 
records coders, cases receiving a diagnosis code for any particular condition 
have not been validated with the actual medical record.  
 
 The Massachusetts acute care hospital databases are mutually exclusive for single 
episodes of care within a particular hospital. The highest level of care for a given 
episode of care is the one reported. For instance, if a person is treated at the 
emergency department of Hospital A, and then is admitted as an inpatient to 
Hospital A, the patient’s data would only be reported by Hospital A to the inpatient 
hospital database, not to the emergency department database. However, the data 
for a patient transferred from the emergency department of Hospital A to the 
emergency department of Hospital B, and released to home from the emergency 
department of Hospital B, would be reported by both Hospital A and Hospital B to 
the emergency department database. 
 
Other Technical Notes: 
 The data release guidelines, including suppression standards, are developed by the 
data stewards of each database. Hospital and emergency department discharge 
counts of 1-10 are required to be suppressed. Where row and column totals are 
provided, “complementary suppression” may also be applied to protect the back 
calculation of suppressed values.  
 
 The statistics provided in the subsections of Chapter III under “national 
epidemiology,” are presented in accordance with the scientific reports from which 
they are referenced. As such, the terminology used in presenting national race and 
ethnicity data in these subsections may differ from the racial and ethnic groupings 
and terminology used for the Massachusetts data.  
 
 Since no data sources were able to be identified for developing statewide estimates 
of Massachusetts residents with neurodegenerative or neurotoxic conditions (with 
the exception of childhood lead exposure), these chapters largely provide national 
estimates.  
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CHAPTER III B: CENTRAL NERVOUS SYSTEM NEOPLASMS 
 
Overview:  
 
National Epidemiology  
 
Neoplastic disorders of the central nervous system (CNS) include both primary and 
secondary tumors: 
 
Primary tumors originate from cells within the brain and other sites within the CNS and 
may be benign (non-cancerous) or malignant. They can also be of uncertain behavior. 
 
Secondary neoplasms, all malignant, represent metastases from a primary cancer in 
another part of the body (most commonly lung and breast), which has invaded the nervous 
system. Incidence rates for secondary neoplasms vary significantly, and there is currently 
no mandated reporting mechanism or systematic method for ascertaining the incidence of 
secondary neoplasms, which are estimated to occur in 20-40% of individuals diagnosed 
with cancer.1 In addition, the treatment and prognosis, with respect to metastatic CNS 
neoplasms, is significantly different than that for primary CNS neoplasms, which are the 
focus of this report. 
 
While exposure to cranial radiation therapy, immunodeficiency (e.g., increased risk of 
lymphoma), and genetic/familial factors (e.g., neurofibromatosis, NFI and NF2) have been 
linked to an increased risk for developing a brain tumor, or type of CNS neoplasm, most 
brain tumors are not associated with a specific etiology or known risk factors. Documented 
cases of malignant CNS neoplasms are found to be higher in Europe, North America and 
New Zealand/Australia; however, the incidence is likely underestimated in developing 
countries. While the incidence of brain tumors increases with advancing age, primary CNS 
neoplasms are the most common solid tumors observed in children, historically accounting 
for 15-20% of all tumors among children in developed countries, and 27% of all childhood 
cancers. 2  
 
The Central Brain Tumor Registry of the United States (CBTRUS), established in 1992, is 
the designated organization responsible for reviewing and analyzing data for all primary 
brain and other CNS tumors. The epidemiological data analyzed by CBTRUS is provided 
by the National Program of Cancer Registries (NPCR)/Centers for Disease Control and 
Prevention (CDC); and the Surveillance, Epidemiology and End Results (SEER) program/ 
National Cancer Institute (NCI). According to the most recent statistical report issued by 
CBTRUS in 2013, it is estimated that 66,240 new cases of primary brain and other CNS 
tumors will be diagnosed in 2014, of which 22,810 cases will be malignant and 43,430 will 
be non-malignant. 3 It is important to note that CBTRUS estimates include lymphomas, 
other hematopoietic neoplasms (e.g., leukemia), and tumors of the nasal cavity and spinal 
cord, in accordance with the Consensus Conference on Brain Tumor Definition. 4 
 
During the 2006-2010 time period reviewed in the CBTRUS report, the average annual 
age-adjusted incidence rates for primary CNS tumors were 21.0 per 100,000 population, 
with regional incidence rates ranging from 15.2 to 26.5 per 100,000 population. Average  
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annual rates for malignant tumors ranged from 5.0-8.8 per 100,000, while rates for non-
malignant primary tumors ranged from 9.0 to 19.1 per 100,000 population.  Females (58%) 
were more likely than males (42%) to be diagnosed with a primary CNS neoplasm. 
However, males (55%) were more likely to be diagnosed with malignant CNS neoplasms 
than females, who account for 64% of non-malignant primary tumors. While the median 
age at time of diagnosis was 59 years, persons 75 years or older had the highest incidence 
rate for CNS neoplasms (81.0 per 100,000 population). Children, ages 0-14 years, had the 
lowest incidence rate (5.1 per 100,000 population).  
 
CNS Tumor Subtypes 
 
Primary tumors of the central nervous system (CNS) are classified, or coded, with 
reference to: 
 
Topography: referring to location, or site of origin, within the central nervous system 
 
Behavior: which may be benign, uncertain or malignant. Malignant CNS neoplasms rarely 
metastasize to structures/organs outside the CNS. 
 
Morphology: which includes the cell type (histology); degree of differentiation as compared 
to normal tissue; and grade or degree of malignancy. Meningiomas, which arise within the 
coverings of the brain (meninges), and gliomas of varying grades, comprised of glial 
(support) or precursor (blast) cells are the most common types of brain tumors. 5 
 
According to the recent CBTRUS report, meningioma, a principally benign tumor, was the 
most common tumor type in the United States, accounting for approximately one third of all 
tumors and 53.8 % of all non-malignant tumors. Glioblastoma was the second most 
frequently reported tumor subtype and most common malignant tumor, accounting for 
45.2% of cases; the highest incidence rate was observed in adults, 75 to 84 years of age. 
Overall, incidence rates for most histological subtypes were significantly higher for Whites 
than those observed for Blacks, American Indians/Alaskan Natives (AI/AN), and 
Asian/Pacific Islanders. However, Blacks had the highest incidence rates compared to 
other racial groups for tumors of the pituitary gland, meningiomas, and 
craniopharyngiomas, which arise from embryonic tissue adjacent to the pituitary gland, and 
are observed in both adults and children.  Adults and children of Hispanic ethnicity also had 
significantly higher incidence rates, in comparison to non-Hispanics, for pituitary tumors. 
Asian/Pacific Islander and White children/adolescents (ages 0-19) had the highest 
incidence rates, while AI/AN children exhibited the lowest rate. 
 
Outcome and Potential Long-Term Consequences 
 
Prognosis, outcome and survival for individuals diagnosed with primary CNS neoplasms 
are related to tumor subtype and all the associated variables reviewed above. Availability 
and efficacy of treatment options, including neurosurgical intervention, chemotherapy and 
radiotherapy are also key prognostic indicators. Regarding prevalence, the American Brain 
Tumor Association estimates that more than 688,000 people in the U.S. are living with a 
diagnosis of primary brain or other CNS tumor, and that the majority (approximately 
550,000) have been diagnosed with a non-malignant CNS neoplasm. 6 
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National survival rates for individuals with malignant brain tumors are based on the 
Surveillance, Epidemiology and End Results (SEER) data from 18 registries for the years 
1995 to 2010. According to SEER, five-year relative survival for individuals diagnosed with 
malignant brain tumors from 2004 to 2010 was 35%.  Individuals with glioblastomas had the 
poorest survival with 35% of cases alive after one year and only 4.7% after five years. 
Individuals with pilocytic astrocytomas had the best survival with 97.9% alive after one year 
and 94.4% alive after five years.1 
 
Methodology:  
 
The data source used for most of the Massachusetts data presented in this chapter is from 
the Massachusetts Cancer Registry for the time period 2008-2010. Massachusetts death 
data are from the Registry of Vital Records and Statistics, MDPH. Additional data notes are 
available in Chapter III A.  
 
The Massachusetts Cancer Registry (MCR) collects reports of newly diagnosed cancer 
cases from health care facilities and practitioners throughout Massachusetts, including 
acute care hospitals, radiation centers, endoscopy centers, surgical centers, independent 
laboratories, medical practice associations, radiation/oncology centers and private practice 
physicians, as required by Massachusetts law. Additionally, the MCR has reciprocal 
reporting agreements with 34 states and territories to obtain data on Massachusetts 
residents diagnosed out of state.  Currently the MCR collects information on in situ and 
invasive cancers and benign tumors of the brain and associated tissues. Each year, the 
North American Association of Central Cancer Registries (NAACCR) reviews cancer 
registry data for quality, completeness, and timeliness. For 2008-2010, the MCR’s annual 
case count was estimated by NAACCR to be more than 95% complete each year. The 
MCR has achieved the gold standard for this certification element as well as for six other 
certification elements for each diagnosis year since 1997.  
 
A slightly modified version of the national ICD-O-based (International Classification of 
Diseases for Oncology, 3rd edition) consensus definition of topography codes defining 
central nervous system tumors was utilized for the purposes of this report (see Appendix B-
1 for a detailed listing of these codes). Topography codes for the spinal cord, cauda equina, 
spinal meninges, nasal cavity and meninges (NOS) were excluded from the case definition 
in order to present data specific to brain and CNS tumors. The data analyzed were limited 
to brain and CNS tumors whose behavior was benign, of uncertain behavior (which 
includes borderline malignant, low malignant potential, uncertain malignant potential), or 
malignant.  For the purpose of these analyses, tumor behaviors were categorized as non-
malignant (including benign and uncertain) and malignant.  Age group, race/ethnicity, and 
gender by tumor behavior were also analyzed. All counts were rounded to the nearest 
whole number.  
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Table B1:  Malignant and Non-malignant* Brain and CNS Tumors by Anatomic Site, 
MA Residents, 2008-2010 
 
 
Annual Counts 
Average 
Annual 
Count*** 
Average 
Annual 
Percent of 
Total*** 
Average Annual 
Crude Rate per 
100,000 persons 
Site: 2008 2009 2010 2008-2010 2008-2010 2008-2010 
Cerebral Meninges 448 504 432 461 34.4 7.0 
Cerebrum 25 28 28 27 2.0 0.4 
Frontal Lobe 154 142 122 139 10.4 2.1 
Temporal Lobe 106 98 101 102 7.6 1.5 
Parietal Lobe 76 66 71 71 5.3 1.1 
Occipital Lobe 16 8 12 12 0.9 ** 
Ventricle, NOS 23 22 23 23 1.7 0.3 
Cerebellum, NOS 29 35 30 31 2.3 0.5 
Brain Stem 29 20 21 23 1.7 0.4 
Overlapping Lesion of 
Brain 
76 51 45 57 4.3 0.1 
Brain, NOS 69 78 87 78 5.8 1.2 
Olfactory Nerve 0 0 0 0 0 0 
Optic Nerve 4 6 10 7 0.5 ** 
Acoustic Nerve 74 88 72 78 5.8 1.2 
Cranial Nerves, NOS 13 10 13 12 0.9 ** 
Overlapping Lesion of 
Brain and CNS 
1 1 1 1 0.1 ** 
Nervous System, NOS 6 4 5 5 0.4 ** 
Pituitary Gland 118 144 154 139 10.4 2.1 
Craniopharyngeal Duct 1 1 0 1 <0.1 ** 
Pineal Gland 3 3 8 5 0.4 ** 
Total 1,271 1,309 1,235 1,272 100 19. 6 
 
Source: Massachusetts Cancer Registry 
Notes: *Non-malignant tumors include benign tumors and tumors of uncertain behavior. Tumors of the spinal 
cord/meninges, cauda equina, and nasal cavity are excluded. 
**Rates based on average annual counts 1-19 are suppressed. 
***Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 Please note that the following statistics do not include tumors of the spinal  
cord, cauda equina, spinal meninges, nasal cavity and meninges (NOS). The most 
common site for a brain and CNS tumor was in the cerebral meninges (34.4% of all 
sites), with a crude rate significantly higher than other sites. 
 
 Brain tumors in the lobes of the cerebrum comprised 26.2% of all tumors, making 
the cerebrum as a whole the second most common site.  Tumors located in the 
frontal and temporal lobes were the most common. 
 
 The pituitary gland was the third most common site for a brain and CNS tumor.  The 
histology of nearly all of these tumors was benign pituitary tumors. 
 
 Meningioma, a predominantly benign tumor found in the meninges, was the most 
common histological type of brain and CNS tumor diagnosed in Massachusetts from 
2008 to 2010.  There were 1,378 meningiomas of the brain diagnosed during this 
period, or 36% of all brain tumors. (Data by histology not shown in table.) 
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 Glioblastoma, a malignant tumor, was the second most common histological type of 
brain and CNS tumor with 795 cases diagnosed from 2008 to 2010, or 20.9% of all 
brain tumors.  Most were located in the lobes of the cerebrum (81%) followed by 
overlapping lesion of the brain and the CNS (16%). (Data by histology not shown in 
table.) 
 
 From 2008 to 2010, there were on average 421 deaths per year in Massachusetts 
with either malignant or non-malignant brain and CNS tumor (excluding spinal cord) 
as the underlying cause of death.  Of these deaths, 52% were males and 48% were 
females (data not shown). 
 
Table B2:  Brain and CNS Tumors by Age Group, MA Residents, 2008-2010 
 
Non-malignant 
Tumors* 
2008-2010 Average Annual Values 
Age Group 
(Years) 
Average 
Annual 
Count*** 
Percentage 
of Total*** 
Average Annual 
Crude Rate per 
100,000 persons 
0-2 3 0.3 ** 
3-5 2 0.3 ** 
6-18 24 3.2 2.2 
19-21 8 1.0 ** 
22-29 32 4.2 4.5 
30-39 50 6.6 6.1 
40-49 110 14.6 11.1 
50-59 152 20.1 16.6 
60-69 157 20.8 25.8 
70+ 217 28.7 34.1 
Total 755 100 11.7 
    
Malignant 
Tumors 
2008-2010 Average Annual Values 
Age Group 
(Years) 
Average 
Annual 
Count*** 
Percentage 
of Total*** 
Average Annual 
Crude Rate per 
100,000 persons 
0-2 11 2.2 ** 
3-5 9 1.8 ** 
6-18 33 6.7 3.1 
19-21 6 1.1 ** 
22-29 21 4.2 3.0 
30-39 27 5.5 3.3 
40-49 53 10.6 5.3 
50-59 98 18.8 10.7 
60-69 93 18.0 15.3 
70+ 164 31.2 25.7 
Total 517 100 7.9 
 
Source: Massachusetts Cancer Registry 
Note: *Non-malignant tumors include benign tumors and tumors of uncertain behavior. Tumors of the spinal cord/meninges, 
cauda equina, and nasal cavity are excluded. 
**Rates based on average annual counts 1-19 are suppressed. 
***Column counts may not add to total and column percentages may not add to 100 due to rounding. 
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 The overall crude rate of non-malignant brain tumors was statistically significantly 
higher compared to malignant brain tumors. 
 
 Both non-malignant and malignant brain tumors were most common among people 
aged 70 years and older, with statistically significantly elevated rates compared to 
other age groups in both categories. 
 
 Nearly 50% of malignant and non-malignant brain tumors occurred among people 
aged 60 years and older. 
 
Table B3:  Brain and CNS Tumors by Race/Ethnicity, MA Residents, 2008-2010 
 
Non-malignant Tumors* 2008-2010 Average Annual Values 
Race/Ethnic Group 
Average Annual 
Count** 
Percentage of 
Total** 
Average Annual 
Crude Rate per 
100,000 
persons 
White, non-Hispanic 641 84.9 12.6 
Black,  non-Hispanic 48 6.4 11.3 
Asian, non-Hispanic 22 2.9 6.4 
Hispanic 36 4.8 6.1 
Other/Unknown 8 1.0 *** 
Total 755 100 11.7 
    
Malignant Tumors 2008-2010 Average Annual Values 
Race/Ethnic Group 
Average Annual 
Count** 
Percentage of 
Total** 
Average Annual 
Crude Rate per 
100,000 
persons 
White, non-Hispanic 466 90.1 9.0 
Black, non-Hispanic 16 3.1 *** 
Asian, non-Hispanic 10 1.9 *** 
Hispanic 24 4.6 4.0 
Other/Unknown 1 0.1 *** 
Total 517 100 7.9 
 
Source: Massachusetts Cancer Registry 
Note: * Non-malignant tumors include benign tumors and tumors of uncertain behavior. Tumors of the spinal 
cord/meninges, cauda equina, and nasal cavity are excluded.  
**Column counts may not add to total and column percentages may not add to 100 due to rounding. 
***Rates based on average annual counts 1-19 are suppressed. 
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 Both White and Black, non-Hispanics had significantly elevated crude rates of non-
malignant brain tumors compared to malignant brain tumors. 
 
 White, non-Hispanics had significantly elevated crude rates of malignant brain 
tumors compared to Hispanics.  The counts for Black, non-Hispanics and Asian, 
non-Hispanics were too small to compare rates. 
 
 
Table B4:  Brain and CNS Tumors by Sex, MA Residents, 2008-2010 
 
 
 
Source: Massachusetts Cancer Registry   
Notes: *Non-malignant tumors include benign tumors and tumors of uncertain behavior. Tumors of the spinal 
cord/meninges, cauda equina, and nasal cavity are excluded. 
**Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 
 
 While there was no statistically significant difference in sex for malignant brain 
tumors, females had a significantly elevated crude rate for non-malignant brain 
tumors. 
 
 
 
 
 
 
 
 
 
 
 
 
Non-malignant 
Tumors:* 
2008-2010 Average Annual Values 
Sex 
Average Annual 
Count 
Percentage of Total** 
Average Annual 
Crude Rate per 
100,000 persons 
Male  276 36.6 8.8 
Female 479 63.4 14.2 
Total 755 100 11.7 
    
Malignant Tumors 2008-2010 Average Annual Values 
Sex 
Average Annual 
Count 
Percentage of Total** 
Average Annual 
Crude Rate per 
100,000 persons 
Male 274 52.9 8.6 
Female 243 47.1 7.2 
Total 517 100 7.9 
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Table B5:  Insurance at Diagnosis for All Brain and CNS Tumors, MA Residents, 
2008-2010 
 
Payer Type Category Percent** 
Medicaid*** 7.4 
Medicare*** 30.2 
Medicare/Medicaid 3.2 
Private Insurer 44.2 
Insurance, NOS 9.2 
Other Government Payment 0.2 
Free Care or Health Safety Net 0.8 
Commonwealth Care Plans* Unknown 
Self Pay 0.3 
Unknown 4.6 
 
Source: Massachusetts Cancer Registry 
Notes: *Commonwealth Care was not collected as an insurance category from 2008-2010. 
 Tumors of the spinal cord/meninges, cauda equina, and nasal cavity are excluded. 
**Percentages may not add up to 100 due to rounding. 
***Exclusive of cases listed as Medicare/Medicaid. 
 
 
 The most common payer at diagnosis for brain tumor cases was private insurance 
(44.2%), followed by Medicare (30.2%).  Medicare includes Medicare alone, 
Medicare administered through a private insurance, and Medicare with a private 
supplement. 
 
Summary of Findings: 
 
 During the period 2008 to 2010, the average annual number of brain and CNS 
tumors outside of the spinal cord diagnosed and reported to the MCR was 517 for 
malignant tumors and 755 for non-malignant tumors. 
 
 While the majority of these non-malignant brain and CNS tumors were located in the 
meninges, the acoustic nerve, or the pituitary gland, the majority of malignant tumors 
were located in the lobes of the cerebrum. 
 
 Nearly half of all these brain and CNS tumors were diagnosed among people age 60 
years and older.  Approximately four percent of non-malignant brain tumors and ten 
percent of malignant brain tumors were diagnosed among those ages 18 years and 
younger. 
 
 While there was no statistically significant difference in sex for these malignant brain 
and CNS tumors, females had a statistically significantly elevated crude rate for non-
malignant brain tumors. 
 
 From 2008 to 2010, there were on average 421 deaths per year in Massachusetts 
with either malignant or non-malignant brain and CNS tumor (outside the spinal 
cord) as the underlying cause of death.  Of these deaths, 52% were males and 48% 
were females. 
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Limitations: 
 
While the MCR is a population based surveillance database which captures nearly all 
incident cases of brain and CNS tumors among Massachusetts residents, it is not a follow 
up database.  The only follow up that occurs is an annual match with death data from the 
Massachusetts Registry of Vital Records and Statistics to determine if a case has died.  As 
a result of this lack of follow up, it is not possible to track metastases to the brain from other 
primary sites, the most common being lung, breast, colorectal, and skin.  
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CHAPTER III C: INFECTIOUS DISEASES ASSOCIATED WITH DISORDERS OF THE 
CENTRAL NERVOUS SYSTEM 
 
Overview: 
 
National Epidemiology 
 
This category of acquired brain injury (ABI) includes diseases caused by a variety of 
infectious agents (e.g., bacteria, viruses), which invade the central nervous system (CNS) 
and produce an inflammatory response in the brain. Disorders are generally categorized 
as: 
 
Meningitis referring to an inflammation of the coverings (meninges) of the brain 
 
Encephalitis referring to an inflammation of the brain 
 
Meningoencephalitis referring to an inflammation of both the brain and meninges 
 
Encephalomyelitis referring to an inflammation of both the brain and spinal cord 
 
CNS infectious disorders may be classified as primary, resulting from an agent that causes 
primary infection of the brain, or secondary, a systemic infection that also affects the brain. 
Some secondary agents affecting the CNS (e.g., neurosyphilis), which may become 
manifest after a prolonged incubation period, are also progressive and associated with 
dementia (see chapter regarding Progressive Disorders of the CNS). Other infectious 
processes may be chronic or recurrent (e.g., infection of shunt placed in the brain for 
treatment of hydrocephalus) or circumscribed, causing focal neurological deficits (e.g., 
tuberculoma of the CNS, abscess). Certain CNS and peripheral nervous system (PNS) 
inflammatory disorders also represent reactivation of an infectious agent, such as the 
varicella-zoster virus (VZV) which causes chickenpox and may later cause herpes zoster 
(shingles), most commonly diagnosed in persons ages 60 years and older.  
 
The epidemiology of CNS infectious disorders varies with respect to the infectious agent, 
age, season, gender, and geography. The route of infection is also varied (i.e., respiratory, 
body fluids, fecal-oral, mosquito-transmitted, etc.), as is the likelihood of acquisition of 
infection, which may also be related to an individual’s living situation (e.g., students in 
college dormitories who have higher risk for meningococcal meningitis).  Historically, the 
incidence of infectious disorders has also fluctuated and, in part, has been related to 
epidemics, as well as the availability of effective preventative measures, prophylactic 
treatment and vaccines (e.g., syphilis, tuberculosis meningitis, polio, Haemophilis 
influenzae b). For example, prior to the 1960s and the development of the measles 
vaccine, approximately 4 million cases of measles were reported annually in the U.S. Of 
these, 400-500 died; 48,000 were hospitalized; 1,000 developed encephalitis; and 7,000 
developed post-infectious seizure disorders. Currently and contrastingly, there has been an 
average of approximately 60, mostly imported, reported cases annually in the U.S., 
although recently there have been several outbreaks. It is important to note, in this regard, 
that 20 million cases of measles continue to be reported worldwide, resulting in 164,000 
deaths per year. 1 
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Individuals who are immunocompromised (e.g., individuals on cancer chemotherapy or with 
uncontrolled HIV infection; transplant recipients) are at greater risk for secondary 
opportunistic CNS infections, as well as direct infection of the brain that may occur with the 
human immunodeficiency virus (HIV). It is estimated that more than 1.1 million individuals 
(13 years of age and older), including an approximate 16% who are unaware of their 
infection, are living with HIV in the U.S.  It is estimated that 50% of adults who develop 
acquired immune deficiency syndrome (AIDS), as a result of HIV infection, will exhibit HIV-
related neurological complications, in addition to increased risk for other CNS infections 
and conditions, including neoplasms (e.g., lymphoma), degenerative spinal cord disease 
(e.g., vacuolar myelopathy), neuropsychiatric disorders and dementia: i.e., AIDS dementia 
complex (ADC) or HIV-associated dementia (HAD). Children with HIV infection are also at 
risk for exhibiting developmental disorders, smaller than normal skull size (microcephaly) 
and vacuolar myelopathy. 2 Since the introduction and availability of highly active 
antiretroviral therapy (HAART), also known as combination antiretroviral therapy (CART), 
mortality, medical morbidity and the incidence of dementia (ADC/HAD) related to HIV 
infection has been reduced significantly. However, HIV-associated neurocognitive disorders 
(HAND), evidenced in disorders of memory, learning and executive skill, have been 
documented to persist at high rates in individuals in all stages of HIV disease, including 
those who are medically asymptomatic and have viral suppression and improved immune 
status achieved in response to HAART. 3 
 
CNS Infection Subtypes 
 
The categories of infectious agents affecting the CNS include the following: 
 
Viral: Aseptic meningitis is usually caused by enteroviruses, but many other viruses and 
other agents can cause aseptic meningitis. Causes of viral encephalitis include rabies, 
arboviruses (e.g., West Nile virus) and herpes simplex (types 1 and 2). In Massachusetts, 
the arbovirus, eastern equine encephalitis virus, is a rare but catastrophic cause of brain 
injury. Herpes simplex encephalitis (HSE) is the most commonly documented sporadic 
(non-epidemic) cause of encephalitis and accounts for 10% of all cases of encephalitis. As 
noted above, HIV, a type of retrovirus, may also be a cause of primary CNS infection. It is 
important to note, however, that up to 70-75% of encephalitis cases remain undiagnosed, 
as to specific cause.  
 
Bacterial: Pneumococcal meningitis is the most common and most severe form of bacterial 
meningitis, with 6,000 cases reported annually in the United States. Meningococcal 
meningitis, a highly contagious disease, affects 2,600 individuals annually, with higher risk 
observed in college students living in dormitories, infants, and persons with compromised 
immunity.4 Lyme disease, a bacterial infection, may also cause meningitis and encephalitis. 
Approximately 30,000 cases of Lyme disease are reported to the CDC annually, and 
thirteen states, including Massachusetts, account for 95% of Lyme disease cases.5 
 
Fungal: The most common fungal meningitis and encephalitis are caused by Cryptococcus 
neoformans, which is most often diagnosed in persons with immune compromise, but can 
also occur in healthy individuals. There are other fungi which can cause CNS infections that 
occur in specific geographic regions. Fungal meningitis is frequently recurrent (50% of 
individuals). 
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Parasitic: The one-celled parasite Toxoplasma gondii can cause CNS and eye infections 
in neonates and other individuals. Other parasites include cysticercosis, caused by larval 
cysts of the pork tapeworm, and cerebral malaria. While these disorders are rare among 
the U.S. population, exposure may occur when traveling outside the U.S. 
 
Prions:  Prion diseases, also referred to as transmissible spongiform encephalopathies 
(TSEs), are rare degenerative, fatal disorders of the CNS, caused by an abnormal 
proteinaceous infectious agent (i.e., prion protein or PrP). Prion diseases primarily occur 
sporadically, but may also be inherited or acquired through exposure to contaminated 
instruments or biologic products (e.g., transplant tissue or organs). Examples of human 
prion diseases include classic Creutzfeldt-Jakob disease (CJD) and variant (vCJD), 
resulting from exposure to beef products affected by bovine spongiform encephalopathy 
(BSE), or “mad cow” disease. From 1979 through 2006, there have been approximately 
7,000 deaths in the U.S. related to classic CJD, with most cases occurring in persons 65 
and older. 6,7 
 
Outcome and Potential Long-Term Consequences 
 
Mortality and residual neurological sequelae exhibited in individuals who experience CNS 
infection are disease-specific and also dependent upon age; severity of infection; timeliness 
of diagnosis; availability of effective treatment options; general health and, in particular, 
immunocompetence. The prevalence of permanent neurological, neurobehavioral, and 
neuropsychological impairments among survivors has not, for the most part, been 
quantified or systematically documented. For some categories of CNS infection (e.g., viral 
meningitis), most individuals will not experience significant residual disabilities; however, a 
small percentage may exhibit post-infectious neurocognitive disorders, which serve to 
diminish functional capacity. 8 As noted above, persons living with HIV infection, and others 
with compromised immunity (e.g., persons receiving chemotherapy or prescribed steroids) 
are at greater risk for developing neurological consequences related to CNS infection. 
 
Methodology:  
 
The data sources used for most of the Massachusetts data provided in this chapter are 
from the Massachusetts Inpatient Hospital Discharge, Outpatient Observation Stay, and 
Emergency Department Discharge Databases which are described in detail in Chapter IIIA. 
Although the etiologic agents associated with many of the conditions examined in this 
chapter are reportable to the Massachusetts Department of Public Health under 
Massachusetts Law, CNS manifestations associated with these infections are not directly 
reportable and not completely ascertained. 
 
The ICD-9-CM codes utilized to define infectious diseases associated with disorders of the 
CNS are listed in detail in Appendix B-2. Since there was no available national consensus 
definition on which to base the analyses, authors began with the list of ICD-9-CM 
diagnostic codes specific to infectious conditions utilized in the previous MRC-MDPH 
epidemiology study of ABI. These were subsequently adopted and currently utilized by the 
Massachusetts Office of Medicaid (OOM) to determine eligibility for the Acquired Brain 
Injury Home and Community-Based Services (HCBS) waiver programs. The HCBS ABI 
diagnostic code list was modified for the purposes of this report to also include ICD-9-CM 
codes representing infectious-related progressive disorders associated with dementia. 
Codes representing peripheral neuropathies and unspecified or specified complications of 
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infectious disease (e.g., chickenpox with unspecified complication) were excluded, as 
documentation of an ABI could not be determined in the absence of a comprehensive 
review of the medical record or post-acute follow-up assessment, which is the process 
utilized for eligibility determination for the HCBS waivers. 
 
The resulting list of ICD-9-CM codes was used to develop counts and rates of inpatient 
hospitalizations, observation stays and emergency department discharges associated with 
infectious disease-related ABI among Massachusetts residents. A discharge with any of 
these codes in any discharge diagnosis field of the state databases represented a case 
associated with infectious disease-related acquired brain injury.  
 
Table C1. Inpatient Hospitalizations, Observation Stays and Emergency Department 
Discharges Associated with Infectious Disease-related Acquired Brain Injury, MA 
Residents, 2008-2010 
 
Data Source 2008 2009 2010 
Average 
Annual 
Count** 
Average 
Annual 
Percent 
of Total 
Events** 
Average 
Annual 
Crude 
Rate per 
100,000 
persons 
Inpatient Hospitalizations 2,311 2,173 2,014 2,166 71.4 33.2 
Observation Stays 148 143 100 130 4.3 2.0 
Total Hospital Stays 
(Inpatient + 
Observation) 
2,459 2,316 2,114 2,296 75.7 35.2 
       
Emergency Department 
Visits 
743 976 491 737 24.3 11.3 
Total Events (Hospital 
Stays, ED Visits) 
3,202 3,292 2,605 3,033 100 46.5 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Note: **Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 
 Over the three year period analyzed, there was an average of 2,296 hospital stays 
and 737 emergency department discharges annually for infectious disease-related 
ABI among MA residents.  
 
o Observation stays made up 5.7% of the total average annual hospital stays. 
These are generally short duration stays, averaging 33.2 hours. 
 
 The mean and median lengths of stay for inpatient hospitalizations in 2010 were 8.5 
days and 4 days, respectively (data not shown). 
 
 Approximately one third of hospital stays associated with infectious disease-related 
ABI were for viral meningitis, which is less likely to be associated with long term 
neurologic impairments and need for supportive services (data not shown). 
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Table C2.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with Infectious Disease-related 
Acquired Brain Injury, by Age Group, MA Residents, 2008-2010 
 
 
Age Group 
(Years) 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent 
of Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
0 to 2 214 9.3 97.2 38 5.2 17.3 
3 to 5 55 2.4 24.7 23 3.2 10.4 
6 to 18 268 11.7 24.8 125 17.0 11.6 
19 to 21 82 3.6 27.4 61 8.3 20.5 
22 to 29 212 9.2 29.8 140 19.0 19.7 
30 to 39 259 11.3 31.2 106 14.4 12.8 
40 to 49 324 14.1 32.6 99 13.4 9.9 
50 to 59 323 14.1 35.3 67 9.1 7.3 
60 to 69 241 10.5 39.4 39 5.2 6.3 
70+ 320 13.9 50.2 39 5.3 6.1 
Total 2,296 100 35.2 737 100 11.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 The rate of hospital stays for infectious disease-related ABI among children from 
birth through two years of age (97.2 per 100,000 persons) was significantly higher 
than the rate in any other age group.  
 
o Residents ages 70 years and older had the second highest rate with 50.2 
hospital stays per 100,000 persons. 
 
 Nearly half (46.8%) of the emergency department visits for infectious disease-related 
ABI were among residents 22-49 years of age.  
  
 35 
 
Table C3.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with Infectious Disease-related 
Acquired Brain Injury by Sex, MA Residents, 2008-2010 
 
Sex 
Average 
Annual 
Hospital 
Stay Count* 
Percent 
of Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
Male 1,134 49.4 36.9 358 48.6 11.3 
Female 1,163 50.6 33.7 379 51.4 11.3 
Total 2,296 100 35.2 737 100 11.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 Males and females represent nearly equal proportions of both hospital stays and 
emergency department visits associated with infectious disease-related ABI. 
 
Table C4.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with Infectious Disease-related 
Acquired Brain Injury, by Race/Ethnicity, MA Residents, 2008-2010 
 
Race/Ethnic 
Group 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent of 
Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
White, NH 1,604 69.8 31.5 509 69.1 10.0 
Black, NH 255 11.1 58.3 65 8.8 14.9 
Hispanic 262 11.4 43.0 99 13.4 16.2 
Asian, NH 64 2.8 17.6 24 3.3 6.6 
Other/ 
Unknown 
112 4.9  40 5.4  
Total 2,296 100 35.2 737 100 11.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis. Column percent totals may not add up to 100 due to 
rounding. 
Notes: Other and unknown race counts include discharges among patients listed as Native Hawaiian, Pacific 
Islander, American Indian or Alaska Native, "other" race and unknown race; rates are not able to be 
calculated for this category. 
‘NH’ indicates non-Hispanic. 
*Column counts may not add to total and column percentages may not add to 100 due to rounding. 
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 Black, non-Hispanics had the highest crude rate of hospital stays associated with 
infectious disease-related ABI (58.3 per 100,000 persons), followed by Hispanics 
(43.0 per 100,000 persons). Asian, non-Hispanics had the lowest crude rate. 
 
o There was no difference in the rankings of rates by race and ethnicity after 
age-adjustment (data not shown). 
 
 Hispanics and Black, non-Hispanics also had higher crude rates of emergency 
department visits for these conditions,16.2 and 14.9 per 100,000 persons, 
respectively, compared with White, non-Hispanics and Asian, non-Hispanics. 
 
 
Table C5.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with Infectious Disease-related 
Acquired Brain Injury, by Executive Office of Health and Human Services (EOHHS) 
Region of Residence, MA Residents, 2008-2010 
 
EOHHS Region 
of Residence 
 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent 
of Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
I.   Western 278 12.1 33.4 54 7.3 6.5 
II.  Central 290 12.6 33.9 84 11.4 9.8 
III. Northeast 435 18.9 33.8 139 18.9 10.8 
IV. MetroWest 500 21.8 33.1 204 27.8 13.5 
V.  Southeast 430 18.7 33.9 133 18.1 10.5 
VI. Boston 
Region 
364 15.9 47.5 122 16.6 15.9 
Total 2,296 100 35.2 737 100 11.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Note:*Column counts may not add to total and column percentages may not add to 100 due to rounding. 
Totals may include cases of unknown region of residence.  
 
 Residents of the Boston region had the highest average annual crude hospital stay 
rate for infectious disease-related ABI, 47.5 per 100,000 persons. There was no 
significant difference between annual hospital stay rates across all other regions, 
where rates were approximately 33 per 100,000 persons. 
 
o After age adjustment, hospital stay rates remained highest in Boston region 
residents. 
 
 More than one quarter (27.8%) of the emergency department visits for infectious 
disease related ABI were among residents of the MetroWest region. 
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Table C6.  Average Annual Primary Payer Type Category for Inpatient 
Hospitalizations, Observation Stays and Emergency Department Discharges 
Associated with Infectious Disease-related Acquired Brain Injury, MA Residents, 
2008- 2010 
 
Payer Type Category 
Percent of 
Inpatient 
Hospitalization 
Total 
Percent of 
Observation 
Stay Total 
Percent of 
Emergency 
Department Visit 
Total 
Medicaid 19.8 24.6 21.0 
Medicare 22.6 12.8 10.8 
Commercial Insurer 50.6 54.2 52.8 
Other Government Payment 0.8 ** ** 
Free Care or Health Safety Net 3.1 ** 6.2 
Worker's Comp ** 0.0 ** 
Auto Insurance ** ** ** 
Commonwealth Care Plans 2.0 ** 2.3 
Self Pay 0.9 ** 5.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Notes:** denotes suppressed values reflecting a percentage based on a count of 1-10.  
 
 Commercial insurers were the primary payers listed for at least half of inpatient 
hospitalizations (50.6%), observation stays (54.2%), and emergency department 
visits (52.8%) associated with infectious disease-related ABI. 
 
 Medicare was the second most common primary payer category for inpatient 
hospitalizations (22.6%), while Medicaid ranked second for observation stays 
(24.6%) and emergency department visits (21%).  
 
 The percent of discharges where the primary payer was Free Care or Health Safety 
Net was 6.2% for emergency department visits and 3.1% for inpatient stays. 
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Table C7.  Average Annual Inpatient Hospitalizations Associated with Infectious 
Disease-related Acquired Brain Injury by Discharge Disposition Category and Age 
Group, MA Residents, 2008-2010 
 
Disposition Category 
Age Category 
0-21 years 
22-49 
years 
50-
64years 
65+years Total 
In-Hospital Death  1-10 ** 25 40 88 
Home with or without Services 536 616 273 163 1,588 
Medicare Long Term Hospital 1-10 **  14 16 43 
Other† 1-10 16 1-10  1-10 24 
Other Facility‡ 13 1-10 1-10 1-10 32 
Psychiatric Hospital 1-10 1-10 0 1-10 1-10 
Rehabilitation Hospital or Unit 1-10 ** 62 56 177 
Rest Home 0 0 0 1-10 1-10 
Shelter 0 0 0 0 0 
Skilled Nursing Facility 1-10 ** 48 128 204 
Short Stay Hospital 34 35 25 23 117 
Total 607 778 459 437 2,281 
 
Source: MA Inpatient Hospital Discharge Database, Center for Health Information and Analysis.  
Notes:** denotes complementary suppressed values to protect calculation of values in the cells with a  
count of 1-10. Total includes all dispositions except cases of unknown disposition.  
† “Other” includes “left against medical advice” and “discharge other.” 
‡ “Other Facility” includes intermediate care facility, hospice medical facility, federal healthcare facility 
and “another type of institution not defined elsewhere.” Additional detail on disposition categories can be  
found in Chapter III A.  
 
 The majority (69.6%) of inpatient hospitalizations resulted in patients being 
discharged to home, with or without services; 8.9% were discharged to a skilled 
nursing facility, 7.8% were discharged to a rehabilitation hospital, and 5.1% were 
discharged to a short stay hospital.   
 
 Approximately four percent (3.9%) of inpatient hospitalizations associated with 
infectious disease-related ABI during this period resulted in the patient dying during 
the hospitalization.  
 
Summary of Findings: 
 
 Infectious disease-related ABI accounted for an average of 2,296 hospital stays and 
737 emergency department discharges annually in MA for the time period studied. 
 
 Many infectious disease-related ABI discharges resulted from infections not likely to 
cause long-term impairment (data not shown). 
 
 The sizable discrepancy between mean (8.5 days) and median (4 days) length of 
stay reflects high degree of variability in severity and duration of illness among 
individuals with infectious disease-related ABI.  
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 Hospital stay rates were highest in the youngest (0-2 years of age) and oldest (70 
years and older) age groups. 
 
 Black, non-Hispanics and Hispanics had higher crude rates of hospital stays and 
emergency department visits associated with infectious disease-related ABI 
compared with White, non-Hispanics and Asian, non-Hispanics. 
 
 Boston region residents had the highest crude rate of hospital stays associated with 
infectious disease-related ABI compared with other regions. 
 
 Commercial insurers were the primary payer for inpatient hospitalizations (50.6%), 
observation stays (54.2%) and emergency department visits (52.8%) associated with 
infectious disease-related acquired brain injury. 
 
 Most persons with discharges associated with infectious disease-related acquired 
brain injury treated in the inpatient setting were discharged home; 7.8% were 
discharged to rehabilitation hospitals; and another 16% were discharged to facilities 
providing specialized care, such as skilled nursing facilities, short stay hospitals, and 
Medicare long-term hospitals.   
 
Limitations: 
 
 Although the etiologic agents associated with many of the included discharge codes 
are reportable to the Massachusetts Department of Public Health under 
Massachusetts Law, CNS manifestations associated with these infections are not 
directly reportable.  Supplemental clinical information gathered on reported cases 
does not comprehensively cover all possible complications, and surveillance data 
may be incomplete due to a variety of factors.  In addition, some of the included 
conditions manifest after the initial infection and after MDPH follow-up is complete.  
For these reasons, infectious disease surveillance data were determined not to be 
sufficient for this report. 
 
 These data provide only an estimate of total discharges for infectious disease-
related ABI, with limited information in regards to severity or duration of impairment.  
As noted above, the high degree of variability in patient outcomes presents a 
challenge for assessment of services required by patients with a discharge for 
infectious disease-related ABI. 
 
 As there are no ICD-9-CM codes which specify HIV or Lyme Disease 
encephalopathy, data related to these disorders are not included in the discharge 
data analyzed. 
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CHAPTER III D: METABOLIC DISORDERS AFFECTING THE CENTRAL NERVOUS 
SYSTEM 
 
Overview: 
 
National Epidemiology 
 
Acquired metabolic disorders of the central nervous system (CNS) are associated with 
systemic conditions (e.g., organ failure), as well as endocrine, nutritional and toxic 
disorders. The neurological consequences are often generalized and referred to as 
metabolic encephalopathies, although for some disorders focal neuropathological changes, 
or lesions may occur in the context of a diffuse insult to the brain. 
 
With the exception of studies conducted on selected clinical populations, currently in the 
U.S. there is no centralized or mandated reporting mechanism, with respect to the 
metabolic encephalopathies. Thus, national incidence and prevalence estimates, and other 
population-based demographics are not available with respect to individuals who exhibit 
acquired metabolic disorders affecting the CNS. However, the leading cause of metabolic 
encephalopathy is anoxia or hypoxia, referring to an absent or diminished oxygen supply to 
the brain. The brain accounts for 2% of body weight, but utilizes 20% of the oxygen supply, 
most of which is used by the gray matter, or cell bodies of cerebral neurons (nerve cells). 
The brain is exquisitely sensitive to the absence of oxygen, and cell death resulting in 
significant brain injury may occur after only several minutes of oxygen deprivation. Heart 
disease is the leading cause of death in the U.S. (approximately 600,000 annually), and 
cardiovascular events are also a significant cause of anoxic brain injury. In 2013 more than 
568,000 individuals sustained a cardiac arrest, while 720,000 experience a myocardial 
infarction (heart attack) annually.1, 2 While most individuals who sustain an out-of-hospital 
cardiac arrest are over the age of 60 years, adolescents and young adults 15 to 34 years of 
age have been demonstrated to be at increasing risk, particularly African American youth 
who participate in sports activities. 3, 4 
 
Acquired Metabolic Encephalopathy Subtypes 
 
The major categories of acquired metabolic disorders affecting the CNS are reviewed 
below: 
 
A.   Anoxic Encephalopathy 
 
Anoxic/hypoxic disorders and asphyxia (diminished oxygen and excess carbon dioxide, or 
hypercapnia) may be associated with acute events (e.g., cardiac arrest) or chronic medical 
conditions (e.g., chronic obstructive pulmonary disease-COPD); may be caused 
accidentally or intentionally (e.g., suicide attempt by hanging); and may result in permanent 
neurological consequences (e.g., persistent disorder of consciousness), or reversible 
neurological and neurobehavioral findings. The anoxic/hypoxic disorders are categorized 
as follows: 
 
Anoxic Anoxia: This type of anoxia/hypoxia occurs when environmental oxygen is 
diminished, as can occur at high altitudes, resulting in cognitive and mental status changes, 
which are often reversible, but dependent upon duration and severity, may result in anoxic 
brain injury. 
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Anoxic – Ischemic Encephalopathy: 
 
Diminished oxygen levels and blood flow to the brain (ischemia) characterize this disorder. 
Causes include cardiac arrest, heart attack (myocardial infarct), congestive heart failure, 
severe anemia, and peripheral circulatory failure (shock). Anoxic-ischemic encephalopathy 
can also occur in response to respiratory compromise or arrest; traumatic asphyxia, 
intentional (e.g., strangulation) or accidental; diseases which paralyze the respiratory 
muscles (e.g., Guillian-Barre syndrome); pulmonary disease (e.g., COPD); complications of 
anesthesia; and choking incidents. With respect to the latter, adults who are elderly, 
prescribed psychiatric medications, intoxicated or edentulous, as well as persons with 
neurological disorders, are at greater risk for asphyxiation by choking on food, or a so-
called “café coronary.” Children under the age of one year who ingest small, round 
cylindrical foods (e.g., hot dog pieces) are also at greater risk for food-related asphyxia. 
 
Suffocation can also occur in children who are accidentally entrapped in refrigerators; 
ingest uninflated balloons; or are subjected to intentional and unintentional strangulation or 
suffocation. At least 1600 deaths related to infant suffocation occur annually in the U.S., 
and infants who sleep with their parents are estimated to be 20 times more at risk for 
suffocation than infants who sleep alone. 5 Older children and youth (ages 6-19 years), who 
are predominantly male (87%), are also at risk for death and significant hypoxic brain injury 
secondary to the “choking game,” and each year more than 1,000 people die accidentally 
from engaging in controlled strangulation during sexual activity, or autoerotic asphyxia.  6, 7 
 
Histotoxic Hypoxia/Anoxia: This category includes anoxia/hypoxia associated with toxic 
exposure (e.g., cyanide; carbon monoxide), which may be accidental or intentional (e.g., 
suicide attempt). (See chapter regarding Neurotoxic Disorders for discussion of toxic 
encephalopathy).  
 
Hypoxic Ischemic Encephalopathy (HIE): This type of anoxic/ischemic disorder is 
associated with intrapartum asphyxia and hypoxia. The incidence of HIE at term is 
estimated to be 2.5 per thousand live births in developed countries. 8 Significant sequelae 
may include intellectual disability, seizures and cerebral palsy. 
 
Overutilization Anoxia: This type of anoxia is related to prolonged seizure activity (i.e., 
status epilepticus). 
 
B. Endocrinopathies 
 
Approximately 26 million people, representing 8.3% of the population, have diabetes, the 
most common endocrine disease, and it is anticipated that the incidence of diabetes will 
double in the next 25 years. Currently, 10-15% of diabetics have Type I  (“juvenile onset”) 
diabetes, which is usually diagnosed before age 20 years, but can occur at any age. Type I 
diabetes is caused by a lack of insulin due to destruction of insulin-producing cells in the 
pancreas. Type II diabetes is related to insulin resistance and associated with obesity and 
other risk factors (e.g., race). Neurological consequences of diabetes include peripheral 
neuropathy, stroke, and retinopathy, the leading cause of acquired blindness in persons, 
aged 20 to 74 years.9 Metabolic encephalopathy may also occur and be associated with an 
accidental or intentional overdose of insulin or anti-diabetic agent resulting in low blood 
sugar and hypoglycemic encephalopathy, which may also be caused by other conditions 
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(e.g., protracted intoxication). Hyperglycemic encephalopathy may result from elevated 
blood sugar. Both hyperglycemia and hypoglycemia may result in diffuse brain injury, coma 
and other disorders of consciousness. 
 
Other diseases affecting the endocrine organs, including the thyroid, adrenal, and 
parathyroid glands, as well as the neuroendocrine system (i.e., pituitary gland and 
hypothalamus within the brain), may result in a range of neuropsychiatric and 
neurocognitive disorders. 
 
C. Nutritional Disorders Associated with Encephalopathy 
 
Malnutrition and vitamin deficiencies may result in developmental disorders, 
polyneuropathies, optic neuropathy, and degenerative neurological disorders associated 
with dementia. For example, Combined Systems Disease, which results from an acquired 
defect in the intestinal absorption of Vitamin B12, results in degenerative spinal cord 
disease and progressive neurocognitive impairment. A common disorder associated 
mostly, but not exclusively, with chronic alcoholism, malnutrition, and thiamine deficiency, is 
Wernicke’s disease, or encephalopathy, associated with oculomotor abnormalities, gait 
disorder, mental status changes and residual amnestic disorder (Korsakoff psychosis). 
 
D. Systemic Diseases Associated with Encephalopathy 
 
Organ diseases may also result in metabolic encephalopathy, which includes hepatic 
encephalopathy associated with Reye Syndrome in children and adolescents; and in 
adults, cirrhosis of the liver, and other chronic liver diseases. Uremic encephalopathy is 
associated with acute or chronic renal disease. Metabolic encephalopathy may also be 
associated with electrolyte abnormalities (e.g., elevated or diminished sodium levels), 
dialysis treatment (dialysis encephalopathy or dementia) and systemic infection (sepsis). 10 
 
Outcome and Potential Long-Term Consequences 
 
Mortality and outcome related to the metabolic encephalopathies are disease-specific and 
also dependent upon the severity of the metabolic disturbance, general health, underlying 
cause, timely diagnosis and intervention, which in some cases may result in reversal of 
symptoms (e.g., intervention to correct hypoglycemia). The neuropathological findings and 
residual neurobehavioral, neurocognitive, and sensorimotor impairments associated with 
the metabolic disorders affecting the CNS are also disease/disorder-specific. Metabolic 
encephalopathies are also associated with mental status changes, including psychosis, and 
disorders of consciousness, which may be transient (e.g., confusion, delirium) or 
permanent (e.g., irreversible coma). In some instances, individuals may exhibit progressive 
neurological deficits (see chapter on Progressive Disorders of the CNS) after a period of 
apparent recovery (e.g., delayed post-anoxic encephalopathy). 11 
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Methodology:  
 
Massachusetts does not possess a registry of all persons identified with metabolic 
conditions affecting the central nervous system. To estimate the magnitude of this category 
of ABI in Massachusetts, the statewide inpatient hospital, outpatient observation stay and 
emergency department discharge databases were analyzed. These databases are 
described in detail in Chapter III A.  
 
The ICD-9-CM codes utilized to define metabolic conditions associated with disorders of 
the CNS are listed in Appendix B-3. Since there was no available national consensus 
definition on which to base the analyses, authors began with the list of ICD-9-CM 
diagnostic codes specific to metabolic conditions utilized in the previous MRC-MDPH 
epidemiology study of ABI. These were subsequently adopted and currently utilized by the 
Massachusetts Office of Medicaid (OOM) to determine eligibility for the Acquired Brain 
Injury Home and Community-Based Services (HCBS) waiver programs. The HCBS ABI 
diagnostic code list was modified for the purposes of this report to also include ICD-9-CM 
codes representing metabolic disorders with onset in childhood (e.g., respiratory arrest of 
the newborn); metabolic conditions associated with coma (e.g., secondary diabetes mellitus 
with coma); hepatic encephalopathy; and diagnoses known to be associated with anoxia 
(e.g., cardiac arrest). ICD-9-CM codes associated with neurotoxic disorders of the CNS and 
codes associated with toxic metabolic encephalopathy or encephalitis were excluded, and 
these disorders are discussed in Chapter III E (Neurotoxic Disorders). 
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Table D1. Inpatient Hospitalizations, Observation Stays and Emergency Department 
Discharges Associated with Metabolic Disorders Affecting the Central Nervous 
System, MA Residents, 2008-2010 
 
Data Source 2008 2009 2010 
Average 
Annual 
Count* 
Average 
Annual 
Percent of 
Total 
Events* 
Average 
Annual 
Crude Rate 
per 100,000 
persons 
Inpatient Hospitalizations 
8,565 9,316 10,234 9,372 65.1 143.8 
Observation Stays 
218 228 267 238 1.7 3.7 
Total Hospital Stays 
(Inpatient + 
Observation) 
8,783 9,544 10,501 9,609 66.8 147.5 
       
Emergency Department 
Visits 4,865 4,767 4,707 4,780 33.2 73.3 
Total Hospital-treated 
Events (Hospital Stays, 
ED Visits) 
13,648 14,311 15,208 14,389 100 220.8 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 
 On average, there were 9,609 hospital stays and 4,780 emergency department visits 
for a total of 14,389 hospital-treated events annually related to metabolic disorders 
affecting the central nervous system among MA residents during the period 2008-
2010. 
 
 Fewer than two percent (1.7%) of total hospital stays for these conditions were 
discharged from an observation stay bed. These were generally short duration stays. 
 
 The average annual inpatient hospitalization rate associated with metabolic 
conditions affecting the central nervous system was approximately twice the average 
annual emergency department discharge rate (143.8 vs. 73.3 per 100,000 persons). 
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Table D2. Average Annual Counts and Crude Rates of Hospital Stays and Emergency 
Department Discharges Associated with Metabolic Disorders Affecting the Central 
Nervous System by Age Group, MA Residents, 2008-2010 
 
Age Group 
(Years) 
Average 
Annual 
Hospital 
Stay Count* 
Percent of 
Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
0 to 2 110 1.1 50.0 81 1.7 37.0 
3 to 5 17 0.2 7.6 18 0.4 7.9 
6 to 18 95 1.0 8.8 120 2.5 11.1 
19 to 21 44 0.5 14.9 74 1.5 24.8 
22 to 29 162 1.7 22.9 251 5.2 35.3 
30 to 39 306 3.2 36.9 301 6.3 36.2 
40 to 49 1,145 11.9 115.3 520 10.9 52.3 
50 to 59 2,139 22.3 234.1 754 15.8 82.6 
60 to 69 1,805 18.8 295.4 742 15.5 121.4 
70+ 3,786 39.4 594.4 1,919 40.1 301.3 
Total 9,609 100 147.5 4,780 100 73.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding 
Totals include cases with unknown age. 
**Rates based on counts <20 are considered unstable. 
 
 
 The highest rate of hospitalization stays were among residents 70 years of age and 
older, with a rate more than four times as high of the population as a whole. 
 
o The leading diagnoses associated with these hospital stays in this age group 
were associated with metabolic encephalopathy (37.6%) and cardiac arrests 
(30.2%) (data not shown). 
 
o Adults aged 60 to 69 years and 50 to 59 years had the second and third 
highest rates, respectively. 
 
 Similar to the hospital stay rate, the highest rate of emergency department 
discharges were among residents 70 years or older, with a rate more than four times 
as high as the general population. 
 
o The vast majority (93.7%) of these emergency department discharges were 
associated with cardiac arrests (data not shown). 
 
o Adults aged 60 to 69 years and 50 to 59 years had the second and third 
highest rates, respectively. 
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Table D3. Average Annual Counts and Crude Rates of Hospital Stays and Emergency 
Department Discharges Associated with Metabolic Disorders Affecting the Central 
Nervous System by Sex, MA Residents, 2008-2010 
 
Sex 
Average 
Annual 
Hospital 
Stay Count* 
Percent of 
Total 
Hospital 
Stay* 
Average 
Annual 
Hospital 
Stay Rate 
per 100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
Female 4077 42.4 121.2 1750 36.6 52.0 
Male 5532 57.6 175.5 3029 63.4 96.1 
Total 9,609 100 147.5 4,780 100 73.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding. 
Totals include cases with unknown gender. 
 
 
 Overall, males had a higher rate of hospital stays and emergency department visits 
for these conditions compared to their female counterparts. 
 
 
Table D4. Average Annual Counts and Crude Rates of Hospital Stays and Emergency 
Department Discharges Associated with Metabolic Disorders Affecting the Central 
Nervous System by Race and Ethnicity, MA Residents, 2008-2010 
 
Race/Ethnic 
Group 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent of 
Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
White, NH 7,814 81.3 153.3 3,997 83.6 78.5 
Black, NH 652 6.8 149.3 287 6.0 65.7 
Hispanic 651 6.8 106.9 225 4.7 36.9 
Asian, NH 168 1.8 46.6 50 1.0 13.8 
Other/ 
Unknown 
324 3.4  221 4.6  
Total 9,609 100 147.5 4,780 100 73.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.    
Notes: Other and unknown race counts include discharges among patients listed as Native Hawaiian, Pacific 
Islander, American Indian or Alaska Native, "other" race and unknown race; rates are not able to be 
calculated for this category. 
‘NH’ indicates non-Hispanic. 
*Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 Crude hospital stay rates among White, non-Hispanics and Black, non-Hispanics 
were higher than Asian, non-Hispanics and Hispanics. 
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o After age adjustment, Black, non-Hispanics and Hispanics had higher age-
adjusted rates compared to White, non-Hispanics and Asian, non-Hispanics 
(data not shown). 
 
 White, non-Hispanics had the highest crude rate of emergency department visits for 
these conditions compared to Black, non-Hispanics, Hispanics, and Asian, non-
Hispanics. 
 
o After adjustment for age, Black, non-Hispanics had the highest rates 
compared to other racial/ethnic groups (data not shown). 
 
 
Table D5. Average Annual Counts and Crude Rates of Hospital Stays and Emergency 
Department Discharges Associated with Metabolic Disorders Affecting the Central 
Nervous System by Executive Office of Health and Human Services (EOHHS) Region 
of Residence, MA Residents, 2008-2010 
 
EOHHS 
Region 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent 
of Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average Annual 
Emergency 
Department Visit 
Rate per 100,000 
persons 
I.  Western 1,301 13.5 156.6 730 15.3 87.8 
II.  Central  1,076 11.2 126.0 646 13.5 75.7 
III. Northeast  1,963 20.4 152.7 926 19.4 72.1 
IV. MetroWest 1,721 17.9 113.8 946 19.8 62.6 
V.  Southeast  2,451 25.5 193.4 1113 23.3 87.8 
VI. Boston  
     Region  
1,093 11.4 142.7 415 8.7 54.2 
Total 9,609 100 147.5 4,780 100 73.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding 
Totals include cases with unknown EOHHS region. 
 
 
 Residents of the Southeast region had the highest average annual crude rate of 
hospital stays related to these conditions while residents of the Central and 
MetroWest regions had the lowest crude rate of hospital stays.  
 
o After age adjustment, residents of the Southeast and Boston regions had the 
highest average annual rate of hospital stays, while residents of the Metro 
West region had the lowest rate of hospital stays (data not shown). 
 
 Residents of the Southeast and Western regions had the highest average annual 
crude rate of emergency department visits, while residents of the Boston region had 
the lowest crude rate of emergency department visits. 
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o After age adjustment, residents of the Southeast and Western regions had 
the highest rate of emergency department visits, while residents of the 
MetroWest region had the lowest age-adjusted rate of emergency department 
visits (data not shown). 
 
 Regional differences in rates may reflect differences not controlled for during age 
adjustment and/or care provided outside the state and not captured by these 
databases.  
 
Table D6. Average Annual Primary Payer Type Category for Inpatient 
Hospitalizations, Observation Stays and Emergency Department Discharges 
Associated with Metabolic Disorders Affecting the Central Nervous System, MA 
Residents, 2008-2010 
 
Payer Type Category 
Percent of 
Inpatient 
Hospitalization 
Totals 
Percent of 
Observation 
Stay Totals 
Percent of 
Emergency 
Department Visit 
Totals 
Medicaid 15.8 28.6 12.4 
Medicare 59.3 39.8 50.3 
Commercial Insurer 19.7 23.3 23.9 
Other Government Payment 1.2 0.7 1.1 
Free Care or Health Safety Net 1.4 1.4 1.8 
Worker's Compensation 0.2 3.0 2.8 
Auto Insurance 0.2 0.0 1.2 
Commonwealth Care Plans 1.4 2.0 1.3 
Self Pay 0.8 1.3 5.2 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Note: *Column percentages may not add to 100 due to rounding and unknown values excluded from the 
table. 
 
 Medicare was the primary payer listed for more than half (59.3%) of inpatient 
hospitalizations related to metabolic disorders affecting the central nervous system, 
while commercial insurers and Medicaid ranked second and third (19.7% and 
15.8%, respectively). 
 
 Medicare was also the leading primary payer for observation stays (39.8%) and for 
emergency department visits (50.3%) with Medicaid (28.6%) and commercial 
insurers (23.9%) ranked second for each, respectively. 
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Table D7. Average Annual Inpatient Hospital Discharges Associated with Metabolic 
Disorders Affecting the Central Nervous System, by Discharge Disposition Category 
and Age Group, MA Residents, 2008-2010 
 
Disposition 
Category 
Age Category 
 
0-21 
years 
22-49 years 50-64 years 65+years Total 
In- Hospital Death  63 326 628 1,468 2,484 
Home with or 
without Services 
146 771 1,445 1,107 3,469 
Medicare Long 
Term Hospital 
1-10 ** 82 99 234 
Psychiatric  
Hospital 
1-10 46 30 ** 110 
Rehabilitation 
Hospital or Unit 
14 98 172 279 564 
Rest Home 1-10 1-10 1-10 1-10 1-10 
Shelter 1-10 1-10 1-10 1-10 1-10 
Skilled Nursing 
Facility 
1-10 ** 499 1,459 2,126 
Short Stay Hospital 19 94 159 147 419 
Other Facility‡ 12 32 72 109 226 
Other† 1-10 62 64 ** 141 
Total 
275 1,644 3,161 4,711 9,791 
 
Sources: MA Inpatient Hospital Discharge Database, Center for Health Information and Analysis.   
Notes:** denotes complementary suppressed values to protect calculation of values in the cells with a count 
of 1-10. Total includes all dispositions except cases of unknown disposition. 
† “Other” includes “left against medical advice” and “discharge other” 
‡ “Other Facility” includes intermediate care facility, hospice medical facility, federal healthcare facility and 
“another type of institution not defined elsewhere”.  
Additional detail on disposition categories can be found in Chapter III A.  
 
 Approximately one-third (35.4%) of inpatient hospitalizations resulted in patients 
being discharge to home, with or without services; 5.8% were discharged to a 
rehabilitation hospital or unit, and 4.3% of patients were discharged to a short stay 
hospital. 
 
 Of the inpatient hospitalizations for metabolic disorders affecting the central nervous 
system during this period, 25.4% resulted in the individual dying during the 
hospitalization.  
 
 The mean and median lengths of stay for metabolic disorders affecting the central 
nervous system related inpatient hospitalizations in 2010 were 8.2 days and 5 days, 
respectively (data not shown).  
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Summary of Findings: 
 
 Metabolic conditions affecting the central nervous system pose a substantial public 
health problem with an average of 9,609 hospital stays and 4,780 emergency 
department visits, annually, among MA residents related to these conditions for the 
time period studied. 
 
 Hospital stay and emergency department visit rates were highest among adults 70 
years of age and older. 
 
 Although 35% of persons with metabolic diseases affecting the central nervous 
system treated in the inpatient setting were discharged to home, many were also 
discharged to skilled nursing facilities (21.7%). 
 
 Approximately one quarter (25.4%) of the total hospital stays for these conditions, 
resulted in death during the hospitalization. 
 
 Medicare and Medicaid were the primary payer categories for the majority (75.1% 
combined) of inpatient hospitalizations and emergency department visits (62.7% 
combined) for these conditions.  
 
Limitations: 
 
 In addition to the limitations described in Chapter III A, these data provide only crude 
metabolic acquired brain injury severity indicators (i.e., level of care and length of 
stay). More sophisticated measures, often present in statewide surveillance 
registries, can be useful in understanding the long-term impact of these conditions, 
however, Massachusetts currently does not have a registry to specifically track 
metabolic acquired brain injuries. 
 
 Cases with toxic metabolic encephalopathy were excluded from this chapter since 
these cases encompass a broad range of disorders and conditions, described in 
Chapter III E regarding neurotoxic disorders affecting the CNS. 
 
 Cases of encephalopathy related to renal, endocrine and nutritional disorders are 
not included in the discharge data analyzed, as no ICD-9-CM codes specifically 
identify these conditions.  
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CHAPTER III E: NEUROTOXIC DISORDERS  
 
Introduction: 
 
This category of acquired brain injury includes a wide range of disorders associated with 
exposure to toxins, poisons, and infectious agents, as well as medicinal and other 
biological substances. Exposure may be accidental or intentional (e.g., suicide attempt), 
and may occur in an occupational, residential, or environmental context. The route of 
exposure is varied (e.g., inhalation, dermal contact, or ingestion) and for certain disorders 
prenatal exposure may occur (e.g., maternal exposure to lead). 
 
Currently, there is no established centralized or mandated reporting system with respect to 
the majority of toxic disorders affecting the CNS. Therefore, the incidence and prevalence 
of neurotoxic disorders in the United States, as well as Massachusetts, is unknown. It is 
also important to note that for most disorders, analysis of hospital and emergency 
department discharge data would not adequately capture the neurological consequences of 
exposure to toxins as most of the International Classification of Diseases (ICD-9-CM) 
codes are not specific to encephalopathy and other CNS effects related to toxic exposure. 
Therefore, this chapter is largely descriptive of this category of neurological diseases and 
conditions and does not follow the format of most of the other subchapters in Chapter III. 
 
Neurotoxic Disorder Subtypes: 
 
While moderate exposure to a multitude of substances may potentially result in injury to the 
CNS, delineated below are the major categories of toxins associated with ABI and other 
neurological consequences: 
 
Bacterial Toxins: This category includes tetanus, which affects approximately one per 
million individuals annually in the United States. Exposure may be related to injection of 
contaminated heroin, but primarily transmitted via scratches and puncture wounds 
sustained in the home or garden. Less common bacterial toxins include diphtheria and 
botulism. 
 
Illicit Drugs and Alcohol: Alcoholism and addiction to stimulants (e.g., cocaine, 
amphetamines); opioid drugs (e.g., heroin); and hallucinogens (e.g., mescaline, ecstacy), 
as well as misuse of prescribed medications (e.g., analgesics) may result in a range of 
neurological complications and consequences. These include brain hemorrhages; systemic 
disease and metabolic encephalopathy (e.g., liver failure and associated hepatic 
encephalopathy); and neurocognitive impairment, including dementia. Individuals who 
engage in IV drug abuse are also at risk for HIV infection, and if infected, transmission of 
the HIV to non-addicted sexual partners, as well as prenatal transmission to offspring. 
Drug overdose deaths have more than tripled since 1990, with the majority of the 
approximate 36,000 deaths in 2008 caused by prescription drugs, most commonly opioid 
analgesics (e.g., OxyContin). 1   
 
Metals: One of the leading and preventable causes of toxic encephalopathy in children, as 
well as adults, is lead poisoning, or plumbism. The leading cause of plumbism among 
children is exposure to lead paint within the home. Due to the historic implementation of 
statutory and regulatory initiatives associated with childhood lead poison prevention 
strategies, and screening and treatment guidelines established by the U.S. Centers for 
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Disease Control and Prevention (CDC), the incidence of significantly elevated rates of lead 
poisoning among young children living in Massachusetts has declined since 1995. 
However, in 2013, 8,263 children aged 0-72 months had lead levels higher than the most 
current CDC reference value of 5 µg/dL. The CDC reference value represents a level 
above which presents significant health concerns. This value is based on the U.S. 
population of children ages 1-5 years who are in the highest 2.5% of children when tested 
for lead in their blood as part of the National Health and Nutrition Examination Survey 
(NHANES). The CDC reference value will be updated every four years. It is important to 
note that 25% of children aged 9-48 months, including children mandated by law for 
screening (i.e., at 9-12, 24 and 36 months of age), were not screened for lead poisoning. 2 
These data suggest that lead exposures still have a significant impact on public health, 
including the potential for toxic encephalopathy. 
 
Other so-called “heavy” metals include mercury, thallium, cadmium, manganese and zinc, 
as well as inorganic phosphorous and organophosphorous compounds used in insecticides 
and other pesticides. Some metals are also radioactive (e.g., uranium, plutonium), and in 
some instances, metals have been utilized for medicinal purposes with resultant CNS 
consequences. For example, arsenic had been historically prescribed for the treatment of 
syphilis; however, currently arsenic encephalopathy is more likely to occur with accidental 
exposure or intentional ingestion (i.e., suicide attempt) of rodenticides or other pesticides. 
Other metals used for medicinal purposes include gold for treatment of arthritis, lithium, and 
Cisplatin, an antineoplastic agent. 
 
Prescribed Medications: Prescribed medications, if taken for nonmedical purposes (e.g., 
abuse of prescription analgesics) or in excess, and in some instances chronically at 
therapeutic levels, may result in reversible or permanent neurological sequelae. These 
include antineoplastic agents, antipsychotics, sedative-hypnotics, and antidepressants. 
Treatment of psychosis with phenothiazines (e.g., Thorazine), for example, may result in 
extrapyramidal symptoms, such as parkinsonism and tardive dyskinesia (abnormal 
involuntary movements), while treatment with Haldol and phenothiazines may result in 
neuroleptic malignant syndrome (NMS), a potentially fatal disorder, more commonly 
observed in young adult males. 3  
 
Radiation Exposure: Injury to the CNS, which may be acute or delayed, may occur as a 
complication of cranial radiation treatment of brain neoplasms. Environmental exposure to 
radiation may also occur accidentally (e.g., nuclear plant incident) or intentionally (e.g., 
exposure to radioactive weapons). 
 
Toxic Gas Exposure: Exposure to carbon monoxide, an odorless exogenous toxin, may 
result in transient neurological symptoms, but when exposure is prolonged results in anoxic 
encephalopathy (see Chapter III D for discussion of anoxic disorders). A wide range of 
other gasses may result in toxic encephalopathy, with exposure occurring in the context of 
the workplace (e.g., exterminators exposed to cyanide gas); inhalant abuse (e.g., glue 
sniffing); military combat and acts of terrorism (e.g., weaponized nerve agents; Sarin).     
 
Venom and Other Neurotoxins: Central and peripheral neurotoxic disorders may also 
result from bites and stings inflicted by a variety of animal and marine species, including 
snakes, ticks, scorpions, spiders, jellyfish, and octopi.  Neurotoxic effects may also occur 
as a result of ingesting certain plants (e.g., wild mushrooms) or fish (e.g., blowfish-induced 
paralysis). Ingesting fish from mercury contaminated industrial wastewater may also result 
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in toxic encephalopathy, or Minamata disease, a notable and particularly profound example 
of industrial contamination of the food supply. 4, 5 
 
Outcome and Potential Long-Term Consequences: 
 
The acute and long-term neurological consequences related to neurotoxins are dependent 
upon multiple exposure variables, including the specific toxic agent, as well as the duration, 
magnitude, and age at time of exposure. Other factors affecting outcome include: accurate 
differential diagnosis; identification and removal, when indicated, of the source of toxic 
exposure (e.g., lead paint); prevention of re-exposure; and the availability of an effective 
antidote or other treatment option, such as a chelating agent to facilitate excretion of lead 
or other metals from the body. Pharmacologic re-evaluation and treatment of unintended 
negative side effects may be of benefit in addressing the neurotoxic symptoms associated 
with prescribed medication. Treatment for addiction and ongoing supports to maintain 
abstinence are indicated for neurotoxic disorders associated with substance abuse.  
 
It is important to note, however, that many neurotoxic exposures result in permanent 
neurological sequelae, neurobehavioral disorders, and neurocognitive impairment, 
including dementia and persistent disorders of consciousness. Some neurotoxins are also 
carcinogenic, and maternal exposure may result in teratogenic effects, or birth defects, and 
compromised intellectual capacity (e.g., fetal alcohol syndrome). 
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CHAPTER III F: NEUROVASCULAR DISEASES and CONDITIONS 
 
Overview:  
 
National Epidemiology  
 
Acute stroke, referring to the sudden disruption of blood flow carrying oxygen and nutrients 
to the brain, is the most common neurovascular disorder and second leading cause of 
acquired brain injury. Each year more than 795,000 people in the U.S. experience a stroke, 
approximately 130,000 of whom have a fatal outcome. Men are at greater risk for stroke in 
most age groups; however, women are more likely to die from stroke. In comparison to 
Whites, Blacks exhibit approximately twice the risk of having a first stroke and are also 
more likely to die following a stroke. American Indians and Alaskan Natives are also at 
greater risk for stroke, in comparison to Hispanics and Asians. The prevalence of and 
highest death rates from stroke are in the southeastern United States, or so-called “Stroke 
Belt.” However, these regional disparities are related to an unequal Black/White racial 
distribution, socioeconomic status, and the prevalence of chronic disease and other risk 
factors. 
 
Medical conditions associated with an increased risk for stroke include: hypertension; 
abnormally high cholesterol and triglyceride levels; diabetes mellitus; coronary artery 
disease (CAD); and arrhythmia (abnormal heart beat). Individuals who experience a 
previous stroke or a transient ischemic attack (TIA) are also at greater risk for suffering a 
stroke. A TIA occurs when blood flow to the brain is briefly interrupted, and may be caused 
by blood clots or fat deposits (plaques) within the cerebral arteries. TIAs result in temporary 
neurological signs and symptoms, without confirmed evidence (e.g., neuroimaging) of 
acute infarction, meaning cell death or necrosis secondary to vascular insufficiency. While 
no permanent residual impairments are associated with TIAs, approximately one third of 
those who experience a TIA will experience a stroke, particularly in the absence of medical 
treatment for the underlying cause with medication (e.g., anti-clotting medication) or in 
some instances, surgical intervention (e.g., carotid endarterectomy to remove fatty plaque). 
Personal modifiable risk factors associated with stroke include smoking, obesity, physical 
inactivity, high sodium intake, drug and alcohol abuse.1-3 Women who use birth control pills; 
who have a history of migraine with aura (visual disturbances); and those who experience 
pregnancy-related complications, including a history of multiple miscarriages, preeclampsia 
(hypertension and excess protein) and eclampsia (uncontrolled preeclampsia and 
seizures), are at greater risk for stroke. 4 
 
The majority of individuals who sustain a stroke are 60 years of age and older, but stroke 
may occur at any age, beginning in the perinatal period. Perinatal stroke occurs in one per 
3,500 live births, and children with certain medical conditions are also at greater risk for 
stroke, including those with sickle cell disease, congenital heart defects, and cerebral 
arteriopathy, or arterial disease. Some arteriopathies are genetic, such as the condition 
known as CADASIL, or cerebral autosomal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy. Children also exhibit many of the same risk factors associated 
with adult stroke, including obesity, hypertension, smoking, Type 1 and Type 2 diabetes. 
Boys have a 1.28 fold higher risk for stroke than girls; and Black children have a two-fold 
higher risk for stroke, in comparison to White children. 5, 6  
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Neurovascular Disorder Subtypes 
 
Neurovascular disorders may be classified as: 
 
Hemorrhagic: referring to the non-traumatic disruption of cerebral blood flow caused by 
bleeding from or rupture of blood vessels, often associated with hypertension. 
Hemorrhages may occur within brain tissue (i.e., ICH: intracerebral hemorrhage); in the 
space between the arachnoid and pia mater, or coverings (meninges) of the brain (i.e., 
SAH: subarachnoid hemorrhage); or within the ventricles, or cavities within the brain where 
cerebrospinal fluid (CSF) is stored and made. Intraventricular hemorrhages (IVH), which 
primarily occur in premature infants, may result in cerebral palsy, hydrocephalus (i.e., 
excessive CSF in brain), and neurodevelopmental disorders. The neurological 
consequences of IVH are related to the severity and magnitude, or grade, of the 
hemorrhage. 
 
Brain hemorrhages are also associated with structural vascular abnormalities or 
malformations, such as aneurysms. An aneurysm is a balloon-like dilation and weakness of 
the arterial wall, which may be familial, but is usually acquired with age and occurs more 
frequently in females than in males.  In the U.S. more than 30,000 individuals experience 
SAHs related to aneurysms annually, and 60-65% will die before reaching a hospital or 
within the first 30 days of their stroke.7,8 An arteriovenous malformation (AVM), another type 
of vascular malformation of presumed prenatal origin, affects the capillaries between 
arteries and veins, which become entangled and compromise blood flow.  It is estimated 
that approximately 300,000 individuals in the U.S. are living with AVMs of the brain and 
spinal cord. Of these, an estimated 12% will experience neurological consequences 
associated with the size and site of the AVM within the CNS, including seizures, headache 
disorders, cognitive impairment, and a wide range of other neurological sequelae. 
Approximately 50% of neurologically symptomatic AVMs are also associated with the 
development of aneurysms and risk of hemorrhage.9  Moyamoya disease, a rare 
progressive disorder in which the walls of the internal carotid arteries become constricted, 
is also associated with hemorrhagic strokes and TIAs in both adults and children.  
 
Ischemic: referring to the disruption of the normal blood flow to the brain resulting from 
obstruction (occlusion) or narrowing (stenosis) of the arteries that supply the brain, most 
commonly caused by atherosclerosis (i.e., fatty deposits or plaque). Other causes of 
ischemia include thrombi, or blood clots, formed within the arteries of the brain and emboli, 
which include blood clots and other debris from sites outside the CNS, most commonly the 
heart, that travel to the brain via the bloodstream and block an artery within the brain.  
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Overall, most strokes (85%) are classified as ischemic and caused by cerebral infarction 
resulting in a constellation of neurological signs and symptoms, or clinical stroke. It is 
important to note, however, that not all individuals who experience a stroke will present with 
these signs and symptoms, but more subtle, somatic or atypical symptoms, such as 
headache, fatigue, malaise.  Others may present as so-called “silent strokes” resulting from 
CNS infarction, particularly within the right hemisphere (side) of the brain that may result in 
mild cognitive impairment, behavioral and other symptoms that may not be recognized as 
cerebrovascular-related events. “Silent infarcts” are more prevalent in women and also in 
Blacks. 10 Children with sickle cell disease and congenital heart defects are at greater risk 
for ischemic stroke.  
 
Outcome and Potential Long-term Consequences 
 
Mortality and outcome with respect to the neurovascular disorders are dependent upon 
subtype (i.e., ischemic vs. hemorrhagic); degree of cerebrovascular compromise (e.g., 
severity of atherosclerotic disease); age; general health; and genetic predisposition. 
Timeliness of intervention in response to an acute neurovascular event may also influence 
outcome. For example, intravenous treatment with either tissue plasminogen activator (tPA) 
or recombinant tissue plasminogen activator (rt-PA), has been demonstrated to reduce 
morbidity and improve recovery when administered within three hours, to individuals who 
experience ischemic stroke caused by blood clots and meet clinical eligibility criteria for this 
treatment.11,12 The residual focal neurological, neurobehavioral and neurocognitive 
consequences of stroke and other neurovascular events are also related to the perfusion 
territory, or areas of the brain supplied by the involved blood vessels, and the associated 
site(s) of neurovascular injury.  
 
Identification and treatment of underlying medical conditions and risk factors 
(e.g., hypertension, atrial fibrillation, hypercholesterolemia) is critical to reducing the 
incidence of stroke. It is also important to note that although men and women share many 
of the same stroke risk factors, there are risks that are unique, or as noted above occur 
more frequently in women, which have recently been incorporated into prevention 
guidelines that address these gender-specific healthcare needs. 13 With respect to vascular 
malformations, comprehensive clinical assessment, diagnostic neuroradiology, intervention 
for risk factors, and when indicated, neurosurgical intervention (e.g., surgical clipping of 
aneurysms; endovascular embolization for AVMs), may also serve to prevent or diminish 
the risk of hemorrhagic stroke.  
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Methodology:  
 
Massachusetts does not possess a registry of all persons identified with neurovascular 
conditions. To estimate the size of this health problem in Massachusetts, the statewide 
inpatient hospital, outpatient observation stay and emergency department discharge 
databases were analyzed. These databases are described in detail in Chapter IIIA. Two 
other data sources were considered for this purpose: the MA Paul Coverdell Acute Stroke 
Registry (Coverdell) and data from the Primary Stroke Service (PSS) hospitals in MA. The 
Coverdell Registry was not used because it does not account for all stroke cases across 
the state; it only represents up to 58 of the 70 primary stroke service hospitals in MA and is 
collected primarily for quality improvement purposes. PSS data was not used because it 
does not include diagnoses of hemorrhagic stroke. Additionally, neither Coverdell nor PSS 
data includes diagnoses of other neurovascular conditions discussed in this chapter.  
 
A nationally developed ICD-9-CM-based consensus definition of stroke was applied to the 
statewide databases listed above to develop the counts and rates of discharges associated 
with these conditions among Massachusetts residents. This definition (detailed in Appendix 
B-4) is from the Joint Commission on Disease-specific Care14. For the development of a full 
operational definition of neurovascular conditions beyond stroke that can lead to acquired 
brain injury, (i.e., including categories listed in this chapter as “other cerebrovascular 
disease or condition” and “fetal/neonatal hemorrhage”) the authors began with the list of 
ICD-9-CM diagnostic codes specific to neurovascular conditions utilized in the previous 
MRC-MDPH epidemiology study of ABI. These were subsequently adopted and are 
currently utilized by the Massachusetts Office of Medicaid (OOM) to determine eligibility for 
the Acquired Brain Injury Home and Community-Based Services (HCBS) waiver programs. 
The HCBS ABI diagnostic code list was modified for the purposes of this report to also 
include ICD-9-CM codes for conditions related to the perinatal and neonatal period. A 
discharge with an ICD-9-CM code reflecting any of these conditions in any discharge 
diagnosis field of the state databases mentioned above represented a discharge 
associated with a neurovascular disease or condition. 
 
Acute stroke is the primary focus of this chapter, as it makes up the majority of discharges 
among neurovascular conditions. Tables F1 - F7 provide counts and rates of stroke 
diagnoses, which may include individuals with diagnoses of other neurovascular conditions.  
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Table F1. Inpatient Hospitalizations, Observation Stays and Emergency Department 
Discharges Associated with a Discharge Diagnosis of Stroke, MA Residents, 2008-
2010 
 
Data Source 2008 2009 2010 
Average 
Annual 
Count* 
Average 
Annual 
Percent of 
Total 
Events* 
Average 
Annual 
Rate per 
100,000 
persons 
Inpatient Hospitalizations 19,133 19,232 19,769 19,378 85.0 297.4 
Observation Stays 787 789 810 795 3.5 12.2 
Total Hospital Stays (Inpatient 
+ Observation) 
19,920 20,021 20,579 20,173 88.5 309.6 
        
Emergency Department Visits 2,468 2,687 2,736 2,630 11.5 40.4 
Total Hospital-treated Events 
(Hospital Stays, ED Visits) 
22,388 22,708 23,315 22,804 100 349.9 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding.  
 
 
 On average, there were 20,173 hospital stays and 2,630 emergency department 
discharges annually related to a diagnosis of stroke among MA residents. This 
includes both hemorrhagic and ischemic strokes. 
 
 Of the emergency department discharges during this period, on average, annually, 
1,714 (65.2%) of these were transferred to another, unspecified facility (data not 
shown). These cases may have been later admitted and may be represented in the 
hospital stay counts. 
 
 Only 3.5% of total hospital-treated events for stroke were discharged from an 
observation stay bed. These are generally short duration stays. 
 
 From 2008-2010, of the ischemic stroke patients reported to the MA Coverdell 
Stroke Registry who arrived at the hospital within 2 hours of the time they were last 
known to be without stroke symptoms (“last known well time”) and were eligible for 
intravenous (IV) thrombolytic therapy, 75.4% received IV tissue plasminogen 
activator (IV tPA) within 3 hours of last known well time. (Source: MA Coverdell 
Stroke Registry, MDPH. Data not shown.) 
 
 In addition to the counts presented in Table F1, there were 5,689 hospital stays and 
1,458 emergency department visits associated with a transient ischemic attack 
(TIAs); and 7,455 hospital stays and 1,522 emergency department visits associated 
with other cerebrovascular conditions on average annually, which were not 
associated with a diagnosis of a stroke (data not shown). 
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 There were 410 hospital discharges on average, annually, associated with 
neurovascular conditions occurring primarily in the perinatal and neonatal period, 
and which were not associated with a diagnosis of a stroke (data not shown).  
 
Table F2.  Average Annual Counts and Crude Rates of Stroke-related Hospital Stays 
and Emergency Department Discharges by Age Group, MA Residents, 2008-2010 
 
Age 
Group 
(Years) 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent of 
Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate per 
100,000 
persons 
0 to 2 42 0.2 19.1 1-10 NA NA 
3 to 5 1-10 NA NA 1-10 NA NA 
6 to 18 42 0.2 3.9 17 0.6 1.6 
19 to 21 ** ** 
 
** 
12 0.5 4.0 
22 to 29 84 0.4 11.9 47 1.8 6.6 
30 to 39 228 1.1 27.5 103 3.9 12.4 
40 to 49 790 3.9 79.5 240 9.1 24.1 
50 to 59 2,035 10.1 222.8 422 16.1 46.2 
60 to 69 3,772 18.7 617.2 487 18.5 79.7 
70+ 13,156 65.2 2,065.3 1,295 49.2 203.3 
Total 20173 100 309.6 2630 100 40.4 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Notes:*Column counts may not add to total and column percentages may not add to 100 due to rounding.   
**Denotes complementary suppressed values to protect calculation of values in the cells with a count of 1-10. 
NA indicates that percents and rates are not shown for suppressed values.  
Rates based on counts less than 20 are considered unstable.  
 
 The highest rate of hospital stays for stroke was among residents 70 years of age 
and older, with a rate more than six times that of the population as a whole.  
 
o Persons age 50 years and older cumulatively made up 94.0% of hospital 
stays. 
 
 The highest rate of emergency department discharges for stroke was also among 
persons 70 years of age and older, approximately five times that of the general 
population.  
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Table F3.  Average Annual Counts and Crude Rates of Stroke-related Hospital Stays 
and Emergency Department Discharges by Sex, MA Residents, 2008-2010 
 
Sex 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent of 
Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit 
Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
Male 9,854 48.8 312.7 1,321 50.2 41.9 
Female 10,319 51.2 306.6 1,308 49.8 38.9 
Total 20,173 100 309.6 2,630 100 40.4 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Notes: *Column counts may not add to total and column percentages may not add to 100 due to rounding.   
Totals may include cases of unknown sex. 
 
 Overall, males and females had statistically similar rates of hospital stays and 
emergency department visits for stroke. 
 
 On average, females 70 years of age and older had 7,386 stroke-related hospital 
stays, the subgroup with the highest stroke rates, versus 5,770 for males in the 
same subgroup (data not shown). 
 
 In the 70 years and older subgroup, females had 715 emergency department visits 
on average annually, while males had 580 visits (data not shown). 
 
Table F4.  Average Annual Counts and Crude Rates of Stroke-related Hospital Stays 
and Emergency Department Discharges by Race and Ethnicity, MA Residents, 2008-
2010 
 
Race/Ethnic 
Group 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent of 
Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate  
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
White, NH 17,518 86.8 343.8 2,271 86.4 44.6 
Black, NH 1,044 5.2 239.0 122 4.7 28.0 
Hispanic 736 3.7 121.0 113 4.3 18.5 
Asian, NH 351 1.7 97.3 50 1.9 13.9 
Other/Unknown 524 2.6  74 2.8  
Total 20,173 100 309.6 2,630 100 40.4 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Notes: Other and unknown race counts include discharges among patients listed as Native Hawaiian, Pacific 
Islander, American Indian or Alaska Native, "other" race and unknown race; rates are not able to be 
calculated for this category. ‘NH’ indicates non-Hispanic.  
*Column counts may not add to total and column percentages may not add to 100 due to rounding.   
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 White non-Hispanics had a higher crude rate of hospital stays for stroke, compared 
with Black non-Hispanics, Hispanics, and Asian non-Hispanics. However, after 
adjusting for age, Black non-Hispanics had the highest rate of hospital stays. The 
lowest crude and age adjusted rates of hospital stays were among Asian, non-
Hispanics (age adjusted data not shown). 
 
 White non-Hispanics had the highest crude rate of emergency department visits for 
stroke, compared with Black non-Hispanics, Asian non-Hispanics, and Hispanics.  
 
o After adjusting for age, only Asian, non-Hispanics had a statistically different 
(lower) rate of emergency department visits compared with all other races.  
 
 
Table F5.  Average Annual Counts and Crude Rates of Stroke-related Hospital Stays 
and Emergency Department Discharges by Executive Office of Health and Human 
Services (EOHHS) Region of Residence, MA Residents, 2008-2010 
 
EOHHS 
Region of 
Residence 
Average 
Annual 
Hospital 
Stay Count* 
Percent 
of Total 
Hospital 
Stays* 
 
Average 
Annual 
Hospital 
Stay Rate 
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
I.   Western 2,854 14.1 343.4 265 10.1 31.9 
II.  Central  2,577 12.8 301.6 305 11.6 35.7 
III. Northeast  4,291 21.3 333.8 562 21.4 43.7 
IV. MetroWest 4,178 20.7 276.2 540 20.5 35.7 
V.  Southeast  4,332 21.5 341.8 754 28.7 59.5 
VI. Boston  
     Region  1,938 9.6 253.1 204 7.7 26.6 
Total 20,173 100 309.6 2,630 100 40.4 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding 
and/or inclusion of cases of unknown region. 
 
 Residents of the Western, Northeast, and Southeast regions had the highest 
average annual crude rates of hospital stays for stroke.  
 
o The age-adjusted hospital stay rate for residents of the MetroWest region was 
significantly lower than for all other regions (data not shown).  
 
 Average annual emergency department visit rates were highest in residents of the 
Southeast region, even after age adjustment. 
 
 Regional differences in rates may reflect differences not controlled for during age 
adjustment and/or care provided outside the state and not captured by these 
databases. 
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Table F6. Average Annual Primary Payer Type Category for Stroke-related Inpatient 
Hospitalizations, Observation Stays and Emergency Department Discharges, MA 
Residents, 2008-2010 
 
Payer Type Category 
Percent Inpatient 
Hospitalizations 
Percent 
Observation 
Stays 
Percent 
Emergency 
Department Visits 
Medicaid 4.9 4.8 8.2 
Medicare 73.0 64.9 57.6 
Commercial Insurer 18.8 27.7 28.0 
Other Government Payment 0.7 ** 0.8 
Free Care or Health Safety Net 1.0 ** 2.0 
Worker's Compensation 0.1 ** ** 
Auto Insurance 0.1 ** ** 
Commonwealth Care Plans 0.9 ** 1.2 
Self Pay 0.4 ** 1.6 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis. 
Note:** denotes suppressed values reflecting a percentage based on a count of 1-10. Column percentages 
may not add up to 100% due to missing and invalid values. 
 
 
 Medicare was the primary payer listed for nearly three-quarters (73%) of inpatient 
hospitalizations, while commercial insurers and Medicaid ranked second and third 
(18.8% and 4.9%, respectively).  
 
 Medicare was also the leading primary payer category for emergency department 
visits for stroke, accounting for 57.6% of all visits. Commercial insurers and Medicaid 
ranked second and third (28.0% and 8.2%, respectively).  
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Table F7. Average Annual Stroke-related Inpatient Hospitalizations by Discharge 
Disposition Category and Age Group, MA Residents, 2008-2010 
 
Disposition Category 
Age Category 
0-21 years 
22-49 
years 
50-64 
years 
65+years Total 
In- Hospital Death 
1-10 ** 212 1,283 1,583 
Home with or without 
Services 74 668 2277 7,080 10,099 
Medicare Long Term 
Hospital 1-10 ** 69 257 349 
Psychiatric Hospital 1-10 1-10 1-10 33 42 
Rehabilitation Hospital 
or Unit 12 213 600 2,016 2,841 
Rest Home 1-10 1-10 1-10 ** ** 
Shelter 1-10 1-10 1-10 1-10 1-10 
Skilled Nursing Facility 1-10 ** 262 3638 3944 
Short Stay Hospital 1-10 ** 144 420 639 
Other Facility‡ 1-10 ** 46 331 396 
Other† 1-10 ** 36 51 103 
Total 112 1,124 3,655 15,123 20,014 
 
Source: MA Inpatient Hospital Discharge Database, Center for Health Information and Analysis.   
Notes:** denotes complementary suppressed values to protect calculation of values in the cells with a count 
of 1-10. Total includes all dispositions except cases of unknown disposition.  
† “Other” includes “left against medical advice” and “discharge other.” 
‡ “Other Facility” includes intermediate care facility, hospice medical facility, federal healthcare facility and 
“another type of institution not defined elsewhere.”  
Additional detail on disposition categories can be found in Chapter III A.  
 
 Fifty percent of inpatient hospitalizations resulted in individuals being discharged to 
home, with or without services; 19.7% were discharged to a skilled nursing facility; 
14.2% were discharged to a rehabilitation hospital; and 3% were discharged to a 
short stay hospital. 
 
 Among those discharged to home, an average annual of 6,192 (61.3%) were listed 
as discharged to home with no services. Of the 38.7% discharged with services, 
those services included time-limited home health care, IV therapy, or hospice (data 
not shown). 
 
 Eight percent of inpatient hospitalizations for stroke during this period resulted in 
death during the hospitalization.  
 
 The mean and median lengths of stay for stroke-related inpatient hospitalizations in 
2010 were 5.7 days and 4.0 days, respectively (data not shown).  
 
 Of the inpatient discharges associated with neurovascular conditions occurring 
primarily in the perinatal and neonatal period, and which were not associated with a 
diagnosis of a stroke (482 on average annually), 71.7% were discharged to home, 
and 15.1% were discharged to a short-stay hospital (data not shown). 
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Summary of Findings: 
 
 Stroke is a substantial public health problem, resulting in an average annual number 
of over 20,000 hospital stays and over 2,600 emergency department visits among 
MA residents for the time period studied. TIAs contributed nearly 5,700 additional 
hospitalization events annually during this period.  
 
 Hospital-treated event rates for stroke are highest among adults 70 years of age and 
older. 
 
 Publicly-funded payers (Medicaid, Medicare, Free Care/Health Safety Net, Other 
Government Payment, Commonwealth Care) were the primary payers for at least 
80.5%, 69.7%, and 69.8% of the inpatient hospitalizations, observation stays, and 
emergency department visits, respectively (on average, annually) for  hospital-
treated stroke events in MA. 
 
 
Limitations: 
 
 In addition to the limitations described in Chapter III A, these data provide only crude 
stroke severity indicators (i.e., level of care and length of stay). More sophisticated 
measures, such as the National Institute of Health’s Stroke Scale and treatment with 
IV thrombolytics, can be useful in understanding the long-term impact of stroke.  
 
 Individuals transferred to another, unspecified facility from an emergency 
department visit (65.2%) may have been transferred and admitted to an inpatient 
setting, and therefore may be included in inpatient hospitalization counts.  
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CHAPTER III G: TRAUMATIC BRAIN INJURY 
 
Overview:  
 
National Epidemiology  
 
Traumatic brain injury (TBI) is the leading cause of acquired brain injury (ABI), and the 
Centers for Disease Control and Prevention estimates that approximately 1.7 million 
persons sustain TBI annually in the United States. The majority (80.7%) of individuals are 
examined, treated and released from emergency departments (ED), while 16.3 % are 
hospitalized and 3% (52,000 annually) die of their injuries. In contrast to other types of 
ABIs, the causes of TBI are due to external mechanisms such as falls, motor vehicles, 
firearms, and strikes by an object or person. These events can be further classified as 
unintentional (or “accidental”) or intentional, which include interpersonal violence and 
suicide. Traumatic brain injuries can also occur during activities of daily living, in 
occupational contexts, or during sports and recreation. 
 
Overall, falls are the leading cause of TBI, accounting for more than 50% of TBIs in children 
0 to 14 years of age. The highest percentage (60.7%) of TBIs associated with falls is 
observed in adults 65 years of age or older. Adults 75 years of age or older exhibit the 
highest rates for TBI necessitating hospitalization, as well as the highest TBI-related death 
rates. It is also important to note that from 2002-2006, ED visits for TBI related to falls 
increased by 46% in adults 65 and older, while hospitalization for TBI related to falls 
increased by 34%, and deaths increased by 27% in this age group.  
 
Motor vehicle/traffic-related events are the second leading cause of TBI (17.3%). The 
highest number and rate for TBI-related ED visits for motor vehicle/traffic-related injury is 
observed in adults 20-24 years of age, while the highest number and rate for hospitalization 
is observed in the 15-19 age group. Events in which an individual is struck by/against an 
object is the second leading cause of TBI in children, ages 0 to 14. Assaults account for 
10% of TBIs. 
 
Overall, males are 1.4 times more likely than females to sustain a TBI. However, gender 
disparities become less pronounced with advancing age, and among adults ages 75 or 
older, the number and population rates for TBI-related ED visits for females exceeds that 
for males. With respect to race, Whites exhibit the highest percentage of persons with TBI 
(>78 %). However, Blacks exhibit the highest rate for TBI-related hospitalizations and ED 
visits. 1 Among American Indians and Alaskan Natives (AI/AN), motor vehicle-related 
events and assaults are the leading causes of TBI. 2    Risk factors associated with both the 
occurrence and severity of TBI include non-use of prevention strategies (e.g., seatbelt); 
premorbid psychiatric disorders; and substance use/abuse at time of injury. 3 
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TBI Subtypes 
 
Traumatic brain injuries, which may be mild, moderate or severe, are also classified as 
follows: 
 
Closed Head Injury (CHI) occurs when a blunt force is applied to the head or the head 
strikes an object (e.g., fall to hard surface). These injuries may be associated with skull 
fractures. 
 
Penetrating Head Injury is most often associated with intentional causes of TBI (e.g., 
homicide or suicide attempt) and results from a missile-like object (e.g., bullet) or sharp 
instrument (knife), which forcefully enters the skull and brain. 
 
Crush Injury can occur when large, heavy objects compress the head. These injuries may 
occur in industrial/occupational settings when the head is crushed by equipment or building 
materials, and may also occur when the head is compressed (rolled over) in a motor-
vehicle/traffic-related injury. 
 
Blast Injury is a complex TBI, which results from close exposure to an explosion (e.g., 
Improvised Explosive Device-IED). This type of injury may result in both CHI and 
penetrating TBI and is most commonly observed in military service members who served in 
the Iraq/Afghanistan conflicts (i.e., OIF/OEF veterans). It is important to note that 
individuals who sustain these combat-related injuries are not included in the TBI counts and 
statistical analyses reported by the CDC. Blast TBI is considered the “signature injury” 
sustained by OIF/OEF veterans, and is estimated to occur in approximately 20% of those 
who served. 4 
 
Outcome and Potential Long-Term Consequences 
 
The acute and primary consequences of TBI may include loss of consciousness (LOC), 
which may be brief or prolonged (coma); contusions (bruising) and lacerations of the brain; 
injury to the connecting fibers within the brain ( e.g., axons), referred to as diffuse axonal 
injury (DAI); and other structural injuries related to mechanical forces.  Secondary 
complications may also occur, such as anoxia associated with cardiac and/or respiratory 
arrest; hemorrhages and hematomas (blood mass or clot); elevated intracranial pressure; 
and swelling of the brain (cerebral edema). Recovery and long-term outcome exhibited by 
survivors are related to all the variables described above, as well as age at time of injury, 
and the specific residual neurocognitive, neurobehavioral, sensory and functional 
impairments associated with the sites and severity of injury. 5 
 
Methodology:  
 
Massachusetts does not possess a registry of all persons identified with traumatic brain 
injury. To estimate the magnitude of this health problem in Massachusetts, the statewide 
inpatient hospital, outpatient observation stay and emergency department discharge 
databases were analyzed. These databases are described in detail in Chapter III A. A 
national ICD-9-CM-based consensus definition 6  was applied to these data to develop the  
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counts and rates of discharges for traumatic brain injury among Massachusetts residents. 
This definition (detailed in Appendix B-5) includes diagnosis of fracture of the vault or base 
of the skull; other and unqualified or multiple fractures of the skull; concussion; intracranial 
injury, including contusion, laceration and hemorrhage; injury to the optic chiasm, optic 
pathways or visual cortex; head injury, unspecified; and/or shaken infant syndrome. A 
discharge with an ICD-9-CM code reflecting any of these conditions in any discharge 
diagnosis field of the state databases mentioned above represented a TBI-related case. 
The causes and intents of these injuries are based on the first listed external cause of injury 
code, which is contained in the data for the vast majority of cases related to injury.  
 
Table G1.  Inpatient Hospitalizations, Observation Stays and Emergency Department 
Discharges Associated with a Discharge Diagnosis of Traumatic Brain Injury, MA 
Residents, 2008-2010 
 
Data Source 2008 2009 2010 
Average 
Annual 
Count* 
Average 
Annual 
Percent of 
Total 
Events* 
Average 
Annual 
Rate per 
100,000 
persons 
Inpatient 
Hospitalizations 
6,054 6,359 6,450 6,287 9.4 96.5 
Observation 
Stays 
1,352 1,465 1,484 1,434 2.1 22.0 
Total Hospital 
Stays (Inpatient 
+ Observation) 
7,406 7,824 7,934 7,721 11.5 118.5 
       
Emergency 
Department 
Visits 
52,494 63,039 62,446 59,326 88.5 910.4 
Total Hospital-
treated Events 
(Hospital Stays, 
ED Visits) 
59,900 70,863 70,380 67,048 100 1,028.9 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis. 
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 
 On average, there were 7,721 hospital stays and over 59,000 emergency 
department visits annually related to a diagnosis of TBI among MA residents.  
 
 Over eighteen percent (18.6%) of total hospital stays for TBI were discharged from 
an observation stay bed. These generally represent short duration stays. 
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Table G2.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with a Discharge Diagnosis of 
Traumatic Brain Injury by Age Group, MA Residents, 2008-2010 
Age 
Group 
(Years) 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent of 
Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit 
Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
0 to 2 320 4.1 145.6 5,343 9.0 2,430.6 
3 to 5 87 1.1 39.0 2,568 4.3 1,145.6 
6 to 18 636 8.2 58.9 12,247 20.6 1,134.2 
19 to 21 294 3.8 98.5 3,591 6.1 1,204.6 
22 to 29 527 6.8 74.2 6,738 11.4 948.7 
30 to 39 468 6.1 56.4 5,426 9.1 653.8 
40 to 49 717 9.3 72.2 6,150 10.4 619.4 
50 to 59 812 10.5 88.9 5,181 8.7 567.2 
60 to 69 772 10.0 126.4 3,321 5.6 543.5 
70+ 3,089 40.0 484.9 8,760 14.8 1375.3 
Total 7,721 100 118.5 59,326 100 910.4 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 
 The highest rate of hospital stays for TBI were among residents 70 years of age and 
older, with a rate four times that of the population as a whole.  
 
o The vast majority (88%) of the TBI-related hospital stays in this age group 
were associated with an unintentional fall (data not shown). 
 
o Infants and children 0-2 years and persons 60-69 years of age had the 
second highest rates (these two age groups were statistically comparable). 
 
 The highest rate of emergency department discharges for TBI was among children 
0-2 years of age, over two times that of the general population.  
 
o The vast majority (81%) of the TBI-related emergency department discharges 
in this age group were associated with an unintentional fall (data not shown). 
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Table G3.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with a Discharge Diagnosis of 
Traumatic Brain Injury by Sex, MA Residents, 2008-2010 
 
Sex 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent of 
Total 
Hospital 
Stay* 
Average 
Annual 
Hospital 
Stay Rate 
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit 
Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
Female 3,352 43.4 99.6 27,401 46.2 814.3 
Male 4,369 56.6 138.6 31,924 53.8 1012.9 
Total 7,721 100 118.5 59,326 100 910.4 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Note: *Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 
 Overall, males had a higher rate of hospital stays and emergency department visits 
for TBI than females.  
 
o Average annual hospital stays associated with TBI were higher in males 
compared with females for individuals ages 0-69 years; however, among  
individuals ages 70 years and older, females predominated (data not shown). 
 
o Average annual emergency department visits associated with TBI were 
higher among males compared with females for individuals ages 0-59 years; 
females outnumbered males for all residents ages 60 years and older (data 
not shown).  
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Table G4.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with a Discharge Diagnosis of 
Traumatic Brain Injury by Race and Ethnicity, MA Residents, 2008-2010 
Race/Ethnic 
Group 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent 
of Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate per 
100,000 
persons 
White, NH 6,239 80.8 122.5 46,254 78.0 907.8 
Black, NH 462 6.0 105.9 4,209 7.1 964.0 
Hispanic 536 6.9 88.1 5,353 9.0 879.4 
Asian, NH 167 2.2 46.2 1,188 2.0 329.0 
Other/ 
Unknown 
317 4.1  2,322 3.9  
Total 7,721 100 118.5 59,326 100 910.4 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.  
Notes:*Column counts may not add to total and column percentages may not add to 100 due to rounding. 
Other and unknown race counts include discharges among patients listed as Native Hawaiian, Pacific 
Islander, American Indian or Alaska Native, "other" race and unknown race; rates are not able to be 
calculated for this category. 
‘NH’ indicates non-Hispanic. 
 
 White, non-Hispanics had the highest crude rate of hospital stays for TBI, while 
Asian, non-Hispanics had the lowest. 
 
o After adjusting for age, there was no statistical difference in rates among 
White, non-Hispanics, Black, non-Hispanics, or Hispanics.  
 
 Black, non-Hispanics had the highest crude rate of emergency department visits for 
TBI, while Asians had the lowest. 
 
o After adjusting for age, rates among White and Black non-Hispanics were 
statistically similar. 
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Table G5.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with a Discharge Diagnosis of 
Traumatic Brain Injury, by Executive Office of Health and Human Services (EOHHS) 
Region of Residence, MA Residents, 2008-2010 
 
EOHHS 
Region 
Average 
Annual 
Hospital 
Stay 
Count* 
Percent 
of Total 
Hospital 
Stays* 
Average 
Annual 
Hospital 
Stay Rate 
per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit 
Count* 
Percent of 
Total 
Emergency 
Department 
Visits* 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
I.   Western 1,065 13.8 128.1 6,146 10.4 739.5 
II.  Central  1,083 14.0 126.8 7,852 13.2 919.2 
III. Northeast  1,563 20.2 121.6 13,267 22.4 1032.0 
IV.MetroWest 1,668 21.6 110.3 13,560 22.9 896.5 
V. Southeast  1,335 17.3 105.4 11,679 19.7 921.5 
VI. Boston 
     Region 
1,004 13.0 131.1 6,796 11.5 887.3 
Total 
7,721 100 118.5 59,326 100 910.4 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Note:*Column counts may not add to total and column percentages may not add to 100 due to rounding. 
 
 Residents of the MetroWest and Northeast regions had the highest average annual 
numbers of hospital stays for TBI.  
 
o MetroWest and Southeast region residents had the lowest age adjusted rates 
per 100,000 residents (data not shown). 
 
 Average annual emergency department visits were also highest in residents of the 
MetroWest and the Northeast regions.  
 
o Age adjusted rates of emergency department visits for TBI per 100,000 
residents were highest in residents of the Northeast region and lowest in 
residents of the Western region (data not shown).  
 
 Note: The regional differences in rates may reflect differences not controlled for 
during age adjustment and/or care provided outside the state and not captured by 
these databases. 
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Table G6.  Average Annual Counts and Crude Rates of Hospital Stays and 
Emergency Department Discharges Associated with a Discharge Diagnosis of 
Traumatic Brain Injury, by Mechanism/Intent of Injury, MA Residents, 2008-2010 
 
Mechanism 
and Intent 
Average 
Annual 
Hospital 
Stay 
Count 
Percent 
of Total 
Hospital 
Stays 
Average 
Annual 
Hospital 
Stay 
Rate per 
100,000 
persons 
Average 
Annual 
Emergency 
Department 
Visit Count 
Percent of 
Total 
Emergency 
Department 
Visits 
Average 
Annual 
Emergency 
Department 
Visit Rate 
per 100,000 
persons 
Unintentional 
Fall 
4,527 58.6 69.5 27,830 46.9 427.1 
Unintentional 
Struck 
by/Against 
272 3.5 4.2 11,823 19.9 181.4 
Unintentional 
Motor Vehicle 
Traffic 
1,314 17.0 20.2 8,230 13.9 126.3 
Unintentional 
(All Other 
Mechanisms 
not listed 
above and 
Unspecified 
Mechanism) 
481 6.2 7.4 3,644 6.1 55.9 
Suicide/Self-
Inflicted (All 
mechanisms) 
39 0.5 0.6 85 0.1 1.3 
Homicide/ 
Assault (All 
mechanisms) 
498 6.5 7.6 5,299 8.9 81.3 
Other Intents 23 0.3 0.3 1,126 1.9 17.3 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Notes: ”Other intents” includes undetermined intent and other intent. Column percentages and totals may not 
add up to 100% of cases (N= 7,721 hospital stays and N= 59,326 emergency department visits) due to 
missing cause and intent information.  
 
 The majority of hospital stays (58.6%) for TBI were related to an unintentional fall. 
Motor vehicle traffic crashes accounted for 17% of these hospital stays. 
 
 Among emergency department visits for TBI, 46.9% were related to a fall, while 
almost 20% were related to a strike by/against an object or person. At least 30% of 
the strike by/against injuries occurred in sports (data not shown).  
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Table G7.  Average Annual Primary Payer Type Category for Inpatient 
Hospitalizations, Observation Stays and Emergency Department Discharges 
Associated with a Discharge Diagnosis of Traumatic Brain Injury, MA Residents, 
2008-2010 
 
Payer Type Category 
Percent of Inpatient 
Hospitalization 
Totals 
Percent of 
Observation Stay 
Totals 
Percent of 
Emergency 
Department Visit 
Totals 
Medicaid 10.5 15.6 17.9 
Medicare 47.9 27.0 18.5 
Commercial Insurer 24.8 38.0 42.9 
Other Government 
Payment 
1.0 ** 0.9 
Free Care or Health 
Safety Net 
3.0 2.6 2.5 
Worker's 
Compensation 
1.5 1.7 4.0 
Auto Insurance 8.0 9.5 7.0 
Commonwealth Care 
Plans 
1.5 ** 1.6 
Self Pay 1.7 3.2 4.7 
 
Sources: MA Inpatient Hospital, Outpatient Observation Stay, and Emergency Department Discharge 
Databases, Center for Health Information and Analysis.   
Notes:** denotes suppressed values reflecting a percentage based on a count of 1-10. Column percentages 
may not add up to 100% due to missing and invalid values. 
 
 
 Medicare was the primary payer category listed for almost half (47.9%) of inpatient 
hospitalizations associated with TBI, while commercial insurers and Medicaid ranked 
second and third (24.8% and 10.5%, respectively).  
 
 Commercial insurance was the leading primary payer type category for emergency 
department visits for TBI, accounting for 42.9% of all visits. Medicare and Medicaid 
ranked second and third (18.5% and 17.9%, respectively).  
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Table G8.  Average Annual Inpatient Hospitalizations Associated with a Discharge 
Diagnosis of Traumatic Brain Injury, by Discharge Disposition Category and Age 
Group, MA Residents, 2008-2010 
 
Disposition 
Category 
Age Category 
 
0-21 years 22-49 years 50-64 years 65+years Total 
In-Hospital 
Death  
20 58 52 249 378 
Home with or 
without 
Services 
809 944 620 1,113 3,485 
Medicare Long 
Term Hospital 
1-10 17 ** 58 96 
Psychiatric  
Hospital 
1-10 15 ** 14 47 
Rehabilitation 
Hospital or Unit 
51 176 153 433 814 
Rest Home 0 0 0 1-10 1-10 
Shelter 0 0 1-10 0 1-10 
Skilled Nursing 
Facility 
1-10 35 97 1,129 1,267 
Short Stay 
Hospital 
1-10 ** 23 69 118 
Other Facility‡ 1-10 1-10 13 59 90 
Other† 1-10 53 28 ** 104 
Total 922 1,325 1,015 3,141 6,403 
 
Sources: MA Inpatient Hospital Discharge Database, Center for Health Information and Analysis.   
Notes:** denotes complementary suppressed values to protect calculation of values in the cells with a count 
of 1-10. Total includes all dispositions except cases of unknown disposition.  
† “Other” includes “left against medical advice” and “discharge other.” 
‡ “Other Facility” includes intermediate care facility, hospice medical facility, federal healthcare facility and 
“another type of institution not defined elsewhere.”  
Additional detail on disposition categories can be found in Chapter III A.  
 
 The majority (54%) of inpatient hospitalizations resulted in individuals being 
discharged to home, with or without services; 19.7% were discharged to a skilled 
nursing facility, and 12.7% were discharged to a rehabilitation hospital.  
 
 Among individuals discharged to home, only 23% were listed as discharged to home 
with services such as home health care, IV therapy, or hospice services.  
 
 Almost six percent of inpatient hospitalizations for TBI during this period resulted in 
the individual dying during the hospitalization.  
 
 The mean and median lengths of stay for TBI-related inpatient hospitalizations in 
2010 were 5.3 days and 3 days, respectively (data not shown). 
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Summary of Findings: 
 
 There were an average of over 7,700 hospital stays and over 59,000 emergency 
department visits associated with a traumatic brain injury annually among MA 
residents for the time period studied. 
 
 Hospital stay rates were highest among adults 70 years of age and older, while 
children 0-2 years of age had the highest rates of emergency department-treated 
TBI.  
 
 Although most persons with TBI treated in the inpatient setting were discharged 
home, a sizable proportion of individuals were discharged to facilities providing 
specialized care, such as skilled nursing facilities, and Medicare long term hospitals.  
 
 Only 12.7% of all individuals were discharged to a rehabilitation hospital or unit. 
Among children and youth 0-21 years of age, only 6% were discharged, on average, 
annually to a rehabilitation hospital or unit.   
 
 Medicare and Medicaid were the primary payer for the majority (58.4% combined) of 
inpatient hospitalizations and over one third of emergency department visits for TBI.  
 
Limitations: 
 
 In addition to the limitations described in Chapter III A, these data provide only crude 
TBI severity indicators (i.e., level of care and length of stay). More sophisticated 
measures, often present in trauma registries can be useful in understanding the long 
term impact of these injuries. Massachusetts is in the early development of a 
statewide trauma registry which will provide more detail on injury severity to inform 
resource planning and evaluation.  
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CHAPTER III H: PROGRESSIVE DISORDERS of the CENTRAL NERVOUS SYSTEM 
 
 
Introduction: 
 
Currently, there is no established centralized or mandated reporting system, with respect to 
the progressive disorders of the CNS. It is also important to note that the onset of a 
neurodegenerative disease is usually insidious, and would not result in an acute 
hospitalization or emergency department visit. Thus, analysis of hospital discharge data 
would not adequately capture the magnitude of these diseases and associated conditions. 
Therefore, this chapter is largely descriptive of this category of neurological diseases and 
conditions and does not follow the format of most of the other subchapters in Chapter III. 
 
The degenerative diseases of the central nervous system (CNS) are characterized by a 
gradually progressive course, which may be evidenced in: 
 
 -Deterioration of cognitive capacity, or dementia 
 
 -Progressive movement disorder including ataxia, involuntary movements, dyskinesia, 
and/or other neurological abnormalities (e.g., Parkinson Disease) 
 
 -Motor weakness or paralysis of voluntary muscles (e.g., Amyotrophic Lateral Sclerosis, or 
Lou Gehrig’s Disease) 
 
 -Sensory impairment (e.g., progressive blindness) 
 
 -Neurobehavioral symptoms including hallucinations, psychosis, disinhibition 
 
 -Diminished capacity to independently care for oneself 1 
 
Progressive disorders may occur in the context of acquired disorders of the CNS, which are 
the primary focus of this chapter and discussed below.  
 
Progressive Disorders Associated with Acquired Brain Injury: 
 
The progressive disorders associated with ABI result in a wide range of neurological 
impairments and span all etiological categories. Progression of disease is for most 
disorders slow, and for some diseases, symptoms may not become manifest for years, and 
after a prolonged period of incubation, such as the progressive disorders associated with 
infection. Some rare neurological diseases may be rapidly progressive once symptoms 
become manifest. Detailed below are descriptions of representative examples of acquired 
progressive disorders of the CNS: 
 
AIDS Dementia Complex (ADC) or HIV-Associated Dementia (HAD) is a dementing 
disorder associated with the advanced stages of HIV infection and severe 
immunosuppression, which may be complicated by opportunistic CNS infection and other 
HIV-related CNS conditions. ADC/HAD is an acquired dementia, associated with motor  
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impairment, mental status changes and vacuolar myelopathy (spinal cord pathology). Since 
the introduction of combination highly active antiretroviral therapy (HAART), the incidence 
of ADC/HAD in adults with HIV infection has been significantly reduced. A similar disorder 
occurs in children with AIDS, but this disorder occurs more frequently and results in 
progressive encephalopathy and reversal of developmental milestones associated with 
microcephaly, or developmental delay associated with static encephalopathy. 2 
 
Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease 
associated with repetitive head trauma and evidenced in cognitive impairment, confusion, 
behavioral disinhibition, depression and suicidal behavior. Originally described in boxers 
and referred to as dementia pugilistica or “punch drunk” syndrome, CTE has primarily been 
confirmed on post-mortem examination of the brains of deceased professional and amateur 
athletes, including college and high school athletes, who have experienced multiple  
symptomatic concussions and/or subconcussive hits. Other causes of CTE include 
traumatic brain injuries sustained in military combat and as a result of interpersonal 
violence or self-injurious behavior (e.g., head banging). Onset of symptoms of CTE can 
become manifest within months or years after concussive events. 3 
 
Creutzfeldt-Jakob Disease (CJD) is a fatal degenerative disorder caused by an infectious 
prion protein (see Chapter III C regarding Infectious Diseases associated with Disorders of 
the CNS). Onset may be progressive or sudden, and associated with diffuse loss of 
neurons (nerve cells) within the brain; profound and rapid dementia; and stimulus-sensitive 
myoclonus (abnormal muscle contractions).  
 
Delayed Postanoxic Encephalopathy and Leukoencephalopathy is a rare and poorly 
understood disorder characterized by a period of recovery (1-4 weeks) after an anoxic 
episode, followed by deterioration of mental status and cognitive capacity. While some may 
recover from this second episode, others exhibit progressive deterioration, associated with 
neuropathological changes in the white matter of the brain (leukoencephalopathy) and the 
basal ganglia resulting in parkinsonian symptoms. This syndrome is most often observed in 
individuals who have experienced carbon monoxide poisoning, but may occur after other 
types of anoxic events reviewed in the chapter on metabolic disorders (Chapter III D) of the 
CNS. 4 
 
Multi-infarct Dementia (MID) results from the cumulative effects of multiple strokes, which 
may present with observable neurological findings or more subtle symptoms (i.e., so-called 
“silent strokes”). Binswanger Disease, a type of vascular dementia, is associated with 
diffuse degeneration of the subcortical white matter within the brain (leukoaraiosis), 
hypertension, and small vessel atherosclerosis resulting in ischemic changes or strokes. 
Progressive neurocognitive impairment may occur in a gradual or step-like fashion, and 
other clinical symptoms associated with Binswanger Disease include gait disorder, 
personality changes, and depression  5, 6 (see Chapter III F regarding neurovascular 
disorders for detailed review of stroke).  
 
Neurosyphilis refers to invasion of the CNS by Treponemapallidum, which causes 
syphilis, a sexually-transmitted disease (STD). Since World War II and the introduction of 
treatment with penicillin, the incidence of syphilis has declined significantly. The CDC  
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estimates that, on average, 55,400 people are diagnosed with syphilis in some stage in the 
U.S., and therefore at risk for acute brain injury as a result of the infection. While historically 
syphilis primarily occurred among heterosexual men and women of racial and ethnic 
minority groups, since 2000 the largest numbers of cases have been documented among 
men who have sex with men (MSM). 7 The most common initial neurological manifestation 
of syphilis within the CNS is meningitis. Approximately 15-20 years after an original, 
untreated syphilis infection, individuals may present with paretic neurosyphilis, also referred 
to as general paresis or dementia paralytica, a progressive disorder. Associated findings 
include ocular abnormalities, seizures, neuropsychiatric symptoms, and lesions of the 
spinal cord (tabesdorsalis or tabetic neurosyphilis).   
 
Paraneoplastic Disorders include a group of rare neurological conditions representing the 
remote effects of cancers outside the CNS (e.g., small cell cancer of the lung) and an 
autoimmune response. Paraneoplastic disorders are characterized by the relatively rapid 
development of a broad range of neurological symptoms, which may include seizures; 
mental status changes (e.g., confusion, hallucinations, delusions); polyneuropathy; 
retinopathy; cerebellar degeneration; and dementia. 8 
 
Progressive Multifocal Leukoencephalopathy (PML) is a degenerative white matter 
disease (leukoencephalopathy) caused by a human polyomavirus, designated as the JC 
virus (JCV). Individuals living with immunocompromising conditions, including HIV infection, 
are most commonly diagnosed with PML, and other at-risk populations include individuals 
treated with immunosuppressive chemotherapy for autoimmune disorders, including 
multiple sclerosis, systemic lupus erythematosis and rheumatoid arthritis. Clinical 
symptoms associated with PML include progressive paralysis, mental status changes, 
visual impairment (e.g., cortical blindness), aphasia, and neurocognitive impairment. 9 
 
Subacute Combined Degeneration (Combined System Disease) is a degenerative 
disorder affecting the white matter (myelin) of the spinal cord and brain, which results from 
Vitamin B12 (cobalamin) deficiency or malabsorption. Clinical presentation includes 
progressive muscle weakness, paresthesias (e.g., “pins and needles” sensation), sensory 
loss (e.g., visual impairment secondary to optic neuropathy), neurocognitive impairment 
and neuropsychiatric disorder. Persons at risk for this disorder include individuals 
diagnosed with pernicious anemia, prolonged use of antacid medication (e.g., proton pump 
inhibitors: PPIs), small intestine disease, and other nutritional absorption disorders. 10, 11 
 
Subacute Sclerosing Panencephalitis (SSPE) is a fatal, progressive neurological 
disorder related to measles (rubeola), primarily affecting children and young adults, with a 
higher incidence in males than females. Clinical presentation includes cognitive 
deterioration, uncontrollable jerking movements (myoclonic jerks), and mental status 
changes. The incidence of SSPE in the United States has declined significantly as a result 
of widespread immunization with the measles vaccine. 12 
 
Wernicke-Korsakoff Syndrome refers to two neurological disorders associated with 
Vitamin B1 (thiamine) deficiency. Wernicke disease, or encephalopathy, (reviewed in the 
chapter on metabolic disorders affecting the CNS) is characterized by oculomotor 
abnormalities, confusion and ataxia. The memory disorder which occurs subsequent to the 
occurrence of Wernicke disease is referred to as Korsakoff amnesia or psychosis, and 
when neurocognitive impairment persists, Wernicke-Korsakoff syndrome. This disorder 
primarily, but not exclusively, occurs in alcoholics. Other at risk groups include the elderly 
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who are malnourished, individuals with anorexia nervosa, and women who experience 
extreme vomiting during pregnancy (hyperemesis gravidarum), as well as those who have 
undergone bariatric surgery or who require long-term dialysis or treatment with diuretics. 
Untreated, Wernicke disease is potentially fatal, while the neurocognitive and neurological 
symptoms associated with Wernicke-Korsakoff syndrome are progressive and associated 
with degenerative lesions within the CNS. 13 
 
Other Progressive Disorders of the CNS 
 
Most progressive disorders of the CNS occur spontaneously, while some are hereditary 
(e.g., Huntington Disease or Chorea) or familial (heredodegenerative).  Some 
neurodegenerative disorders are associated with multiple risk factors (e.g., multiple 
sclerosis: MS). The majority of individuals diagnosed with progressive disorders of the CNS 
are older adults (i.e., 60 years or older), but degenerative disorders of the CNS can occur 
at any age. 
 
The most common degenerative disease associated with dementia is Alzheimer’s Disease. 
It is estimated that 5.2 million individuals, two-thirds of whom are women, are currently 
living with Alzheimer’s Disease in the United States. In Massachusetts, approximately 
120,000 people, age 65 and older, are estimated to have Alzheimer’s Disease. 14 Another 
leading degenerative disorder is Parkinson’s Disease, an extrapyramidal disorder 
associated with depletion of the neurotransmitter dopamine. An estimated 500,000 
individuals in the U.S. are living with Parkinson’s Disease, and 50,000 new cases are 
reported annually. 15 
 
Outcome and Potential Long-Term Consequences 
 
The majority of degenerative disorders of the CNS are irreversibly progressive and fatal, 
secondary to the lack of efficacious treatment interventions. However, the natural history, 
survival rates, and manifestations of these disorders vary with the etiology; the presence 
and severity of the underlying disease (e.g., stage of HIV infection); the specific nerve cells 
(neurons) affected, and their functional relationship to other cells and systems within the 
CNS. For certain progressive disorders intervention with medication may provide 
symptomatic relief (e.g., L-dopa for Parkinson’s Disease); may serve to halt the progression 
of disease (e.g., antibiotics for treatment of neurosyphilis); or may result in remission (e.g., 
treatment of PML with combination highly active antiretroviral therapy).  
 
 References: 
1. Ropper AH, Samuels MA, Klein JP. Degenerative diseases of the nervous system. In: 
Adams and Victor’s Principles of Neurology. 10thed. New York, NY: McGraw-Hill 
Education; 2014: 1060-1131. 
 
2. HIV InSite. University of California, San Francisco Medical Center website. 
http://hivinsite.ucsf.edu/InSite?page=kb-04-01-03#S3X Accessed June 1, 2014. 
 
3. What is CTE ? CTE Center, Boston University website. 
http://www.bu.edu/cte/about/what-is-cte/  Accessed May 13, 2014.  
 
 85 
 
4. Posner JB, Saper CB, Schiff ND, Plum F. Plum and Posner’s Diagnosis of Stupor and 
Coma. 4thed. New York, NY: Oxford University Press; 2007. 
 
5. NINDS Multi-Infarct Dementia Information Page. National Institute of Neurological 
Disorders and Stroke website. 
http://www.ninds.nih.gov/disorders/multi_infarct_dementia.htm  Accessed May 14, 
2014. 
 
6. NINDS Binswanger’s Disease Information Page. National Institute of Neurological 
Disorders and Stroke website. 
http://www.ninds.nih.gov/disorders/binswangers/binswangers.htm  Accessed May 13, 
2014. 
 
7. Syphilis-CDC Fact Sheet. Centers for Disease Control and Prevention website. 
http://www.cdc.gov/std/syphilis/STDFact-Syphilis-detailed.htm  Accessed May 13, 
2014. 
 
8. NINDS Paraneoplastic Syndromes Information Page. National Institute of Neurological 
Disorders and Stroke website. 
http://www.ninds.nih.gov/disorders/paraneoplastic/paraneoplastic.htm  Accessed May 
13, 2014. 
 
9. NINDS Progressive Multifocal Leukoencephalopathy Information Page. National 
Institute of Neurological Disorders and Stroke website.  
http://www.ninds.nih.gov/disorders/pml/pml.htm Accessed May 14, 2014. 
 
10. Subacute Combined Degeneration. U.S. National Library of Medicine, National 
Institutes of Health website. 
http://www.nlm.nih.gov/medlineplus/ency/article/000723.htm  Accessed May 14, 2014. 
 
11. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 
receptor antagonist use and vitamin B12 deficiency. JAMA. 2013; 310 (22): 2435-2442. 
doi:10.1001/jama.2013.280490 
 
12.   NINDS Subacute Sclerosing Panencephalitis Information Page.  National Institute of       
Neurological Disorders and Stroke website.       
http://www.ninds.nih.gov/disorders/subacute_panencephalitis/subacute_panencephali
tis.htm  Accessed August 15, 2014. 
 
13.   Wernicke-Korsakoff Syndrome. U.S. National Library of Medicine, National Institutes 
         of Health website. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001776/     
         Accessed May 14, 2014. 
 
14.   Alzheimer’s Facts and Figures. Alzheimer’s Association website.   
  http://www.alz.org/alzheimers_disease_facts_and_figures.asp#quickFacts  Accessed   
  May 12, 2014.  
 
 
 
 86 
 
15.   Parkinson’s Disease Backgrounder. National Institute of Neurological Disorders and   
  Stroke website. 
http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease_backgrou
nder.htm  Accessed May 14, 2014. 
 
  
 87 
 
CHAPTER III I: SUMMARY of DATA FINDINGS 
 
1. Acquired brain injury (ABI), as defined in Chapters III A- III H in this report, is a 
substantial public health problem in Massachusetts. Figure B summarizes the 
average annual number of hospital stays and Figure C, the average annual number 
of emergency department visits (2008-2010), associated with selected categories of 
ABI, including traumatic brain injury, stroke, ABI-related infectious diseases, and 
metabolic disorders affecting the central nervous system. During the same time 
period, 1,272 primary brain and CNS tumors (excluding the spinal cord) were newly 
diagnosed in Massachusetts residents on average, annually. 
 
 
2. Consistent with national epidemiological data, the leading causes of ABI-related 
hospitalization and ED visits in Massachusetts, for the categories quantified in this 
report, were traumatic brain injury (TBI) and stroke. 
 
3. Individuals who sustain an ABI associated with many metabolic diseases and 
conditions (see Chapter III D for discussion); most neurotoxic disorders (see Chapter 
III E for discussion); and progressive/neurodegenerative disorders of the central 
nervous system (CNS) reviewed in Chapter III H are not represented or 
underestimated in the discharge data analyzed for this report. As noted in the 
methodology sections of the chapters referenced, as well as the data considerations 
reviewed in Chapter III A, these disorders/diseases are not captured due to the lack 
of a specific ICD-9-CM code for the disorder (e.g., HIV encephalopathy), or because 
an acute hospitalization or emergency department visit would not have been 
necessitated at the time the diagnosis was made (e.g., diagnosis of Alzheimer’s 
Disease). 
 
4. The majority of hospital stays for metabolic disorders affecting the central nervous 
system, stroke, and TBI  were among persons 60 years of age or older. These older 
adults represented 50% of hospital stays for TBI; 84% for stroke; and 58% for 
metabolic disorders affecting the CNS. In addition, approximately 50% of both 
malignant and benign brain and CNS tumors (excluding the spinal cord) are newly 
diagnosed in adults 60 years or older. 
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     Figure B. Average Annual Number of Hospital Stays 
Associated with Select Categories of ABI, MA Residents, 2008-2010 
 
 
Sources: MA Inpatient Hospital and Outpatient Observation Stay Databases, Center for Health Information 
and Analysis 
Note: Categories are not mutually exclusive. 
 
 
  
Figure C. Average Annual Number of Emergency Department Visits 
Associated with Select Categories of ABI, MA Residents, 2008-2010 
 
 
 
Source: MA Emergency Department Discharge Database, Center for Health Information and Analysis 
Note: Categories are not mutually exclusive. 
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 5. With respect to sex, analyses revealed that: 
 Females had an elevated average annual rate of non-malignant brain and 
CNS tumors (excluding the spinal cord) compared with males. The rates by 
sex for malignant brain tumors were similar. 
 Males had a higher average annual rate of hospital stays and emergency 
department visits for metabolic disorders affecting the CNS compared with 
females. 
 Average annual hospital stay and emergency department visit rates for stroke 
were comparable for males and females.  
 Males had a higher average annual rate of hospital stays and emergency 
department visits for TBI than females. 
 
6. Regarding differences related to race/ethnicity, analyses revealed that: 
 White, non-Hispanics had elevated crude rates of malignant brain and CNS 
tumors (excluding the spinal cord), when compared to Hispanics. 
 Black, non-Hispanics and Hispanics had higher crude rates of hospital stays 
and emergency department visits for infectious disease-related ABI, 
compared with White and Asian non-Hispanics. 
 White, non-Hispanics and Black, non-Hispanics had the highest crude rates 
of hospital stays for metabolic disorders affecting the CNS compared with 
other racial/ethnic groups, while White, non-Hispanics had the highest crude 
rates of emergency department visits for these conditions. 
 White, non-Hispanics had the highest crude rate of hospital stays and 
emergency department visits for stroke, in comparison to all other 
racial/ethnic groups. 
 White, non-Hispanics had a higher average annual crude rate of TBI-related 
hospital stays, while Black, non-Hispanics had a higher crude rate of 
emergency department visits, when compared with other racial/ethnic groups. 
 
7.  Children and young adults (i.e., ages 0-21 years of age) accounted for an average of   
17% of the hospital stays and 40% of the emergency department visits for ABI associated 
with traumatic brain injury annually. Infants and children ages 0-2 years had the highest rate 
for TBI-related emergency department visits and the second highest rate for hospital stays. 
Among children and youth 0-18 years of age, infants and children ages 0-2 years also 
exhibited the highest rates for both emergency department visits and hospital stays for 
metabolic disorders affecting the CNS and for infectious disease-related ABI. Children and 
young adults, ages 0-21 years of age also represented 27% of hospital stays and 34% of 
emergency department visits for infectious disease-related ABIs. 
 
8.  Figures D and E depict the average annual number of hospital stays and emergency 
department visits for select categories of ABI by Executive Office of Health and Human 
Services region of residence. Please see respective chapters for a listing of the counts. 
Note, as previously mentioned, these categories are not necessarily mutually exclusive. 
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Figure D. Average Annual Number of Hospital Stays Associated with    
Select Categories of ABI by Executive Office of Health and Human Services  
Region of Residence, 2008-2010, MA Residents 
 
 
 
 
  
 
Sources: MA Inpatient Hospital and Outpatient Observation Stay Databases, Center for Health Information 
and Analysis 
Note: Categories are not mutually exclusive. 
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Figure E. Average Annual Number of Emergency Department Visits Associated with  
 Select Categories of ABI by Executive Office of Health and Human Services 
 Region of Residence, 2008-2010, MA Residents 
 
 
 
Source: MA Emergency Department Discharge Database, Center for Health Information and Analysis 
Note: Categories are not mutually exclusive. 
 
 
 
9. Analyses of data by primary payer and insurance at diagnosis for primary brain and 
CNS tumors (excluding the spinal cord) found that public payer sources (i.e., Medicaid, 
Medicare, Free Care/Health Safety Net, Other Government Payment, and 
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10. The majority of inpatient hospitalizations associated with TBI, infectious-disease related 
ABI, metabolic disorders affecting the CNS and stroke did not result in the individuals being 
transferred to either a rehabilitation hospital or rehabilitation unit within a hospital. Most 
resulted in the individual being discharged home without services or with in-home services 
(i.e., IV therapy services), including 54% of those with a diagnosis of TBI; 50% of those with 
a diagnosis of stroke; and 70% of those with an infectious disorder affecting the CNS. 
Approximately 20% of inpatient hospitalizations associated with a diagnosis of TBI resulted 
in the individuals being discharged/transferred to a skilled nursing facility, compared with 
19.7% associated with stroke, 21.7% of discharges for  metabolic conditions associated 
with ABI, and 8.9% of for infectious disorders associated with ABI.  Fourteen percent of 
stroke-related inpatient hospitalizations resulted in individuals being discharged to a 
rehabilitation hospital/unit compared with 12.7% of hospitalizations associated with TBI. 
11. The majority of inpatient hospitalizations associated with TBI, stroke, infectious-disease 
related ABI, and metabolic disorders affecting the CNS, resulted in individuals surviving 
their hospitalization (94.1%, 92.1%, 96.1%, and 74.6%, respectively). 
Final Note: As stated in the preceding subchapters, these data provide only estimates of 
total discharges for select causes of ABI, with limited information in regards to severity or 
duration of impairment. The high degree of variability in patient outcomes presents a 
challenge for assessment of services required by individuals with a discharge for a 
condition associated with ABI. 
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CHAPTER IV: PREVENTION of ACQUIRED BRAIN INJURY - CURRENT 
STRATEGIES and INITIATIVES 
 
Traumatic Brain Injury Prevention 
Fall-related Traumatic Brain Injury Prevention Initiatives: 
 
Falls are the leading cause of traumatic brain injuries in Massachusetts and nationally. The 
Massachusetts Department of Public Health’s Division of Violence and Injury Prevention 
has had a strong role in promoting the prevention of older adult falls, beginning as a co-
founder of the statewide MA Falls Prevention Coalition in 2007.  In the early years, the 
Coalition received funding to host three Falls Prevention symposia, and initiated a Keys to 
Your Independence social marketing campaign, which included a toll-free information line 
within MDPH that is still active today (1-800-227-SAFE).  The current Coalition is chaired 
by representatives from MDPH, the MA Senior Care Association, and the Home Care 
Alliance of MA and maintains a broad-based voluntary membership of over 100 that 
includes members from the Brain Injury Association of MA and injury 
prevention/rehabilitation hospital communities.  The Coalition holds an annual Falls 
Prevention Awareness Day event at the MA State House each September, joining a 
national effort that occurs each fall season to recognize the importance of raising 
awareness about preventing falls, sponsored by the National Council on Aging.   
 
MDPH is also responsible for facilitating the work of the MA Commission on Falls 
Prevention; MDPH chairs this 11 member statutory body of stakeholders (created by a 
health care reform law passed in 2010) that is charged with studying the impact of falls on 
older adults in MA and recommending strategies to legislators and state policymakers on 
how to reduce the injuries and health care costs associated with them.  The Commission’s 
first report: “Phase 1 Report: The Current Landscape” was submitted in September 2013.1 
 
MDPH’s Division of Violence and Injury Prevention is also the recipient of a 5-year CDC 
Core Injury grant, under which reduction of falls among older adults is a focal area and part 
of a strategic plan for prevention of unintentional injury in the state.  In the past year, the 
grant has afforded MDPH the opportunity to sponsor an evidence-based “Tai-Chi for 
Healthy Aging” instructor program in three regions of the state to help proliferate availability 
of these programs to older adults in their communities.  
Finally, fall injury prevention in older adults is one of four priority health conditions being 
addressed through the distribution of more than $40 million in grants, which were awarded 
to nine community-based partnerships in Massachusetts. This effort, the Prevention and 
Wellness Trust Fund, which was created by the Legislature and administered by the 
MDPH, aims to help fight chronic illness and improve health outcomes while reducing 
health care costs. Funding to these communities will be used to improve clinical screening 
of fall risk factors, referrals for and management of these risks and for the development of 
community-based fall prevention activities, such as tai chi and other methods aimed at 
improving strength and balance among older adults.  
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Prevention of Falls Related to Work in Construction: 
Falls to a lower level are also a leading cause of work-related injury deaths in 
Massachusetts. There are also hundreds of non-fatal work-related falls to lower levels each 
year. The majority of these work-related falls occur in the construction industry. The 
prevention of falls in construction has been identified by MDPH as an occupational health 
priority. MDPH’s occupational Fatality Assessment and Control Evaluation (FACE) Project, 
funded by CDC, conducts in-depth investigations of work-related falls to identify 
contributing factors and uses these case reports to disseminate prevention 
recommendations to contractors, construction workers and other stakeholders through the 
state.2  FACE has also developed a series of education materials (available in multiple 
languages) on preventing falls from ladders, scaffolding and roofs in residential 
construction that are disseminated through city and town building permit offices, and other 
venues. In 2013-14, MDPH collaborated with the Massachusetts Department of Labor 
Standards (DLS), other state agencies and the Occupational Health and Safety 
Administration (OSHA) in promoting the “Safety Pays, Falls Cost” national campaign to 
prevent falls in construction.3 Campaign posters were displayed throughout the state on 
public buses, the MBTA subway and the digital billboards along the state highways. Emails 
with links to resources on fall prevention in construction went out to over 28,000 
Massachusetts licensed residential construction contractors, and DLS and OSHA held 
multiple fall prevention trainings for contractors.  
 
Sports-related Traumatic Brain Injury Prevention Initiatives: 
Following passage of state legislation on sports concussions in 2010, the Massachusetts 
Department of Public Health, in partnership with key stakeholders, has worked extensively 
to ensure that these injuries are recognized as soon as possible and managed 
appropriately. The state has developed regulations requiring standardized procedures for 
students, coaches, school, parents and medical professionals on prevention, training, 
management and return to activity decisions, and is actively implementing these policies 
within Massachusetts middle and high schools to reduce the long term health impact of 
sports-related concussions for student athletes. 
Motor Vehicle-related Traumatic Brain Injury Prevention Initiatives: 
The Massachusetts Department of Public Health is involved in a number of prevention 
initiatives to reduce motor vehicle injuries. These include a project, in partnership with the 
Registry of Motor Vehicles (RMV), examining and improving the effectiveness of the 
statutorily required two-hour training class for parents of novice teen drivers. Evidence 
shows that parents are the best enforcers of Junior Operator License (JOL) restrictions. 
The JOL law has been shown to reduce motor vehicle occupant injuries in this high-risk 
group.  
Belts Ensure a Safer Tomorrow (BEST) is a statewide coalition of concerned stakeholders 
working to change the state’s seat belt law from secondary to primary enforcement. The 
MDPH supports this effort by providing technical support and data sharing. Additionally, 
since research shows that ignition interlocks decrease injuries related to driving under the 
influence of alcohol, the MDPH plans to increase awareness around this to policymakers. 
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MDPH also provides data and technical assistance to a variety of MA transportation 
partners and to policymakers on issues related to other forms of transportation---including 
bicycle and pedestrian safety – all in an effort to reduce injuries in the Commonwealth. 
Traumatic Brain Injury Prevention – Surveillance Initiatives: The Massachusetts 
Department of Public Health’s Injury Surveillance and Prevention Program utilizes 
numerous statewide databases to provide data on traumatic brain injuries to public health 
professionals involved in strategic planning (for priority setting and establishment of 
performance measures), policy makers, researchers, and advocates. These data have 
been incorporated into the MDPH Strategic Plan for Unintentional Injury Prevention, the 
Massachusetts Strategic Highway Safety Plan (SHSP),4  and the Massachusetts Falls 
Commission’s Phase I Report (referenced above).  In addition, these data are used by 
numerous advisory boards and are incorporated into local, state and national 
presentations.  
Stroke Prevention 
The Massachusetts Department of Public Health’s Division of Prevention and Wellness 
supports state and local efforts to promote a heart-healthy, stroke-free environment to help 
everyone in Massachusetts reach their full potential for optimal health. Work within the 
division contributes to several statewide and national programs and initiatives that aim to 
reduce disparities, disease, disability, and death related to heart disease, stroke and 
corresponding risk factors through evidence-based policy and environmental changes, 
education, quality improvement, and partnerships. Programs and initiatives include:  
 Massachusetts Coordinated Health Promotions and Chronic Disease Prevention 
Plan: Among the goals outlined in this plan is to prevent 20,000 heart attacks and 
strokes by 2017 through coordination of chronic disease prevention strategies that 
focus on shared barriers and risk factors. 
 
 FAST (Face, Arm, Speech, Time): This campaign provides awareness of common 
signs and symptoms of stroke to the public. 
 
 Paul Coverdell Acute Stroke Registry: Data are submitted to the Massachusetts 
Department of Public Health from 51 of the 70 Primary Stroke Service hospitals in 
the state in order to identify opportunities for quality improvement in the treatment of 
stroke patients. 
 
 Million Hearts Campaign: Million Hearts aims to prevent 1 million heart attacks and 
strokes by 2017 through improved access to effective, quality care; promotion of a 
heart-healthy lifestyle; and focusing clinical attention on prevention of these events. 
 
 Prevention and Wellness Trust Fund: The Trust, described in the section on 
Traumatic Brain Injury Prevention, supports community-based partnerships including 
municipalities, healthcare systems, businesses, regional planning organizations, and 
schools. These groups work together to provide research-based interventions that 
will reduce rates of the most prevalent and preventable health conditions, including 
hypertension, a major risk factor for stroke. 
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Prevention of Infectious Disease Affecting the Central Nervous System 
Historically, the major vaccine preventable diseases of childhood were significant causes of 
CNS injury.  On a worldwide basis, diseases such as measles, continue to cause significant 
neurological damage, but vaccines for most of the serious childhood diseases have almost 
eliminated these conditions in the United States.  Meningococcal meningitis and meningitis 
due to Haemophilus influenzae type b have been made rare diseases with the use of 
effective vaccines.  Massachusetts has had, and continues to have, the highest levels of 
childhood immunization in the country and this translates into a rarity of CNS complications 
of vaccine preventable diseases. The Commonwealth has an effective public-private 
collaboration among public health and pediatric care providers, a universal vaccine 
distribution system, and an expanding immunization registry that will contribute to assuring 
the highest possible immunization rates. 
CNS complications from non-vaccine preventable infections have been reduced by 
effective surveillance and disease control programs and by antimicrobial agents.  The 
public health programs involve monitoring disease trends, outbreak investigation, case 
finding and treatment, and application of isolation and quarantine.  For example, effective 
tuberculosis control programs have depended on case finding and treatment, and rates of 
tuberculosis in Massachusetts are low, with only a small number of CNS tuberculosis cases 
identified.   Future success will not only depend on continuing efforts to render active 
tuberculosis cases non-infectious, but also on identifying people with latent tuberculosis 
infection before they progress to active disease and treating them to prevent active disease 
from developing.  Likewise, identification and treatment of active syphilis cases needs to be 
combined with efforts to screen those at higher risk and treat them before infection 
manifests as disease.  Early antibiotic therapy of Lyme disease can reduce the risk of 
subsequent CNS involvement. 
Vector-borne diseases, such as viral encephalitis transmitted by mosquitoes (e.g., eastern 
equine encephalitis, West Nile virus infection) and tick borne infections (e.g., Lyme 
disease), require promotion of preventive behaviors by the public to take action to avoid 
mosquitoes and ticks.  Promoting safer behaviors has resulted in significant decreases in 
the incidence of HIV infection, and near universal access to effective antiviral therapy has 
resulted in a marked reduction in the complications of HIV infection, including AIDS-related 
opportunistic infections of the CNS and HIV dementia. 
Prevention of Metabolic Conditions Affecting the Central Nervous System 
Several of the metabolic conditions affecting the central nervous system are related to 
cardiac arrest and diabetes, two conditions that share many of the same risk factors such 
as family history, overweight and obesity, poor diet, and lack of physical activity.  
In response to rising obesity rates statewide, the Mass in Motion (MiM) initiative was 
launched in January 2009 under the leadership of Governor Deval Patrick, to promote 
wellness and to prevent overweight and obesity in Massachusetts.  The purpose of this 
multifaceted campaign is to promote the importance of healthy eating and active living at  
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home, at work, and in communities throughout the Commonwealth. In particular, the goals 
of MiM are to decrease the number and percentage of both adults and children who are 
overweight and obese; and decrease the prevalence of chronic disease associated with 
unhealthy eating and lack of physical activity. These goals will be accomplished by making 
the promotion of wellness and prevention of overweight and obesity a top public health 
priority; and creating conditions that encourage, nurture, and promote wellness.  The 
Municipal Wellness and Leadership program, a component of MiM, provides grant funding, 
training and technical assistance to cities and towns across the Commonwealth to 
implement community-based healthy eating/active living interventions.  Mass in Motion 
Website: http://www.mass.gov/eohhs/gov/departments/dph/programs/community-
health/mass-in-motion/ 
 
Lead Poisoning Prevention 
The MDPH Bureau of Environmental Health’s Childhood Lead Poisoning Prevention 
Program (BEH/CLPPP) was established for the prevention, screening, diagnosis, and 
treatment of childhood lead poisoning, including the elimination of sources of poisoning 
through research, educational, epidemiologic, and clinical activities. BEH/CLPPP provides 
a range of both primary and secondary prevention services to the children of the 
Commonwealth of Massachusetts, their families and others with an interest in the 
prevention of lead poisoning. BEH/CLPPP has developed linkages with a wide array of 
professionals and programs that provide services to children in order to accomplish the 
fundamental goals of identifying lead poisoned children and ensuring that they receive 
medical and environmental services, as well as preventing further cases of lead poisoning.  
The BEH is currently developing a strategic plan to address the new CDC reference value. 
The new value suggests that childhood exposure to lead at significantly lower levels are at 
greater risk of health impacts than previously understood.  
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Additional prevention information and resources are available through: 
 
American Geriatrics Society 
Falls Prevention in Older Adults (website) 
2010 American Geriatrics Society/British Geriatrics 
Society Clinical Prevention of Falls in Older Persons 
http://americangeriatrics.org/health_care_professionals/
clinical_practice/clinical_guidelines_recommendations/2
010/ 
 
Centers for Disease Control and Prevention 
National Center for Injury Prevention and Control 
1600 Clifton Rd. Atlanta, GA 30333 
1-800-CDC-INFO http://www.cdc.gov/injury/ 
 
Massachusetts Department of Public Health: 
 
Childhood Lead Poisoning Prevention Program 
250 Washington Street 
Boston, MA  02108 
(617) 624-5759 
 
Division of Violence and Injury Prevention 
Bureau of Community Health and Prevention 
250 Washington St., 4th Floor 
Boston, MA 02108 
(617) 624-6060 
 
Division of Prevention and Wellness 
Bureau of Community Health and Prevention 
250 Washington St., 4th Floor 
Boston, MA 02108 
(617) 624-6060 
 
Bureau of Substance Abuse Services 
250 Washington St., 3rd Floor 
Boston, MA 02108 
 
Massachusetts Substance Abuse Information and Education Help Line 
800-327-5050 
www.helpline-online.com 
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CHAPTER V: ORGANIZATIONS FOR PERSONS WITH ACQUIRED BRAIN INJURY,  
     FAMILIES and CARETAKERS  
Listed below are non-profit, charitable and other organizations which provide education and 
promote awareness; advocacy for the prevention and development of services for persons 
with ABI and associated diseases/disorders; and support for acquired brain injury survivors, 
their families, caregivers and significant others.  
 
AIDS Action Committee of Massachusetts 
75 Amory St. 
Boston, MA 02119 
617-437-6200 
http://www.aac.org/ 
 
Alzheimer’s Association 
 
Alzheimer's Association National Office 
 225 N. Michigan Ave., Fl. 17 
 Chicago, IL 60601  
http://www.alz.org/ 
 
Alzheimer's Association Massachusetts/New Hampshire 
480 Pleasant Street 
Watertown, MA 02472  
http://www.alz.org/manh/ 
800-272-3900 
 
American Brain Tumor Association (ABTA) 
8550 W. Bryn Mawr Ave.  
Suite 550 
Chicago, IL 60631 
800-886-2282 
http://www.abta.org/ 
 
American Heart Association 
20 Speen St. 
Framingham, MA 01701 
508-620-1700 
http://www.framingham.com/org/am_heart.htm 
 
American Lyme Disease Foundation, Inc. 
P.O. Box 466 
Lyme, CT 06371 
http://www.aldf.com/ 
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American Parkinson Disease Association 
135 Parkinson Avenue 
Staten Island, NY  10305 
http://www.apdaparkinson.org  
 
American Parkinson Disease Association Massachusetts Chapter 
72 East Concord Street 
Boston, MA  02118 
800-651-8466 
 
American Stroke Association 
7272 Greenville Ave. 
Dallas, TX 75231 
888-4-STROKE  
http://www.strokeassociation.org/STROKEORG/ 
 
Brain Aneurysm Foundation 
269 Hanover St., Building 3 
Hanover, MA 02339 
781-826-5556 
888-BRAIN02 (272-4602) 
http://www.bafound.org 
 
Brain Injury Association of America (BIAA) 
1608 Spring Hill Rd., Suite 110 
Vienna, VA 22182 
703-761-0750 
http://www.biausa.org/ 
 
Brain Injury Association of Massachusetts (BIA-MA) 
30 Lyman St. 
Westborough, MA 01581 
508-475-0032 
800-242-0030 
http://www.biama.org/ 
 
Children’s Hemiplegia and Stroke Association (CHASA) 
4101 W. Green Oaks, Suite 305, #149 
Arlington, TX 76016 
http://www.chasa.org/ 
 
Children’s Neurobiological Solutions (CNS) Foundation 
1223 Wilshire Blvd. #937 
Santa Monica, CA 90403 
866-CNS-5580 (267-5580) 
http://www.cnsfoundation.org 
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Healthy Homes Collaborative 
P.O. Box 31796 
Los Angeles, CA 90031 
323-221-8320 
http://www.healthyhomescollaborative.org 
 
Lyme Disease Association, Inc. 
P.O. Box 1438 
Jackson, NJ 08527 
888-366-6611 
http://www.lymediseaseassociation.org 
 
Meningitis Angels 
P.O. Box 448 
Porter, TX 77365 
281-572-1998 
http://www.meningitis-angels.org 
 
Meningitis Foundation of America, Inc. 
P.O. Box 1818 
El Mirage, AZ 85335 
480-270-2652 
http://www.musa.org 
 
National Brain Tumor Society 
Boston Office 
55 Chapel St., Suite 200 
Newton, MA 02458 
617-924-9997 
http://www.braintumor.org/ 
 
National Meningitis Association, Inc. 
P.O. Box 725165 
Atlanta, GA 31139 
http://www.nmaus.org/ 
 
National Multiple Sclerosis Society 
Greater New England 
101A First Ave. 
Waltham, MA 02451 
800-344-4867 
http://www.nationalmssociety.org/ 
 
National Organization for Rare Disorders (Massachusetts Office) 
1900 Crown Colony Dr., 4th Floor 
Quincy, MA 02169 
617-249-7300 
http://www.rarediseases.org/ 
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National Stroke Association 
9707 E. Easter Lane, Suite B 
Centennial, CO 80112 
800-STROKES (787-6537) 
http://www.stroke.org/ 
 
Sports Legacy Institute 
230 Second Ave., Suite 200 
Waltham, MA 02451 
http://www.sportslegacy.org 
 
The Aneurysm and AVM Foundation (TAAF) 
3636 Castro Valley Blvd, Suite 3 
Castro Valley, CA 94546 
http://www.taafonline.org/ 
 
United Cerebral Palsy (UCP) 
Berkshire County Office 
208 West St. 
Pittsfield, MA 01201 
413-442-1562 
http://www.ucpberkshire.org 
 
MetroBoston Office 
71 Arsenal St. 
Watertown, MA 02702 
617-926-5480 
http://www.ucpboston.org 
 
United Cerebral Palsy 
1825 K Street NW Suite 600 
Washington, DC 20006 
http://www.ucp.org/ 
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GLOSSARY of ACRONYMS and INITIALISMS 
 
 
 
ABI:   Acquired brain injury 
 
ABTA:  American Brain Tumor Association 
 
ADC:   AIDS dementia complex 
 
ADL:  Activities of daily living 
 
ADRC:  Aging and Disability Resource Center 
 
AHA:   American Heart Association 
 
AI/AN:  American Indian/Alaskan Native 
 
ALS:   Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) 
 
ANS:   Autonomic nervous system 
 
ASA:   American Stroke Association 
 
ASAP:  Aging Services Access Points 
 
AVM:   Arteriovenous malformation 
 
BIA-MA:  Brain Injury Association of Massachusetts 
 
BIC:   Brain Injury Commission 
 
BI&SSCSD:  Brain Injury and Statewide Specialized Community Services  Department 
 
CAD:   Coronary artery disease 
 
CART:  Combination antiretroviral therapy 
 
CBTRUS:  Central Brain Tumor Registry of the United States 
 
CDC:   Centers for Disease Control and Prevention 
 
CHI:   Closed Head Injury 
 
CHIA:  Center for Health Information and Analysis 
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CJD:   Creutzfeldt-Jakob disease 
 
CL:   Community Living Division of the Massachusetts Rehabilitation Commission 
 
CLPPP:  Childhood Lead Poisoning Prevention Program 
 
CMS:   Centers for Medicare and Medicaid Services 
 
CN:   Cranial Nerve  
 
CNS:  Central nervous system (brain and spinal cord) 
 
COA:   Councils on Aging 
 
COPD: Chronic obstructive pulmonary disease 
 
CP:   Cerebral palsy 
 
CT:   Computed (computerized) tomography 
 
CTE:   Chronic traumatic encephalopathy 
 
DAI:   Diffuse axonal injury 
 
DCF:   Department of Children and Families 
 
DDS:   Department of Developmental Services 
 
DMH:   Department of Mental Health 
 
DYS:   Department of Youth Services 
 
ED:   Emergency Department 
 
EEC:   Department of Early Education and Care 
 
EEG:   Electroencephalogram 
 
EOE:   Executive Office of Education 
 
EOEA:  Executive Office of Elder Affairs 
 
EOHHS:  Executive Office of Health and Human Services 
 
ESE:   Department of Elementary and Secondary Education 
 
HAART:  Highly active antiretroviral therapy 
 
HAD:   HIV-associated Dementia 
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HAND:  HIV-associated neurocognitive disorder 
 
HCBS:  Home and Community-Based Services 
 
HIV:   Human Immunodeficiency virus 
 
HRSA:  Health Resources and Services Administration 
 
IADL:   Instrumental activities of daily living 
 
ICD-9-CM:  International Classification of Diseases, 9th revision, Clinical  Modification 
 
ICH:   Intracerebral hemorrhage 
 
ICD-O:  International Classification of Diseases for Oncology 
 
ILC:   Independent Living Center 
 
IED:   Improvised explosive device 
 
IVH:   Intraventricular hemorrhage 
 
LOC:  Loss of consciousness 
 
LTSS:  Long Term Support Services 
 
MassCHIP:  Massachusetts Community Health Information Profile 
 
MCB:   Massachusetts Commission for the Blind 
 
MCDHH:  Massachusetts Commission for the Deaf and Hard of Hearing 
 
MCR:   Massachusetts Cancer Registry 
 
MDPH:  Massachusetts Department of Public Health 
 
MID:   Multi-infarct Dementia 
 
MMWR:  Morbidity and Mortality Weekly Report 
 
MRC:   Massachusetts Rehabilitation Commission 
 
MRI:   Magnetic resonance imaging 
 
MS:   Multiple sclerosis 
 
mTBI/MTBI:  Mild traumatic brain injury 
 
NAACCR:  North American Association of Central Cancer Registries 
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NCI:   National Cancer Institute 
 
NFI:   Neurofibromatosis 
 
NH:   Non-Hispanic 
 
NIH:   National Institutes of Health 
 
NINDS:  National Institute of Neurological Disorders and Stroke 
 
NLM:   National Library of Medicine 
 
NMS:   Neuroleptic malignant syndrome 
 
NPCR:  National Program of Cancer Registries 
 
OEF/OIF:  Operation Enduring Freedom/ Operation Iraqi Freedom  
 
OOM:  Office of Medicaid 
 
PFC:   Prefrontal cortex 
 
PML:   Progressive multifocal leukoencephalopathy 
 
PNS:   Peripheral nervous system 
 
PrP:   Prion protein 
 
PSS:   Primary stroke service 
 
PTA:   Post-traumatic amnesia 
 
PTSD:  Post-traumatic stress disorder 
 
ROM:   Range of motion 
 
rt-PA:  Recombinant tissue plasminogen activator 
 
SAH:   Subarachnoid hemorrhage 
 
SAMHSA:  Substance Abuse and Mental Health Services Administration 
 
SBS:   Shaken Baby Syndrome 
 
SEER:  Surveillance, Epidemiology and End Results program 
 
SHIP:   Statewide Head Injury Program of the Massachusetts Rehabilitation  
  Commission 
 
TBI:   Traumatic brain injury 
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TEA:   Transient epileptic amnesia 
 
TGA:   Transient global amnesia 
 
TIA:   Transient ischemic attack 
 
TPA:   Tissue plasminogen activator 
 
TSE:   Transmissible spongiform encephalopathy 
 
VAMC:  Veterans Administration Medical Center 
 
vCJD:  Variant Creutzfeldt-Jakob disease 
 
VZV:   Varicella zoster virus 
 
WHO:  World Health Organization 
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ICD-0 (Third Edition) Topography Codes used for Definition of Brain Neoplasms 
CODE SITE 
C70.0 Cerebral Meninges 
C71.0 Cerebrum 
C71.1 Frontal Lobe 
C71.2 Temporal Lobe 
C71.3 Parietal Lobe 
C71.4 Occipital Lobe 
C71.5 Ventricle, NOS 
C71.6 Cerebellum, NOS 
C71.7 Brain Stem 
C71.8 Overlapping Lesion of Brain 
C71.9 Brain, NOS 
C72.2 Olfactory Nerve 
C72.3 Optic Nerve 
C72.4 Acoustic Nerve 
C72.5 Cranial Nerves, NOS 
C72.8 Overlapping Lesion of Brain and CNS 
C72.9 Nervous System, NOS 
C75.1 Pituitary Gland 
C75.2 Craniopharyngeal Duct 
C75.3 Pineal Gland 
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ICD-9-CM Codes Used for Definition of Infectious Diseases associated with 
Disorders of the CNS 
 
CODE ICD-9-CM  CODE DESCRIPTION 
003.21 Salmonella meningitis 
006.5 Amebic brain abscess 
013.0-
013.3 Tuberculosis of meninges and central nervous system 
013.6-
013.9 Tuberculosis of meninges and central nervous system 
036.0 Meningococcal meningitis 
036.1 Meningococcal encephalitis 
036.81 Meningococcal optic neuritis 
047.0 Meningitis due to coxsackie virus 
047.1 Meningitis due to ECHO virus 
047.8 Other specified viral meningitis 
047.9 Unspecified viral meningitis 
048 Other enterovirus diseases of central nervous system 
049.0 Non-arthropod-borne lymphocytic choriomeningitis 
049.1 Meningitis due to adenovirus 
049.8 
Other specified non-arthropod-borne viral diseases of central nervous 
system 
049.9 Unspecified non-arthropod-borne viral diseases of central nervous system 
052.0 Postvaricella encephalitis 
053.0 Herpes zoster with meningitis 
053.11 Geniculate herpes zoster 
053.12 Postherpetic trigeminal neuralgia 
054.3 Herpetic meningoencephalitis 
054.72 Herpes simplex meningitis 
055.0 Postmeasles encephalitis 
056.00 Rubella with unspecified neurological complication 
056.01 Encephalomyelitis due to rubella 
056.09 Rubella with other neurological complications 
062.0 Japanese encephalitis 
062.1 Western equine encephalitis 
062.2 Eastern equine encephalitis 
062.3 St. Louis encephalitis 
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ICD-9-CM Codes Used for Definition of Infectious Diseases associated with 
Disorders of the CNS 
 
CODE ICD-9-CM  CODE DESCRIPTION 
062.4 Australian encephalitis 
062.5 California virus encephalitis 
062.8 Other specified mosquito-borne viral encephalitis 
062.9 Mosquito-borne viral encephalitis, unspecified 
063.0 Russian spring-summer [taiga] encephalitis 
063.1 Louping ill 
063.2 Central European encephalitis 
063.8 Other specified tick-borne viral encephalitis 
063.9 Tick-borne viral encephalitis, unspecified 
064 Viral encephalitis transmitted by other and unspecified arthropods 
066.2 Venezuelan equine fever 
072.1 Mumps meningitis 
072.2 Mumps encephalitis 
091.81 Acute syphilitic meningitis (secondary) 
094.2 Syphilitic meningitis 
094.3 Asymptomatic neurosyphilis 
094.81 Syphilitic encephalitis 
094.82 Syphilitic Parkinsonism 
094.84 Syphilitic optic atrophy 
094.85 Syphilitic retrobulbar neuritis 
094.86 Syphilitic acoustic neuritis 
094.89 Other specified neurosyphilis 
094.9 Neurosyphilis, unspecified 
098.82 Gonococcal meningitis 
100.81 Leptospiral meningitis (aseptic) 
112.83 Candidal meningitis 
115.01 Histoplasma capsulatum meningitis 
115.11 Histoplasma duboisii meningitis 
115.91 Histoplasmosis meningitis 
130.0 Meningoencephalitis due to toxoplasmosis 
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ICD-9-CM Codes Used for Definition of Infectious Diseases associated with 
Disorders of the CNS 
 
CODE ICD-9-CM  CODE DESCRIPTION 
320.0 Hemophilus meningitis 
320.1 Pneumococcal meningitis 
320.2 Streptococcal meningitis 
320.3 Staphylococcal meningitis 
320.7 Meningitis in other bacterial diseases classified elsewhere 
320.81 Anaerobic meningitis 
320.82 Meningitis due to gram-negative bacteria, not elsewhere classified 
320.89 Meningitis due to other specified bacteria 
320.9 Meningitis due to unspecified bacterium 
321.0 Cryptococcal meningitis 
321.1 Meningitis in other fungal diseases 
321.2 Meningitis due to viruses not elsewhere classified 
321.3 Meningitis due to trypanosomiasis 
321.4 Meningitis in sarcoidosis 
321.8 Meningitis due to other nonbacterial organisms classified elsewhere 
322.0 Nonpyogenic meningitis 
322.1 Eosinophilic meningitis 
322.2 Chronic meningitis 
322.9 Meningitis, unspecified 
323.01 Encephalitis and encephalomyelitis in viral diseases classified elsewhere 
323.1 
Encephalitis, myelitis, and encephalomyelitis in rickettsial diseases classified 
elsewhere 
323.2 
Encephalitis, myelitis, and encephalomyelitis in protozoal diseases classified 
elsewhere 
323.41 
Other encephalitis and encephalomyelitis due to other infections classified 
elsewhere 
323.51 Encephalitis and encephalomyelitis following immunization procedures 
323.61 Infectious acute disseminated encephalomyelitis (ADEM) 
323.62 Other postinfectious encephalitis and encephalomyelitis 
323.81 Other causes of encephalitis and encephalomyelitis 
323.9 Unspecified causes of encephalitis, myelitis, and encephalomyelitis 
324.0 Intracranial abscess 
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ICD-9-CM Codes Used for Definition of Infectious Diseases associated with 
Disorders of the CNS 
 
CODE ICD-9-CM  CODE DESCRIPTION 
324.9 Intracranial and intraspinal abscess of unspecified site 
325 Phlebitis and thrombophlebitis of intracranial venous sinuses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 118 
 
 
 
 
 
 
 
 
 
 
APPENDIX B-3 
  
 119 
 
ICD-9-CM Codes used for Definition of Metabolic Disorders Affecting the CNS 
CODE ICD-9-CM CODE DESCRIPTION 
070.0 Viral hepatitis A with hepatic coma 
070.20 Viral hepatitis B with hepatic coma acute or unspecified without hepatitis delta 
070.21 Viral hepatitis B with hepatic coma acute or unspecified with hepatitis delta 
070.22 Chronic viral hepatitis B with hepatic coma without hepatitis delta 
070.23 Chronic viral hepatitis B with hepatic coma with hepatitis delta 
070.41 Acute hepatitis C with hepatic coma 
070.43 Hepatitis E with hepatic coma 
070.44 Chronic hepatitis C with hepatic coma 
070.49 Other specified viral hepatitis with hepatic coma 
070.6 Unspecified viral hepatitis with hepatic coma 
070.71 Unspecified viral hepatitis C with hepatic coma 
249.20 Secondary DM with hyperosmolarity (non-ketotic coma) 
249.30 Secondary DM with other coma 
250.20 Diabetes with hyperosmolarity (non-ketotic coma) 
250.30 
Diabetes with other coma, Type II or unspecified type, not stated as 
uncontrolled 
250.31 Diabetes with other coma, Type I [juvenile type], not stated as uncontrolled 
250.32 Diabetes with other coma, Type II or unspecified type, uncontrolled 
250.33 Diabetes with other coma, Type I [juvenile type], uncontrolled 
251.0 Hypoglycemic coma 
348.1 Anoxic brain damage 
348.31 Metabolic encephalopathy 
427.5 Cardiac arrest 
572.2 Hepatic encephalopathy 
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ICD-9-CM Codes used for Definition of Metabolic Disorders Affecting the CNS 
CODE ICD-9-CM  CODE DESCRIPTION 
768.5 Severe birth asphyxia 
768.6 Mild or moderate birth asphyxia 
768.7 Hypoxic-ischemic encephalopathy (HIE) 
768.9 Severe hypoxic-ischemic encephalopathy 
770.87 Respiratory arrest of newborn 
774.7 Kernicterus not due to isoimmunization (bilirubin encephalopathy) 
779.85 Cardiac arrest of newborn 
799.01 Asphyxia 
799.1 Respiratory arrest 
994.7 Asphyxia and strangulation 
994.8 Electrocution 
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ICD-9-CM Codes Used  for Definition of Neurovascular Diseases and Conditions 
CODE ICD-9-CM CODE DESCRIPTION 
430* Subarachnoid hemorrhage 
431* Intracerebral hemorrhage 
432.0 Nontraumatic extradural hemorrhage 
432.1 Subdural hemorrhage 
432.9 Unspecified intracranial hemorrhage 
433.00 Occlusion and stenosis of basilar artery, without mention of cerebral infarction 
433.01* Occlusion and stenosis of basilar artery, with cerebral infarction 
433.10* Occlusion and stenosis of carotid artery without cerebral infarction 
433.11* Occlusion and stenosis of carotid artery, with cerebral infarction 
433.20 Occlusion and stenosis of vertebral artery, without mention of cerebral infarction 
433.21* Occlusion and stenosis of vertebral artery, with cerebral infarction 
433.30 
Occlusion and stenosis of multiple and bilateral precerebral arteries, without 
mention of cerebral infarction 
433.31* 
Occlusion and stenosis of multiple and bilateral precerebral arteries, with 
cerebral infarction 
433.80 
Occlusion and stenosis of other specified precerebral artery, without mention of 
cerebral infarction 
433.81* 
Occlusion and stenosis of other specified precerebral artery, with cerebral 
infarction 
433.90 
Occlusion and stenosis of unspecified precerebral artery, without mention of 
cerebral infarction 
433.91* Occlusion and stenosis of unspecified precerebral artery, with cerebral infarction 
434.00* Cerebral thrombosis, without mention of cerebral infarction 
434.01* Cerebral thrombosis, with cerebral infarction 
434.10 Cerebral embolism, without mention of cerebral infarction 
434.11* Cerebral embolism, with cerebral infarction 
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ICD-9-CM Codes Used  for Definition of Neurovascular Diseases and Conditions 
CODE ICD-9-CM  CODE DESCRIPTION 
434.90 Cerebral artery occlusion, unspecified, without mention of cerebral infarction 
434.91* Cerebral artery occlusion, unspecified, with cerebral infarction 
435.0 Basilar artery syndrome 
435.1 Vertebral artery syndrome 
435.2 Subclavian steal syndrome 
435.3 Vertebrobasilar artery syndrome 
435.8 Other specified transient cerebral ischemias 
435.9 Unspecified transient cerebral ischemia 
436* Acute, but ill-defined, cerebrovascular disease 
437.0 Cerebral atherosclerosis 
437.1 Other generalized ischemic cerebrovascular disease 
437.2 Hypertensive encephalopathy 
437.3 Cerebral aneurysm, nonruptured 
437.4 Cerebral arteritis 
437.5 Moyamoya disease 
437.6 Nonpyogenic thrombosis of intracranial venous sinus 
437.7 Transient global amnesia 
437.8 Other ill-defined cerebrovascular disease 
437.9 Unspecified cerebrovascular disease 
348.2 Benign Intracranial Hypertension 
997.02 Iatrogenic cerebrovascular infarct/hemorrhage 
772.10 Intraventricular hemorrhage-Unspecified Grade 
772.11 Intraventricular hemorrhage-Grade I 
772.12 Intraventricular hemorrhage-Grade II 
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ICD-9-CM Codes Used  for Definition of Neurovascular Diseases and Conditions 
CODE ICD-9-CM  CODE DESCRIPTION 
772.13 Intraventricular hemorrhage-Grade I 
772.14 Intraventricular hemorrhage-Grade II 
772.20 Subarachnoid hemorrhage from any perinatal  cause 
767.0 Subdural and cerebral hemorrhage 
 
*Codes used to define stroke, in accordance with Joint Commission on Disease-
specific Care 
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ICD-9-CM Codes Used for Definition of Traumatic Brain injury 
CODE ICD-9-CM CODE DESCRIPTION 
800.0-800.9 Fracture of vault of skull 
801.0-801.9 Fracture of base of skull 
803.0-803.9 Other and unqualified skull fractures 
804.0-804.9 Multiple fractures involving skull or face with other bones 
850.0-850.9 Concussion 
851.0-851.9 Cerebral laceration and contusion 
852.0-852.5 
Subarachnoid, subdural and extradural hemorrhage following 
injury 
853.0-853.1 Other unspecified intracranial hemorrhage following injury 
854.0-854.1 Intracranial injury of other and unspecified nature 
950.1 Injury to the optic chiasm 
950.2 Injury to the optic pathways 
950.3 Injury to the visual cortex 
959.01 Head injury unspecified 
999.55 Shaken Infant Syndrome 
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